id	sid	tid	token	lemma	pos
ajlm-1224	1	1	abstract	abstract	ADJ
ajlm-1224	1	2	introduction	introduction	NOUN
ajlm-1224	1	3	methods	method	NOUN
ajlm-1224	1	4	results	result	VERB
ajlm-1224	1	5	discussion	discussion	NOUN
ajlm-1224	1	6	acknowledgements	acknowledgement	NOUN
ajlm-1224	1	7	references	reference	NOUN
ajlm-1224	1	8	about	about	ADP
ajlm-1224	1	9	the	the	DET
ajlm-1224	1	10	author(s	author(s	NOUN
ajlm-1224	1	11	)	)	PUNCT
ajlm-1224	1	12	franklin	franklin	PROPN
ajlm-1224	1	13	s.	s.	PROPN
ajlm-1224	1	14	azebaze	azebaze	VERB
ajlm-1224	1	15	agueguia	agueguia	NOUN
ajlm-1224	1	16	center	center	NOUN
ajlm-1224	1	17	for	for	ADP
ajlm-1224	1	18	the	the	DET
ajlm-1224	1	19	study	study	NOUN
ajlm-1224	1	20	and	and	CCONJ
ajlm-1224	1	21	control	control	NOUN
ajlm-1224	1	22	of	of	ADP
ajlm-1224	1	23	communicable	communicable	NOUN
ajlm-1224	1	24	diseases	disease	NOUN
ajlm-1224	1	25	(	(	PUNCT
ajlm-1224	1	26	csccd	csccd	NOUN
ajlm-1224	1	27	)	)	PUNCT
ajlm-1224	1	28	,	,	PUNCT
ajlm-1224	1	29	faculty	faculty	NOUN
ajlm-1224	1	30	of	of	ADP
ajlm-1224	1	31	medicine	medicine	NOUN
ajlm-1224	1	32	and	and	CCONJ
ajlm-1224	1	33	biological	biological	ADJ
ajlm-1224	1	34	sciences	science	NOUN
ajlm-1224	1	35	(	(	PUNCT
ajlm-1224	1	36	fmbs	fmbs	ADJ
ajlm-1224	1	37	)	)	PUNCT
ajlm-1224	1	38	,	,	PUNCT
ajlm-1224	1	39	university	university	NOUN
ajlm-1224	1	40	of	of	ADP
ajlm-1224	1	41	yaoundé	yaoundé	PROPN
ajlm-1224	1	42	1	1	NUM
ajlm-1224	1	43	(	(	PUNCT
ajlm-1224	1	44	uy1	uy1	NOUN
ajlm-1224	1	45	)	)	PUNCT
ajlm-1224	1	46	,	,	PUNCT
ajlm-1224	1	47	yaoundé	yaoundé	PROPN
ajlm-1224	1	48	,	,	PUNCT
ajlm-1224	1	49	cameroon	cameroon	PROPN
ajlm-1224	1	50	paul	paul	PROPN
ajlm-1224	1	51	talla	talla	PROPN
ajlm-1224	1	52	department	department	PROPN
ajlm-1224	1	53	of	of	ADP
ajlm-1224	1	54	internal	internal	ADJ
ajlm-1224	1	55	medicine	medicine	NOUN
ajlm-1224	1	56	and	and	CCONJ
ajlm-1224	1	57	specialties	specialty	NOUN
ajlm-1224	1	58	,	,	PUNCT
ajlm-1224	1	59	faculty	faculty	NOUN
ajlm-1224	1	60	of	of	ADP
ajlm-1224	1	61	medicine	medicine	NOUN
ajlm-1224	1	62	and	and	CCONJ
ajlm-1224	1	63	biomedical	biomedical	ADJ
ajlm-1224	1	64	sciences	science	NOUN
ajlm-1224	1	65	(	(	PUNCT
ajlm-1224	1	66	fmbs	fmbs	ADJ
ajlm-1224	1	67	)	)	PUNCT
ajlm-1224	1	68	,	,	PUNCT
ajlm-1224	1	69	yaoundé	yaoundé	PROPN
ajlm-1224	1	70	general	general	ADJ
ajlm-1224	1	71	hospital	hospital	NOUN
ajlm-1224	1	72	,	,	PUNCT
ajlm-1224	1	73	university	university	NOUN
ajlm-1224	1	74	of	of	ADP
ajlm-1224	1	75	yaoundé	yaoundé	PROPN
ajlm-1224	1	76	1	1	NUM
ajlm-1224	1	77	(	(	PUNCT
ajlm-1224	1	78	uy1	uy1	NOUN
ajlm-1224	1	79	)	)	PUNCT
ajlm-1224	1	80	,	,	PUNCT
ajlm-1224	1	81	yaoundé	yaoundé	PROPN
ajlm-1224	1	82	,	,	PUNCT
ajlm-1224	1	83	cameroon	cameroon	PROPN
ajlm-1224	1	84	marie	marie	PROPN
ajlm-1224	1	85	c.	c.	PROPN
ajlm-1224	1	86	okomo	okomo	PROPN
ajlm-1224	1	87	assoumou	assoumou	PROPN
ajlm-1224	1	88	department	department	PROPN
ajlm-1224	1	89	of	of	ADP
ajlm-1224	1	90	microbiology	microbiology	NOUN
ajlm-1224	1	91	,	,	PUNCT
ajlm-1224	1	92	haematology	haematology	NOUN
ajlm-1224	1	93	,	,	PUNCT
ajlm-1224	1	94	parasitology	parasitology	NOUN
ajlm-1224	1	95	and	and	CCONJ
ajlm-1224	1	96	infectious	infectious	ADJ
ajlm-1224	1	97	diseases	disease	NOUN
ajlm-1224	1	98	,	,	PUNCT
ajlm-1224	1	99	faculty	faculty	NOUN
ajlm-1224	1	100	of	of	ADP
ajlm-1224	1	101	medicine	medicine	NOUN
ajlm-1224	1	102	and	and	CCONJ
ajlm-1224	1	103	biomedical	biomedical	ADJ
ajlm-1224	1	104	sciences	science	NOUN
ajlm-1224	1	105	(	(	PUNCT
ajlm-1224	1	106	fmbs	fmbs	ADJ
ajlm-1224	1	107	)	)	PUNCT
ajlm-1224	1	108	,	,	PUNCT
ajlm-1224	1	109	university	university	NOUN
ajlm-1224	1	110	of	of	ADP
ajlm-1224	1	111	yaoundé	yaoundé	PROPN
ajlm-1224	1	112	1	1	NUM
ajlm-1224	1	113	(	(	PUNCT
ajlm-1224	1	114	uy1	uy1	NOUN
ajlm-1224	1	115	)	)	PUNCT
ajlm-1224	1	116	,	,	PUNCT
ajlm-1224	1	117	yaoundé	yaoundé	PROPN
ajlm-1224	1	118	,	,	PUNCT
ajlm-1224	1	119	cameroon	cameroon	PROPN
ajlm-1224	1	120	graeme	graeme	PROPN
ajlm-1224	1	121	b.	b.	PROPN
ajlm-1224	1	122	jacobs	jacobs	PROPN
ajlm-1224	1	123	division	division	PROPN
ajlm-1224	1	124	of	of	ADP
ajlm-1224	1	125	medical	medical	ADJ
ajlm-1224	1	126	virology	virology	NOUN
ajlm-1224	1	127	,	,	PUNCT
ajlm-1224	1	128	department	department	NOUN
ajlm-1224	1	129	of	of	ADP
ajlm-1224	1	130	pathology	pathology	PROPN
ajlm-1224	1	131	,	,	PUNCT
ajlm-1224	1	132	faculty	faculty	NOUN
ajlm-1224	1	133	of	of	ADP
ajlm-1224	1	134	medicine	medicine	NOUN
ajlm-1224	1	135	and	and	CCONJ
ajlm-1224	1	136	health	health	NOUN
ajlm-1224	1	137	sciences	sciences	PROPN
ajlm-1224	1	138	,	,	PUNCT
ajlm-1224	1	139	stellenbosch	stellenbosch	PROPN
ajlm-1224	1	140	university	university	PROPN
ajlm-1224	1	141	,	,	PUNCT
ajlm-1224	1	142	tygerberg	tygerberg	PROPN
ajlm-1224	1	143	,	,	PUNCT
ajlm-1224	1	144	south	south	PROPN
ajlm-1224	1	145	africa	africa	PROPN
ajlm-1224	1	146	cedric	cedric	PROPN
ajlm-1224	1	147	h.	h.	PROPN
ajlm-1224	1	148	mbakam	mbakam	PROPN
ajlm-1224	1	149	center	center	PROPN
ajlm-1224	1	150	for	for	ADP
ajlm-1224	1	151	the	the	DET
ajlm-1224	1	152	study	study	NOUN
ajlm-1224	1	153	and	and	CCONJ
ajlm-1224	1	154	control	control	NOUN
ajlm-1224	1	155	of	of	ADP
ajlm-1224	1	156	communicable	communicable	NOUN
ajlm-1224	1	157	diseases	disease	NOUN
ajlm-1224	1	158	(	(	PUNCT
ajlm-1224	1	159	csccd	csccd	NOUN
ajlm-1224	1	160	)	)	PUNCT
ajlm-1224	1	161	,	,	PUNCT
ajlm-1224	1	162	faculty	faculty	NOUN
ajlm-1224	1	163	of	of	ADP
ajlm-1224	1	164	medicine	medicine	NOUN
ajlm-1224	1	165	and	and	CCONJ
ajlm-1224	1	166	biological	biological	ADJ
ajlm-1224	1	167	sciences	science	NOUN
ajlm-1224	1	168	(	(	PUNCT
ajlm-1224	1	169	fmbs	fmbs	ADJ
ajlm-1224	1	170	)	)	PUNCT
ajlm-1224	1	171	,	,	PUNCT
ajlm-1224	1	172	university	university	NOUN
ajlm-1224	1	173	of	of	ADP
ajlm-1224	1	174	yaoundé	yaoundé	PROPN
ajlm-1224	1	175	1	1	NUM
ajlm-1224	1	176	(	(	PUNCT
ajlm-1224	1	177	uy1	uy1	NOUN
ajlm-1224	1	178	)	)	PUNCT
ajlm-1224	1	179	,	,	PUNCT
ajlm-1224	1	180	yaoundé	yaoundé	PROPN
ajlm-1224	1	181	,	,	PUNCT
ajlm-1224	1	182	cameroon	cameroon	PROPN
ajlm-1224	1	183	elise	elise	PROPN
ajlm-1224	1	184	guiedem	guiedem	PROPN
ajlm-1224	1	185	center	center	PROPN
ajlm-1224	1	186	for	for	ADP
ajlm-1224	1	187	the	the	DET
ajlm-1224	1	188	study	study	NOUN
ajlm-1224	1	189	and	and	CCONJ
ajlm-1224	1	190	control	control	NOUN
ajlm-1224	1	191	of	of	ADP
ajlm-1224	1	192	communicable	communicable	NOUN
ajlm-1224	1	193	diseases	disease	NOUN
ajlm-1224	1	194	(	(	PUNCT
ajlm-1224	1	195	csccd	csccd	NOUN
ajlm-1224	1	196	)	)	PUNCT
ajlm-1224	1	197	,	,	PUNCT
ajlm-1224	1	198	faculty	faculty	NOUN
ajlm-1224	1	199	of	of	ADP
ajlm-1224	1	200	medicine	medicine	NOUN
ajlm-1224	1	201	and	and	CCONJ
ajlm-1224	1	202	biological	biological	ADJ
ajlm-1224	1	203	sciences	science	NOUN
ajlm-1224	1	204	(	(	PUNCT
ajlm-1224	1	205	fmbs	fmbs	ADJ
ajlm-1224	1	206	)	)	PUNCT
ajlm-1224	1	207	,	,	PUNCT
ajlm-1224	1	208	university	university	NOUN
ajlm-1224	1	209	of	of	ADP
ajlm-1224	1	210	yaoundé	yaoundé	PROPN
ajlm-1224	1	211	1	1	NUM
ajlm-1224	1	212	(	(	PUNCT
ajlm-1224	1	213	uy1	uy1	NOUN
ajlm-1224	1	214	)	)	PUNCT
ajlm-1224	1	215	,	,	PUNCT
ajlm-1224	1	216	yaoundé	yaoundé	PROPN
ajlm-1224	1	217	,	,	PUNCT
ajlm-1224	1	218	cameroon	cameroon	PROPN
ajlm-1224	1	219	martha	martha	PROPN
ajlm-1224	1	220	tongo	tongo	PROPN
ajlm-1224	1	221	mesembe	mesembe	PROPN
ajlm-1224	1	222	center	center	PROPN
ajlm-1224	1	223	for	for	ADP
ajlm-1224	1	224	the	the	DET
ajlm-1224	1	225	study	study	NOUN
ajlm-1224	1	226	and	and	CCONJ
ajlm-1224	1	227	control	control	NOUN
ajlm-1224	1	228	of	of	ADP
ajlm-1224	1	229	communicable	communicable	NOUN
ajlm-1224	1	230	diseases	disease	NOUN
ajlm-1224	1	231	(	(	PUNCT
ajlm-1224	1	232	csccd	csccd	NOUN
ajlm-1224	1	233	)	)	PUNCT
ajlm-1224	1	234	,	,	PUNCT
ajlm-1224	1	235	faculty	faculty	NOUN
ajlm-1224	1	236	of	of	ADP
ajlm-1224	1	237	medicine	medicine	NOUN
ajlm-1224	1	238	and	and	CCONJ
ajlm-1224	1	239	biological	biological	ADJ
ajlm-1224	1	240	sciences	science	NOUN
ajlm-1224	1	241	(	(	PUNCT
ajlm-1224	1	242	fmbs	fmbs	ADJ
ajlm-1224	1	243	)	)	PUNCT
ajlm-1224	1	244	,	,	PUNCT
ajlm-1224	1	245	university	university	NOUN
ajlm-1224	1	246	of	of	ADP
ajlm-1224	1	247	yaoundé	yaoundé	PROPN
ajlm-1224	1	248	1	1	NUM
ajlm-1224	1	249	(	(	PUNCT
ajlm-1224	1	250	uy1	uy1	NOUN
ajlm-1224	1	251	)	)	PUNCT
ajlm-1224	1	252	,	,	PUNCT
ajlm-1224	1	253	yaoundé	yaoundé	PROPN
ajlm-1224	1	254	,	,	PUNCT
ajlm-1224	1	255	cameroon	cameroon	PROPN
ajlm-1224	1	256	emilia	emilia	PROPN
ajlm-1224	1	257	lyonga	lyonga	PROPN
ajlm-1224	1	258	center	center	PROPN
ajlm-1224	1	259	for	for	ADP
ajlm-1224	1	260	the	the	DET
ajlm-1224	1	261	study	study	NOUN
ajlm-1224	1	262	and	and	CCONJ
ajlm-1224	1	263	control	control	NOUN
ajlm-1224	1	264	of	of	ADP
ajlm-1224	1	265	communicable	communicable	NOUN
ajlm-1224	1	266	diseases	disease	NOUN
ajlm-1224	1	267	(	(	PUNCT
ajlm-1224	1	268	csccd	csccd	NOUN
ajlm-1224	1	269	)	)	PUNCT
ajlm-1224	1	270	,	,	PUNCT
ajlm-1224	1	271	faculty	faculty	NOUN
ajlm-1224	1	272	of	of	ADP
ajlm-1224	1	273	medicine	medicine	NOUN
ajlm-1224	1	274	and	and	CCONJ
ajlm-1224	1	275	biological	biological	ADJ
ajlm-1224	1	276	sciences	science	NOUN
ajlm-1224	1	277	(	(	PUNCT
ajlm-1224	1	278	fmbs	fmbs	ADJ
ajlm-1224	1	279	)	)	PUNCT
ajlm-1224	1	280	,	,	PUNCT
ajlm-1224	1	281	university	university	NOUN
ajlm-1224	1	282	of	of	ADP
ajlm-1224	1	283	yaoundé	yaoundé	PROPN
ajlm-1224	1	284	1	1	NUM
ajlm-1224	1	285	(	(	PUNCT
ajlm-1224	1	286	uy1	uy1	NOUN
ajlm-1224	1	287	)	)	PUNCT
ajlm-1224	1	288	,	,	PUNCT
ajlm-1224	1	289	yaoundé	yaoundé	PROPN
ajlm-1224	1	290	,	,	PUNCT
ajlm-1224	1	291	cameroon	cameroon	PROPN
ajlm-1224	1	292	george	george	PROPN
ajlm-1224	1	293	mondinde	mondinde	PROPN
ajlm-1224	1	294	ikomey	ikomey	PROPN
ajlm-1224	1	295	center	center	PROPN
ajlm-1224	1	296	for	for	ADP
ajlm-1224	1	297	the	the	DET
ajlm-1224	1	298	study	study	NOUN
ajlm-1224	1	299	and	and	CCONJ
ajlm-1224	1	300	control	control	NOUN
ajlm-1224	1	301	of	of	ADP
ajlm-1224	1	302	communicable	communicable	NOUN
ajlm-1224	1	303	diseases	disease	NOUN
ajlm-1224	1	304	(	(	PUNCT
ajlm-1224	1	305	csccd	csccd	NOUN
ajlm-1224	1	306	)	)	PUNCT
ajlm-1224	1	307	,	,	PUNCT
ajlm-1224	1	308	faculty	faculty	NOUN
ajlm-1224	1	309	of	of	ADP
ajlm-1224	1	310	medicine	medicine	NOUN
ajlm-1224	1	311	and	and	CCONJ
ajlm-1224	1	312	biological	biological	ADJ
ajlm-1224	1	313	sciences	science	NOUN
ajlm-1224	1	314	(	(	PUNCT
ajlm-1224	1	315	fmbs	fmbs	ADJ
ajlm-1224	1	316	)	)	PUNCT
ajlm-1224	1	317	,	,	PUNCT
ajlm-1224	1	318	university	university	NOUN
ajlm-1224	1	319	of	of	ADP
ajlm-1224	1	320	yaoundé	yaoundé	PROPN
ajlm-1224	1	321	1	1	NUM
ajlm-1224	1	322	(	(	PUNCT
ajlm-1224	1	323	uy1	uy1	NOUN
ajlm-1224	1	324	)	)	PUNCT
ajlm-1224	1	325	,	,	PUNCT
ajlm-1224	1	326	yaoundé	yaoundé	PROPN
ajlm-1224	1	327	,	,	PUNCT
ajlm-1224	1	328	cameroon	cameroon	PROPN
ajlm-1224	1	329	citation	citation	PROPN
ajlm-1224	1	330	azebaze	azebaze	VERB
ajlm-1224	1	331	agueguia	agueguia	PROPN
ajlm-1224	1	332	fs	fs	PROPN
ajlm-1224	1	333	,	,	PUNCT
ajlm-1224	1	334	talla	talla	PROPN
ajlm-1224	1	335	p	p	PROPN
ajlm-1224	1	336	,	,	PUNCT
ajlm-1224	1	337	okomo	okomo	PROPN
ajlm-1224	1	338	assoumou	assoumou	PROPN
ajlm-1224	1	339	mc	mc	PROPN
ajlm-1224	1	340	,	,	PUNCT
ajlm-1224	1	341	et	et	PROPN
ajlm-1224	1	342	al	al	PROPN
ajlm-1224	1	343	.	.	PUNCT
ajlm-1224	2	1	involvement	involvement	NOUN
ajlm-1224	2	2	of	of	ADP
ajlm-1224	2	3	cd95	cd95	PROPN
ajlm-1224	2	4	and	and	CCONJ
ajlm-1224	2	5	ligand	ligand	NOUN
ajlm-1224	2	6	in	in	ADP
ajlm-1224	2	7	cd4	cd4	PROPN
ajlm-1224	2	8	+	+	PROPN
ajlm-1224	2	9	t	t	PROPN
ajlm-1224	2	10	-	-	PUNCT
ajlm-1224	2	11	cell	cell	NOUN
ajlm-1224	2	12	and	and	CCONJ
ajlm-1224	2	13	cd8	cd8	PROPN
ajlm-1224	2	14	+	+	PROPN
ajlm-1224	2	15	t	t	PROPN
ajlm-1224	2	16	-	-	PUNCT
ajlm-1224	2	17	cell	cell	NOUN
ajlm-1224	2	18	depletion	depletion	NOUN
ajlm-1224	2	19	and	and	CCONJ
ajlm-1224	2	20	hepatic	hepatic	ADJ
ajlm-1224	2	21	cytolysis	cytolysis	NOUN
ajlm-1224	2	22	in	in	ADP
ajlm-1224	2	23	patients	patient	NOUN
ajlm-1224	2	24	with	with	ADP
ajlm-1224	2	25	chronic	chronic	ADJ
ajlm-1224	2	26	viral	viral	ADJ
ajlm-1224	2	27	hepatitis	hepatitis	PROPN
ajlm-1224	2	28	b.	b.	PROPN
ajlm-1224	2	29	afr	afr	PROPN
ajlm-1224	2	30	j	j	PROPN
ajlm-1224	2	31	lab	lab	PROPN
ajlm-1224	2	32	med	me	VERB
ajlm-1224	2	33	.	.	PUNCT
ajlm-1224	3	1	2021;10(1	2021;10(1	NUM
ajlm-1224	3	2	)	)	PUNCT
ajlm-1224	3	3	,	,	PUNCT
ajlm-1224	3	4	a1224	a1224	PROPN
ajlm-1224	3	5	.	.	PUNCT
ajlm-1224	4	1	https://doi.org/10.4102/ajlm.v10i1.1224	https://doi.org/10.4102/ajlm.v10i1.1224	X
ajlm-1224	4	2	original	original	ADJ
ajlm-1224	4	3	research	research	NOUN
ajlm-1224	4	4	involvement	involvement	NOUN
ajlm-1224	4	5	of	of	ADP
ajlm-1224	4	6	cd95	cd95	PROPN
ajlm-1224	4	7	and	and	CCONJ
ajlm-1224	4	8	ligand	ligand	NOUN
ajlm-1224	4	9	in	in	ADP
ajlm-1224	4	10	cd4	cd4	PROPN
ajlm-1224	4	11	+	+	PROPN
ajlm-1224	4	12	t	t	PROPN
ajlm-1224	4	13	-	-	PUNCT
ajlm-1224	4	14	cell	cell	NOUN
ajlm-1224	4	15	and	and	CCONJ
ajlm-1224	4	16	cd8	cd8	PROPN
ajlm-1224	4	17	+	+	PROPN
ajlm-1224	4	18	t	t	PROPN
ajlm-1224	4	19	-	-	PUNCT
ajlm-1224	4	20	cell	cell	NOUN
ajlm-1224	4	21	depletion	depletion	NOUN
ajlm-1224	4	22	and	and	CCONJ
ajlm-1224	4	23	hepatic	hepatic	ADJ
ajlm-1224	4	24	cytolysis	cytolysis	NOUN
ajlm-1224	4	25	in	in	ADP
ajlm-1224	4	26	patients	patient	NOUN
ajlm-1224	4	27	with	with	ADP
ajlm-1224	4	28	chronic	chronic	ADJ
ajlm-1224	4	29	viral	viral	ADJ
ajlm-1224	4	30	hepatitis	hepatitis	PROPN
ajlm-1224	4	31	b	b	PROPN
ajlm-1224	4	32	franklin	franklin	PROPN
ajlm-1224	4	33	s.	s.	PROPN
ajlm-1224	4	34	azebaze	azebaze	VERB
ajlm-1224	4	35	agueguia	agueguia	NOUN
ajlm-1224	4	36	,	,	PUNCT
ajlm-1224	4	37	paul	paul	PROPN
ajlm-1224	4	38	talla	talla	PROPN
ajlm-1224	4	39	,	,	PUNCT
ajlm-1224	4	40	marie	marie	PROPN
ajlm-1224	4	41	c.	c.	PROPN
ajlm-1224	4	42	okomo	okomo	PROPN
ajlm-1224	4	43	assoumou	assoumou	PROPN
ajlm-1224	4	44	,	,	PUNCT
ajlm-1224	4	45	graeme	graeme	PROPN
ajlm-1224	4	46	b.	b.	PROPN
ajlm-1224	4	47	jacobs	jacobs	PROPN
ajlm-1224	4	48	,	,	PUNCT
ajlm-1224	4	49	cedric	cedric	PROPN
ajlm-1224	4	50	h.	h.	PROPN
ajlm-1224	4	51	mbakam	mbakam	PROPN
ajlm-1224	4	52	,	,	PUNCT
ajlm-1224	4	53	elise	elise	PROPN
ajlm-1224	4	54	guiedem	guiedem	PROPN
ajlm-1224	4	55	,	,	PUNCT
ajlm-1224	4	56	martha	martha	PROPN
ajlm-1224	4	57	tongo	tongo	PROPN
ajlm-1224	4	58	mesembe	mesembe	PROPN
ajlm-1224	4	59	,	,	PUNCT
ajlm-1224	4	60	emilia	emilia	PROPN
ajlm-1224	4	61	lyonga	lyonga	PROPN
ajlm-1224	4	62	,	,	PUNCT
ajlm-1224	4	63	george	george	PROPN
ajlm-1224	4	64	mondinde	mondinde	PROPN
ajlm-1224	4	65	ikomey	ikomey	PROPN
ajlm-1224	4	66	received	receive	VERB
ajlm-1224	4	67	:	:	PUNCT
ajlm-1224	4	68	16	16	NUM
ajlm-1224	4	69	mar	mar	PROPN
ajlm-1224	4	70	.	.	PROPN
ajlm-1224	4	71	2020	2020	NUM
ajlm-1224	4	72	;	;	PUNCT
ajlm-1224	4	73	accepted	accept	VERB
ajlm-1224	4	74	:	:	PUNCT
ajlm-1224	4	75	20	20	NUM
ajlm-1224	4	76	oct	oct	PROPN
ajlm-1224	4	77	.	.	PROPN
ajlm-1224	4	78	2020	2020	NUM
ajlm-1224	4	79	;	;	PUNCT
ajlm-1224	4	80	published	publish	VERB
ajlm-1224	4	81	:	:	PUNCT
ajlm-1224	5	1	15	15	NUM
ajlm-1224	5	2	mar	mar	PROPN
ajlm-1224	5	3	.	.	PROPN
ajlm-1224	5	4	2021	2021	NUM
ajlm-1224	5	5	copyright	copyright	NOUN
ajlm-1224	5	6	:	:	PUNCT
ajlm-1224	5	7	©	©	PROPN
ajlm-1224	5	8	2021	2021	NUM
ajlm-1224	5	9	.	.	PUNCT
ajlm-1224	6	1	the	the	DET
ajlm-1224	6	2	author(s	author(s	PROPN
ajlm-1224	6	3	)	)	PUNCT
ajlm-1224	6	4	.	.	PUNCT
ajlm-1224	7	1	licensee	licensee	NOUN
ajlm-1224	7	2	:	:	PUNCT
ajlm-1224	7	3	aosis	aosis	NOUN
ajlm-1224	7	4	.	.	PUNCT
ajlm-1224	8	1	this	this	PRON
ajlm-1224	8	2	is	be	AUX
ajlm-1224	8	3	an	an	DET
ajlm-1224	8	4	open	open	ADJ
ajlm-1224	8	5	access	access	NOUN
ajlm-1224	8	6	article	article	NOUN
ajlm-1224	8	7	distributed	distribute	VERB
ajlm-1224	8	8	under	under	ADP
ajlm-1224	8	9	the	the	DET
ajlm-1224	8	10	terms	term	NOUN
ajlm-1224	8	11	of	of	ADP
ajlm-1224	8	12	the	the	DET
ajlm-1224	8	13	creative	creative	ADJ
ajlm-1224	8	14	commons	common	NOUN
ajlm-1224	8	15	attribution	attribution	NOUN
ajlm-1224	8	16	license	license	NOUN
ajlm-1224	8	17	,	,	PUNCT
ajlm-1224	8	18	which	which	PRON
ajlm-1224	8	19	permits	permit	VERB
ajlm-1224	8	20	unrestricted	unrestricted	ADJ
ajlm-1224	8	21	use	use	NOUN
ajlm-1224	8	22	,	,	PUNCT
ajlm-1224	8	23	distribution	distribution	NOUN
ajlm-1224	8	24	,	,	PUNCT
ajlm-1224	8	25	and	and	CCONJ
ajlm-1224	8	26	reproduction	reproduction	NOUN
ajlm-1224	8	27	in	in	ADP
ajlm-1224	8	28	any	any	DET
ajlm-1224	8	29	medium	medium	NOUN
ajlm-1224	8	30	,	,	PUNCT
ajlm-1224	8	31	provided	provide	VERB
ajlm-1224	8	32	the	the	DET
ajlm-1224	8	33	original	original	ADJ
ajlm-1224	8	34	work	work	NOUN
ajlm-1224	8	35	is	be	AUX
ajlm-1224	8	36	properly	properly	ADV
ajlm-1224	8	37	cited	cite	VERB
ajlm-1224	8	38	.	.	PUNCT
ajlm-1224	9	1	abstract	abstract	ADJ
ajlm-1224	9	2	background	background	NOUN
ajlm-1224	9	3	:	:	PUNCT
ajlm-1224	9	4	chronic	chronic	ADJ
ajlm-1224	9	5	viral	viral	ADJ
ajlm-1224	9	6	hepatitis	hepatitis	NOUN
ajlm-1224	9	7	b	b	PROPN
ajlm-1224	9	8	(	(	PUNCT
ajlm-1224	9	9	hbv	hbv	NOUN
ajlm-1224	9	10	)	)	PUNCT
ajlm-1224	9	11	is	be	AUX
ajlm-1224	9	12	characterised	characterise	VERB
ajlm-1224	9	13	by	by	ADP
ajlm-1224	9	14	progressive	progressive	ADJ
ajlm-1224	9	15	hepatocyte	hepatocyte	NOUN
ajlm-1224	9	16	destruction	destruction	NOUN
ajlm-1224	9	17	and	and	CCONJ
ajlm-1224	9	18	t	t	NOUN
ajlm-1224	9	19	-	-	PUNCT
ajlm-1224	9	20	cell	cell	NOUN
ajlm-1224	9	21	depletion	depletion	NOUN
ajlm-1224	9	22	.	.	PUNCT
ajlm-1224	10	1	the	the	DET
ajlm-1224	10	2	mechanisms	mechanism	NOUN
ajlm-1224	10	3	of	of	ADP
ajlm-1224	10	4	the	the	DET
ajlm-1224	10	5	cd95	cd95	PROPN
ajlm-1224	10	6	-	-	PUNCT
ajlm-1224	10	7	cd95	cd95	PROPN
ajlm-1224	10	8	ligand	ligand	NOUN
ajlm-1224	10	9	(	(	PUNCT
ajlm-1224	10	10	cd95l	cd95l	NOUN
ajlm-1224	10	11	)	)	PUNCT
ajlm-1224	10	12	signalling	signal	VERB
ajlm-1224	10	13	pathway	pathway	NOUN
ajlm-1224	10	14	during	during	ADP
ajlm-1224	10	15	this	this	DET
ajlm-1224	10	16	chronic	chronic	ADJ
ajlm-1224	10	17	disease	disease	NOUN
ajlm-1224	10	18	and	and	CCONJ
ajlm-1224	10	19	the	the	DET
ajlm-1224	10	20	cirrhotic	cirrhotic	ADJ
ajlm-1224	10	21	process	process	NOUN
ajlm-1224	10	22	remains	remain	VERB
ajlm-1224	10	23	unclear	unclear	ADJ
ajlm-1224	10	24	.	.	PUNCT
ajlm-1224	11	1	objective	objective	NOUN
ajlm-1224	11	2	:	:	PUNCT
ajlm-1224	11	3	we	we	PRON
ajlm-1224	11	4	evaluated	evaluate	VERB
ajlm-1224	11	5	the	the	DET
ajlm-1224	11	6	involvement	involvement	NOUN
ajlm-1224	11	7	of	of	ADP
ajlm-1224	11	8	the	the	DET
ajlm-1224	11	9	cd95	cd95	PROPN
ajlm-1224	11	10	-	-	PUNCT
ajlm-1224	11	11	cd95l	cd95l	NOUN
ajlm-1224	11	12	receptor	receptor	NOUN
ajlm-1224	11	13	-	-	PUNCT
ajlm-1224	11	14	ligand	ligand	NOUN
ajlm-1224	11	15	system	system	NOUN
ajlm-1224	11	16	in	in	ADP
ajlm-1224	11	17	t	t	NOUN
ajlm-1224	11	18	-	-	PUNCT
ajlm-1224	11	19	cell	cell	NOUN
ajlm-1224	11	20	depletion	depletion	NOUN
ajlm-1224	11	21	and	and	CCONJ
ajlm-1224	11	22	hepatic	hepatic	ADJ
ajlm-1224	11	23	cytolysis	cytolysis	NOUN
ajlm-1224	11	24	in	in	ADP
ajlm-1224	11	25	patients	patient	NOUN
ajlm-1224	11	26	with	with	ADP
ajlm-1224	11	27	chronic	chronic	ADJ
ajlm-1224	11	28	hbv	hbv	NOUN
ajlm-1224	11	29	.	.	PUNCT
ajlm-1224	12	1	methods	method	NOUN
ajlm-1224	12	2	:	:	PUNCT
ajlm-1224	12	3	this	this	PRON
ajlm-1224	12	4	was	be	AUX
ajlm-1224	12	5	a	a	DET
ajlm-1224	12	6	cross	cross	ADJ
ajlm-1224	12	7	-	-	ADJ
ajlm-1224	12	8	sectional	sectional	ADJ
ajlm-1224	12	9	study	study	NOUN
ajlm-1224	12	10	conducted	conduct	VERB
ajlm-1224	12	11	from	from	ADP
ajlm-1224	12	12	september	september	PROPN
ajlm-1224	12	13	to	to	ADP
ajlm-1224	12	14	december	december	PROPN
ajlm-1224	12	15	2018	2018	NUM
ajlm-1224	12	16	at	at	ADP
ajlm-1224	12	17	the	the	DET
ajlm-1224	12	18	yaoundé	yaoundé	PROPN
ajlm-1224	12	19	general	general	ADJ
ajlm-1224	12	20	hospital	hospital	NOUN
ajlm-1224	12	21	,	,	PUNCT
ajlm-1224	12	22	cameroon	cameroon	NOUN
ajlm-1224	12	23	.	.	PUNCT
ajlm-1224	13	1	four	four	NUM
ajlm-1224	13	2	ml	ml	NOUN
ajlm-1224	13	3	of	of	ADP
ajlm-1224	13	4	whole	whole	ADJ
ajlm-1224	13	5	blood	blood	NOUN
ajlm-1224	13	6	was	be	AUX
ajlm-1224	13	7	collected	collect	VERB
ajlm-1224	13	8	and	and	CCONJ
ajlm-1224	13	9	analysed	analyse	VERB
ajlm-1224	13	10	.	.	PUNCT
ajlm-1224	14	1	the	the	DET
ajlm-1224	14	2	cd95	cd95	PROPN
ajlm-1224	14	3	and	and	CCONJ
ajlm-1224	14	4	cd95l	cd95l	NOUN
ajlm-1224	14	5	levels	level	NOUN
ajlm-1224	14	6	,	,	PUNCT
ajlm-1224	14	7	as	as	ADV
ajlm-1224	14	8	well	well	ADV
ajlm-1224	14	9	as	as	ADP
ajlm-1224	14	10	the	the	DET
ajlm-1224	14	11	cd4	cd4	PROPN
ajlm-1224	14	12	+	+	PROPN
ajlm-1224	14	13	t	t	PROPN
ajlm-1224	14	14	-	-	PUNCT
ajlm-1224	14	15	cell	cell	NOUN
ajlm-1224	14	16	and	and	CCONJ
ajlm-1224	14	17	cd8	cd8	PROPN
ajlm-1224	14	18	+	+	PROPN
ajlm-1224	14	19	t	t	PROPN
ajlm-1224	14	20	-	-	PUNCT
ajlm-1224	14	21	cell	cell	NOUN
ajlm-1224	14	22	counts	count	NOUN
ajlm-1224	14	23	,	,	PUNCT
ajlm-1224	14	24	were	be	AUX
ajlm-1224	14	25	performed	perform	VERB
ajlm-1224	14	26	by	by	ADP
ajlm-1224	14	27	enzyme	enzyme	NOUN
ajlm-1224	14	28	-	-	PUNCT
ajlm-1224	14	29	linked	link	VERB
ajlm-1224	14	30	immunosorbent	immunosorbent	ADJ
ajlm-1224	14	31	assay	assay	NOUN
ajlm-1224	14	32	and	and	CCONJ
ajlm-1224	14	33	flow	flow	VERB
ajlm-1224	14	34	cytometry	cytometry	NOUN
ajlm-1224	14	35	.	.	PUNCT
ajlm-1224	15	1	results	result	NOUN
ajlm-1224	15	2	:	:	PUNCT
ajlm-1224	15	3	of	of	ADP
ajlm-1224	15	4	the	the	DET
ajlm-1224	15	5	130	130	NUM
ajlm-1224	15	6	hbv	hbv	NOUN
ajlm-1224	15	7	-	-	PUNCT
ajlm-1224	15	8	positive	positive	ADJ
ajlm-1224	15	9	patients	patient	NOUN
ajlm-1224	15	10	,	,	PUNCT
ajlm-1224	15	11	36	36	NUM
ajlm-1224	15	12	(	(	PUNCT
ajlm-1224	15	13	27.7	27.7	NUM
ajlm-1224	15	14	%	%	NOUN
ajlm-1224	15	15	)	)	PUNCT
ajlm-1224	15	16	were	be	AUX
ajlm-1224	15	17	cirrhotic	cirrhotic	ADJ
ajlm-1224	15	18	and	and	CCONJ
ajlm-1224	15	19	94	94	NUM
ajlm-1224	15	20	(	(	PUNCT
ajlm-1224	15	21	72.3	72.3	NUM
ajlm-1224	15	22	%	%	NOUN
ajlm-1224	15	23	)	)	PUNCT
ajlm-1224	15	24	were	be	AUX
ajlm-1224	15	25	non	non	ADJ
ajlm-1224	15	26	-	-	ADJ
ajlm-1224	15	27	cirrhotic	cirrhotic	ADJ
ajlm-1224	15	28	.	.	PUNCT
ajlm-1224	16	1	the	the	DET
ajlm-1224	16	2	cirrhotic	cirrhotic	ADJ
ajlm-1224	16	3	patients	patient	NOUN
ajlm-1224	16	4	had	have	VERB
ajlm-1224	16	5	significantly	significantly	ADV
ajlm-1224	16	6	elevated	elevate	VERB
ajlm-1224	16	7	cd95	cd95	PROPN
ajlm-1224	16	8	(	(	PUNCT
ajlm-1224	16	9	p	p	X
ajlm-1224	16	10	<	<	X
ajlm-1224	16	11	0.001	0.001	NUM
ajlm-1224	16	12	)	)	PUNCT
ajlm-1224	16	13	and	and	CCONJ
ajlm-1224	16	14	cd95l	cd95l	NOUN
ajlm-1224	17	1	(	(	PUNCT
ajlm-1224	17	2	p	p	NOUN
ajlm-1224	17	3	=	=	NOUN
ajlm-1224	17	4	0.001	0.001	NUM
ajlm-1224	17	5	)	)	PUNCT
ajlm-1224	17	6	plasma	plasma	NOUN
ajlm-1224	17	7	levels	level	NOUN
ajlm-1224	17	8	,	,	PUNCT
ajlm-1224	17	9	compared	compare	VERB
ajlm-1224	17	10	with	with	ADP
ajlm-1224	17	11	non	non	ADJ
ajlm-1224	17	12	-	-	ADJ
ajlm-1224	17	13	cirrhotic	cirrhotic	ADJ
ajlm-1224	17	14	patients	patient	NOUN
ajlm-1224	17	15	.	.	PUNCT
ajlm-1224	18	1	the	the	DET
ajlm-1224	18	2	cd4	cd4	PROPN
ajlm-1224	18	3	/	/	SYM
ajlm-1224	18	4	cd8	cd8	PROPN
ajlm-1224	18	5	ratios	ratio	NOUN
ajlm-1224	18	6	were	be	AUX
ajlm-1224	18	7	lower	low	ADJ
ajlm-1224	18	8	in	in	ADP
ajlm-1224	18	9	cirrhotic	cirrhotic	ADJ
ajlm-1224	18	10	patients	patient	NOUN
ajlm-1224	18	11	,	,	PUNCT
ajlm-1224	18	12	compared	compare	VERB
ajlm-1224	18	13	to	to	ADP
ajlm-1224	18	14	non	non	ADJ
ajlm-1224	18	15	-	-	ADJ
ajlm-1224	18	16	cirrhotic	cirrhotic	ADJ
ajlm-1224	18	17	patients	patient	NOUN
ajlm-1224	18	18	(	(	PUNCT
ajlm-1224	18	19	p	p	X
ajlm-1224	18	20	<	<	X
ajlm-1224	18	21	0.001	0.001	NUM
ajlm-1224	18	22	)	)	PUNCT
ajlm-1224	18	23	.	.	PUNCT
ajlm-1224	19	1	there	there	PRON
ajlm-1224	19	2	were	be	VERB
ajlm-1224	19	3	statistically	statistically	ADV
ajlm-1224	19	4	significant	significant	ADJ
ajlm-1224	19	5	correlations	correlation	NOUN
ajlm-1224	19	6	between	between	ADP
ajlm-1224	19	7	cd95	cd95	PROPN
ajlm-1224	19	8	level	level	NOUN
ajlm-1224	19	9	and	and	CCONJ
ajlm-1224	19	10	cd4	cd4	PROPN
ajlm-1224	19	11	+	+	PROPN
ajlm-1224	19	12	t	t	PROPN
ajlm-1224	19	13	-	-	PUNCT
ajlm-1224	19	14	cell	cell	NOUN
ajlm-1224	19	15	counts	count	NOUN
ajlm-1224	19	16	,	,	PUNCT
ajlm-1224	19	17	between	between	ADP
ajlm-1224	19	18	cd95	cd95	PROPN
ajlm-1224	19	19	level	level	NOUN
ajlm-1224	19	20	and	and	CCONJ
ajlm-1224	19	21	cd8	cd8	PROPN
ajlm-1224	19	22	+	+	PROPN
ajlm-1224	19	23	t	t	PROPN
ajlm-1224	19	24	-	-	PUNCT
ajlm-1224	19	25	cell	cell	NOUN
ajlm-1224	19	26	counts	count	NOUN
ajlm-1224	19	27	,	,	PUNCT
ajlm-1224	19	28	between	between	ADP
ajlm-1224	19	29	cd95	cd95	PROPN
ajlm-1224	19	30	level	level	NOUN
ajlm-1224	19	31	and	and	CCONJ
ajlm-1224	19	32	the	the	DET
ajlm-1224	19	33	cd4	cd4	PROPN
ajlm-1224	19	34	/	/	SYM
ajlm-1224	19	35	cd8	cd8	PROPN
ajlm-1224	19	36	ratio	ratio	NOUN
ajlm-1224	19	37	,	,	PUNCT
ajlm-1224	19	38	between	between	ADP
ajlm-1224	19	39	cd95	cd95	PROPN
ajlm-1224	19	40	level	level	NOUN
ajlm-1224	19	41	and	and	CCONJ
ajlm-1224	19	42	fibrosis	fibrosis	NOUN
ajlm-1224	19	43	score	score	NOUN
ajlm-1224	19	44	,	,	PUNCT
ajlm-1224	19	45	and	and	CCONJ
ajlm-1224	19	46	between	between	ADP
ajlm-1224	19	47	cd95l	cd95l	NOUN
ajlm-1224	19	48	level	level	NOUN
ajlm-1224	19	49	and	and	CCONJ
ajlm-1224	19	50	fibrosis	fibrosis	NOUN
ajlm-1224	19	51	score	score	NOUN
ajlm-1224	19	52	.	.	PUNCT
ajlm-1224	20	1	conclusion	conclusion	NOUN
ajlm-1224	20	2	:	:	PUNCT
ajlm-1224	20	3	cd95	cd95	NOUN
ajlm-1224	20	4	and	and	CCONJ
ajlm-1224	20	5	cd95l	cd95l	NOUN
ajlm-1224	20	6	could	could	AUX
ajlm-1224	20	7	be	be	AUX
ajlm-1224	20	8	involved	involve	VERB
ajlm-1224	20	9	in	in	ADP
ajlm-1224	20	10	t	t	NOUN
ajlm-1224	20	11	-	-	PUNCT
ajlm-1224	20	12	cell	cell	NOUN
ajlm-1224	20	13	depletion	depletion	NOUN
ajlm-1224	20	14	and	and	CCONJ
ajlm-1224	20	15	hepatic	hepatic	NOUN
ajlm-1224	20	16	cytolysis	cytolysis	NOUN
ajlm-1224	20	17	during	during	ADP
ajlm-1224	20	18	the	the	DET
ajlm-1224	20	19	pathogenesis	pathogenesis	NOUN
ajlm-1224	20	20	of	of	ADP
ajlm-1224	20	21	chronic	chronic	ADJ
ajlm-1224	20	22	hbv	hbv	NOUN
ajlm-1224	20	23	and	and	CCONJ
ajlm-1224	20	24	could	could	AUX
ajlm-1224	20	25	potentially	potentially	ADV
ajlm-1224	20	26	be	be	AUX
ajlm-1224	20	27	used	use	VERB
ajlm-1224	20	28	as	as	ADP
ajlm-1224	20	29	biomarkers	biomarker	NOUN
ajlm-1224	20	30	for	for	ADP
ajlm-1224	20	31	immunological	immunological	ADJ
ajlm-1224	20	32	and	and	CCONJ
ajlm-1224	20	33	hepatic	hepatic	ADJ
ajlm-1224	20	34	monitoring	monitoring	NOUN
ajlm-1224	20	35	in	in	ADP
ajlm-1224	20	36	patients	patient	NOUN
ajlm-1224	20	37	with	with	ADP
ajlm-1224	20	38	chronic	chronic	ADJ
ajlm-1224	20	39	hbv	hbv	NOUN
ajlm-1224	20	40	.	.	PUNCT
ajlm-1224	21	1	keywords	keyword	NOUN
ajlm-1224	21	2	:	:	PUNCT
ajlm-1224	21	3	hbv	hbv	NOUN
ajlm-1224	21	4	;	;	PUNCT
ajlm-1224	21	5	cd95	cd95	NOUN
ajlm-1224	21	6	-	-	PUNCT
ajlm-1224	21	7	cd95l	cd95l	NOUN
ajlm-1224	21	8	;	;	PUNCT
ajlm-1224	21	9	cd4	cd4	PROPN
ajlm-1224	21	10	+	+	PROPN
ajlm-1224	21	11	t	t	PROPN
ajlm-1224	21	12	-	-	PUNCT
ajlm-1224	21	13	cells	cell	NOUN
ajlm-1224	21	14	;	;	PUNCT
ajlm-1224	21	15	cd8	cd8	PROPN
ajlm-1224	21	16	+	+	PROPN
ajlm-1224	21	17	t	t	PROPN
ajlm-1224	21	18	-	-	PUNCT
ajlm-1224	21	19	cells	cell	NOUN
ajlm-1224	21	20	;	;	PUNCT
ajlm-1224	21	21	cirrhosis	cirrhosis	NOUN
ajlm-1224	21	22	.	.	PUNCT
ajlm-1224	22	1	introduction	introduction	NOUN
ajlm-1224	22	2	the	the	DET
ajlm-1224	22	3	hepatitis	hepatitis	PROPN
ajlm-1224	22	4	b	b	PROPN
ajlm-1224	22	5	virus	virus	NOUN
ajlm-1224	22	6	(	(	PUNCT
ajlm-1224	22	7	hbv	hbv	NOUN
ajlm-1224	22	8	)	)	PUNCT
ajlm-1224	22	9	is	be	AUX
ajlm-1224	22	10	the	the	DET
ajlm-1224	22	11	leading	lead	VERB
ajlm-1224	22	12	cause	cause	NOUN
ajlm-1224	22	13	of	of	ADP
ajlm-1224	22	14	chronic	chronic	ADJ
ajlm-1224	22	15	liver	liver	NOUN
ajlm-1224	22	16	disease	disease	NOUN
ajlm-1224	22	17	and	and	CCONJ
ajlm-1224	22	18	remains	remain	VERB
ajlm-1224	22	19	a	a	DET
ajlm-1224	22	20	major	major	ADJ
ajlm-1224	22	21	global	global	ADJ
ajlm-1224	22	22	health	health	NOUN
ajlm-1224	22	23	burden.1	burden.1	NOUN
ajlm-1224	22	24	chronic	chronic	ADJ
ajlm-1224	22	25	hbv	hbv	NOUN
ajlm-1224	22	26	infection	infection	NOUN
ajlm-1224	22	27	is	be	AUX
ajlm-1224	22	28	denoted	denote	VERB
ajlm-1224	22	29	by	by	ADP
ajlm-1224	22	30	the	the	DET
ajlm-1224	22	31	persistence	persistence	NOUN
ajlm-1224	22	32	of	of	ADP
ajlm-1224	22	33	the	the	DET
ajlm-1224	22	34	hbv	hbv	NOUN
ajlm-1224	22	35	surface	surface	NOUN
ajlm-1224	22	36	antigen	antigen	ADV
ajlm-1224	22	37	in	in	ADP
ajlm-1224	22	38	the	the	DET
ajlm-1224	22	39	host	host	NOUN
ajlm-1224	22	40	for	for	ADP
ajlm-1224	22	41	at	at	ADV
ajlm-1224	22	42	least	least	ADV
ajlm-1224	22	43	6	6	NUM
ajlm-1224	22	44	months.1	months.1	PROPN
ajlm-1224	22	45	viral	viral	ADJ
ajlm-1224	22	46	hepatitis	hepatitis	NOUN
ajlm-1224	22	47	b	b	PROPN
ajlm-1224	22	48	is	be	AUX
ajlm-1224	22	49	characterised	characterise	VERB
ajlm-1224	22	50	by	by	ADP
ajlm-1224	22	51	the	the	DET
ajlm-1224	22	52	progressive	progressive	ADJ
ajlm-1224	22	53	onset	onset	NOUN
ajlm-1224	22	54	of	of	ADP
ajlm-1224	22	55	fibrotic	fibrotic	ADJ
ajlm-1224	22	56	hepatic	hepatic	ADJ
ajlm-1224	22	57	lesions	lesion	NOUN
ajlm-1224	22	58	;	;	PUNCT
ajlm-1224	22	59	the	the	DET
ajlm-1224	22	60	pathogenesis	pathogenesis	NOUN
ajlm-1224	22	61	remains	remain	VERB
ajlm-1224	22	62	unclear.2	unclear.2	ADJ
ajlm-1224	22	63	counts	count	NOUN
ajlm-1224	22	64	of	of	ADP
ajlm-1224	22	65	cd4	cd4	PROPN
ajlm-1224	22	66	+	+	PROPN
ajlm-1224	22	67	and	and	CCONJ
ajlm-1224	22	68	cd8	cd8	PROPN
ajlm-1224	22	69	+	+	PROPN
ajlm-1224	22	70	t	t	PROPN
ajlm-1224	22	71	-	-	PUNCT
ajlm-1224	22	72	cells	cell	NOUN
ajlm-1224	22	73	,	,	PUNCT
ajlm-1224	22	74	which	which	PRON
ajlm-1224	22	75	play	play	VERB
ajlm-1224	22	76	an	an	DET
ajlm-1224	22	77	indispensable	indispensable	ADJ
ajlm-1224	22	78	role	role	NOUN
ajlm-1224	22	79	in	in	ADP
ajlm-1224	22	80	the	the	DET
ajlm-1224	22	81	resolution	resolution	NOUN
ajlm-1224	22	82	of	of	ADP
ajlm-1224	22	83	hbv	hbv	NOUN
ajlm-1224	22	84	infection,2	infection,2	VERB
ajlm-1224	22	85	are	be	AUX
ajlm-1224	22	86	significantly	significantly	ADV
ajlm-1224	22	87	lower	low	ADJ
ajlm-1224	22	88	in	in	ADP
ajlm-1224	22	89	chronic	chronic	ADJ
ajlm-1224	22	90	hbv	hbv	NOUN
ajlm-1224	22	91	,	,	PUNCT
ajlm-1224	22	92	but	but	CCONJ
ajlm-1224	22	93	the	the	DET
ajlm-1224	22	94	mechanisms	mechanism	NOUN
ajlm-1224	22	95	resulting	result	VERB
ajlm-1224	22	96	in	in	ADP
ajlm-1224	22	97	their	their	PRON
ajlm-1224	22	98	depletion	depletion	NOUN
ajlm-1224	22	99	remain	remain	VERB
ajlm-1224	22	100	unclear.3	unclear.3	NUM
ajlm-1224	22	101	the	the	DET
ajlm-1224	22	102	severity	severity	NOUN
ajlm-1224	22	103	of	of	ADP
ajlm-1224	22	104	liver	liver	NOUN
ajlm-1224	22	105	lesions	lesion	NOUN
ajlm-1224	22	106	caused	cause	VERB
ajlm-1224	22	107	by	by	ADP
ajlm-1224	22	108	infection	infection	NOUN
ajlm-1224	22	109	varies	vary	VERB
ajlm-1224	22	110	according	accord	VERB
ajlm-1224	22	111	to	to	ADP
ajlm-1224	22	112	the	the	DET
ajlm-1224	22	113	immune	immune	ADJ
ajlm-1224	22	114	status	status	NOUN
ajlm-1224	22	115	of	of	ADP
ajlm-1224	22	116	the	the	DET
ajlm-1224	22	117	patient.2	patient.2	ADJ
ajlm-1224	22	118	an	an	DET
ajlm-1224	22	119	appropriate	appropriate	ADJ
ajlm-1224	22	120	immune	immune	ADJ
ajlm-1224	22	121	response	response	NOUN
ajlm-1224	22	122	leads	lead	VERB
ajlm-1224	22	123	to	to	ADP
ajlm-1224	22	124	the	the	DET
ajlm-1224	22	125	necrosis	necrosis	NOUN
ajlm-1224	22	126	of	of	ADP
ajlm-1224	22	127	infected	infected	ADJ
ajlm-1224	22	128	hepatocytes	hepatocyte	NOUN
ajlm-1224	22	129	and	and	CCONJ
ajlm-1224	22	130	the	the	DET
ajlm-1224	22	131	elimination	elimination	NOUN
ajlm-1224	22	132	of	of	ADP
ajlm-1224	22	133	the	the	DET
ajlm-1224	22	134	virus.1	virus.1	PROPN
ajlm-1224	22	135	an	an	DET
ajlm-1224	22	136	excessive	excessive	ADJ
ajlm-1224	22	137	immune	immune	ADJ
ajlm-1224	22	138	response	response	NOUN
ajlm-1224	22	139	induces	induce	VERB
ajlm-1224	22	140	massive	massive	ADJ
ajlm-1224	22	141	hepatocyte	hepatocyte	NOUN
ajlm-1224	22	142	destruction	destruction	NOUN
ajlm-1224	22	143	,	,	PUNCT
ajlm-1224	22	144	while	while	SCONJ
ajlm-1224	22	145	immunotolerance	immunotolerance	NOUN
ajlm-1224	22	146	is	be	AUX
ajlm-1224	22	147	marked	mark	VERB
ajlm-1224	22	148	by	by	ADP
ajlm-1224	22	149	abundant	abundant	ADJ
ajlm-1224	22	150	but	but	CCONJ
ajlm-1224	22	151	asymptomatic	asymptomatic	ADJ
ajlm-1224	22	152	viral	viral	ADJ
ajlm-1224	22	153	multiplication	multiplication	NOUN
ajlm-1224	22	154	without	without	ADP
ajlm-1224	22	155	destruction	destruction	NOUN
ajlm-1224	22	156	of	of	ADP
ajlm-1224	22	157	hepatocytes.3	hepatocytes.3	PROPN
ajlm-1224	22	158	in	in	ADP
ajlm-1224	22	159	chronic	chronic	ADJ
ajlm-1224	22	160	carriers	carrier	NOUN
ajlm-1224	22	161	of	of	ADP
ajlm-1224	22	162	hbv	hbv	NOUN
ajlm-1224	22	163	,	,	PUNCT
ajlm-1224	22	164	this	this	DET
ajlm-1224	22	165	immune	immune	ADJ
ajlm-1224	22	166	response	response	NOUN
ajlm-1224	22	167	exists	exist	VERB
ajlm-1224	22	168	,	,	PUNCT
ajlm-1224	22	169	but	but	CCONJ
ajlm-1224	22	170	it	it	PRON
ajlm-1224	22	171	is	be	AUX
ajlm-1224	22	172	insufficient	insufficient	ADJ
ajlm-1224	22	173	to	to	PART
ajlm-1224	22	174	eliminate	eliminate	VERB
ajlm-1224	22	175	the	the	DET
ajlm-1224	22	176	virus.3	virus.3	NOUN
ajlm-1224	22	177	the	the	DET
ajlm-1224	22	178	persistence	persistence	NOUN
ajlm-1224	22	179	of	of	ADP
ajlm-1224	22	180	hbv	hbv	NOUN
ajlm-1224	22	181	in	in	ADP
ajlm-1224	22	182	hepatocytes	hepatocytes	PROPN
ajlm-1224	22	183	leads	lead	VERB
ajlm-1224	22	184	to	to	ADP
ajlm-1224	22	185	repeated	repeat	VERB
ajlm-1224	22	186	attempts	attempt	NOUN
ajlm-1224	22	187	to	to	PART
ajlm-1224	22	188	eliminate	eliminate	VERB
ajlm-1224	22	189	them	they	PRON
ajlm-1224	22	190	by	by	ADP
ajlm-1224	22	191	t	t	PROPN
ajlm-1224	22	192	-	-	PUNCT
ajlm-1224	22	193	cells.2	cells.2	NOUN
ajlm-1224	22	194	this	this	PRON
ajlm-1224	22	195	is	be	AUX
ajlm-1224	22	196	mediated	mediate	VERB
ajlm-1224	22	197	by	by	ADP
ajlm-1224	22	198	several	several	ADJ
ajlm-1224	22	199	immune	immune	ADJ
ajlm-1224	22	200	mechanisms	mechanism	NOUN
ajlm-1224	22	201	,	,	PUNCT
ajlm-1224	22	202	including	include	VERB
ajlm-1224	22	203	apoptosis	apoptosis	NOUN
ajlm-1224	22	204	,	,	PUNCT
ajlm-1224	22	205	which	which	PRON
ajlm-1224	22	206	is	be	AUX
ajlm-1224	22	207	a	a	DET
ajlm-1224	22	208	physiological	physiological	ADJ
ajlm-1224	22	209	process	process	NOUN
ajlm-1224	22	210	of	of	ADP
ajlm-1224	22	211	cell	cell	NOUN
ajlm-1224	22	212	death	death	NOUN
ajlm-1224	22	213	,	,	PUNCT
ajlm-1224	22	214	implementing	implement	VERB
ajlm-1224	22	215	an	an	DET
ajlm-1224	22	216	actual	actual	ADJ
ajlm-1224	22	217	cell	cell	NOUN
ajlm-1224	22	218	lysis	lysis	NOUN
ajlm-1224	22	219	programme.3	programme.3	PROPN
ajlm-1224	22	220	the	the	DET
ajlm-1224	22	221	triggering	triggering	NOUN
ajlm-1224	22	222	of	of	ADP
ajlm-1224	22	223	this	this	DET
ajlm-1224	22	224	‘	'	PUNCT
ajlm-1224	22	225	programmed	programmed	ADJ
ajlm-1224	22	226	death	death	NOUN
ajlm-1224	22	227	’	'	PUNCT
ajlm-1224	22	228	is	be	AUX
ajlm-1224	22	229	done	do	VERB
ajlm-1224	22	230	through	through	ADP
ajlm-1224	22	231	the	the	DET
ajlm-1224	22	232	activation	activation	NOUN
ajlm-1224	22	233	of	of	ADP
ajlm-1224	22	234	specialised	specialised	ADJ
ajlm-1224	22	235	signalling	signal	VERB
ajlm-1224	22	236	pathways	pathway	NOUN
ajlm-1224	22	237	,	,	PUNCT
ajlm-1224	22	238	namely	namely	ADV
ajlm-1224	22	239	the	the	DET
ajlm-1224	22	240	cd95	cd95	PROPN
ajlm-1224	22	241	-	-	PUNCT
ajlm-1224	22	242	cd95	cd95	PROPN
ajlm-1224	22	243	ligand	ligand	NOUN
ajlm-1224	22	244	(	(	PUNCT
ajlm-1224	22	245	cd95l	cd95l	NOUN
ajlm-1224	22	246	)	)	PUNCT
ajlm-1224	22	247	pathway.3	pathway.3	PROPN
ajlm-1224	22	248	cd95	cd95	PROPN
ajlm-1224	22	249	(	(	PUNCT
ajlm-1224	22	250	fas	fas	NOUN
ajlm-1224	22	251	or	or	CCONJ
ajlm-1224	22	252	apo-1	apo-1	NOUN
ajlm-1224	22	253	)	)	PUNCT
ajlm-1224	22	254	is	be	AUX
ajlm-1224	22	255	the	the	DET
ajlm-1224	22	256	receptor	receptor	NOUN
ajlm-1224	22	257	of	of	ADP
ajlm-1224	22	258	cd95l	cd95l	PROPN
ajlm-1224	22	259	(	(	PUNCT
ajlm-1224	22	260	fas	fas	PROPN
ajlm-1224	22	261	ligand	ligand	PROPN
ajlm-1224	22	262	,	,	PUNCT
ajlm-1224	22	263	fasl	fasl	PROPN
ajlm-1224	22	264	)	)	PUNCT
ajlm-1224	22	265	;	;	PUNCT
ajlm-1224	22	266	cd95	cd95	PROPN
ajlm-1224	22	267	belongs	belong	VERB
ajlm-1224	22	268	to	to	ADP
ajlm-1224	22	269	the	the	DET
ajlm-1224	22	270	tumor	tumor	NOUN
ajlm-1224	22	271	necrosis	necrosis	NOUN
ajlm-1224	22	272	factor	factor	NOUN
ajlm-1224	22	273	-	-	PUNCT
ajlm-1224	22	274	receptor	receptor	NOUN
ajlm-1224	22	275	/	/	SYM
ajlm-1224	22	276	nerve	nerve	NOUN
ajlm-1224	22	277	growth	growth	NOUN
ajlm-1224	22	278	factor	factor	NOUN
ajlm-1224	22	279	-	-	PUNCT
ajlm-1224	22	280	receptor	receptor	NOUN
ajlm-1224	22	281	(	(	PUNCT
ajlm-1224	22	282	tnf	tnf	PROPN
ajlm-1224	22	283	-	-	PUNCT
ajlm-1224	22	284	r	r	NOUN
ajlm-1224	22	285	/	/	SYM
ajlm-1224	22	286	ngf	ngf	NOUN
ajlm-1224	22	287	-	-	PUNCT
ajlm-1224	22	288	r	r	NOUN
ajlm-1224	22	289	)	)	PUNCT
ajlm-1224	22	290	family.3	family.3	PROPN
ajlm-1224	22	291	members	member	NOUN
ajlm-1224	22	292	of	of	ADP
ajlm-1224	22	293	this	this	DET
ajlm-1224	22	294	family	family	NOUN
ajlm-1224	22	295	are	be	AUX
ajlm-1224	22	296	characterised	characterise	VERB
ajlm-1224	22	297	by	by	ADP
ajlm-1224	22	298	the	the	DET
ajlm-1224	22	299	presence	presence	NOUN
ajlm-1224	22	300	of	of	ADP
ajlm-1224	22	301	cysteine	cysteine	NOUN
ajlm-1224	22	302	-	-	PUNCT
ajlm-1224	22	303	rich	rich	ADJ
ajlm-1224	22	304	domains	domain	NOUN
ajlm-1224	22	305	in	in	ADP
ajlm-1224	22	306	their	their	PRON
ajlm-1224	22	307	extracytoplasmic	extracytoplasmic	ADJ
ajlm-1224	22	308	portion	portion	NOUN
ajlm-1224	22	309	;	;	PUNCT
ajlm-1224	22	310	cd95	cd95	PROPN
ajlm-1224	22	311	has	have	VERB
ajlm-1224	22	312	three	three	NUM
ajlm-1224	22	313	cysteine	cysteine	ADJ
ajlm-1224	22	314	-	-	PUNCT
ajlm-1224	22	315	rich	rich	ADJ
ajlm-1224	22	316	domains.3	domains.3	PROPN
ajlm-1224	22	317	the	the	DET
ajlm-1224	22	318	‘	'	PUNCT
ajlm-1224	22	319	death	death	NOUN
ajlm-1224	22	320	receptor	receptor	NOUN
ajlm-1224	22	321	’	'	PUNCT
ajlm-1224	22	322	subfamily	subfamily	ADV
ajlm-1224	22	323	is	be	AUX
ajlm-1224	22	324	distinguished	distinguish	VERB
ajlm-1224	22	325	at	at	ADP
ajlm-1224	22	326	the	the	DET
ajlm-1224	22	327	intracytoplasmic	intracytoplasmic	ADJ
ajlm-1224	22	328	portion	portion	NOUN
ajlm-1224	22	329	that	that	PRON
ajlm-1224	22	330	contains	contain	VERB
ajlm-1224	22	331	a	a	DET
ajlm-1224	22	332	domain	domain	NOUN
ajlm-1224	22	333	of	of	ADP
ajlm-1224	22	334	about	about	ADV
ajlm-1224	22	335	80	80	NUM
ajlm-1224	22	336	amino	amino	NOUN
ajlm-1224	22	337	acids	acid	NOUN
ajlm-1224	22	338	called	call	VERB
ajlm-1224	22	339	the	the	DET
ajlm-1224	22	340	‘	'	PUNCT
ajlm-1224	22	341	death	death	NOUN
ajlm-1224	22	342	domain’.3	domain’.3	NOUN
ajlm-1224	22	343	the	the	DET
ajlm-1224	22	344	induction	induction	NOUN
ajlm-1224	22	345	of	of	ADP
ajlm-1224	22	346	apoptosis	apoptosis	NOUN
ajlm-1224	22	347	by	by	ADP
ajlm-1224	22	348	cd95	cd95	PROPN
ajlm-1224	22	349	follows	follow	VERB
ajlm-1224	22	350	its	its	PRON
ajlm-1224	22	351	oligomerisation	oligomerisation	NOUN
ajlm-1224	22	352	by	by	ADP
ajlm-1224	22	353	an	an	DET
ajlm-1224	22	354	agonist	agonist	NOUN
ajlm-1224	22	355	monoclonal	monoclonal	NOUN
ajlm-1224	22	356	antibody	antibody	NOUN
ajlm-1224	22	357	or	or	CCONJ
ajlm-1224	22	358	by	by	ADP
ajlm-1224	22	359	its	its	PRON
ajlm-1224	22	360	natural	natural	ADJ
ajlm-1224	22	361	ligand	ligand	NOUN
ajlm-1224	22	362	,	,	PUNCT
ajlm-1224	22	363	cd95l.3	cd95l.3	NOUN
ajlm-1224	22	364	the	the	DET
ajlm-1224	22	365	latter	latter	ADJ
ajlm-1224	22	366	belongs	belong	VERB
ajlm-1224	22	367	to	to	ADP
ajlm-1224	22	368	the	the	DET
ajlm-1224	22	369	superfamily	superfamily	NOUN
ajlm-1224	22	370	of	of	ADP
ajlm-1224	22	371	tnf	tnf	PROPN
ajlm-1224	22	372	/	/	SYM
ajlm-1224	22	373	ngf.3	ngf.3	PROPN
ajlm-1224	22	374	the	the	DET
ajlm-1224	22	375	cd95	cd95	PROPN
ajlm-1224	22	376	molecule	molecule	NOUN
ajlm-1224	22	377	is	be	AUX
ajlm-1224	22	378	expressed	express	VERB
ajlm-1224	22	379	in	in	ADP
ajlm-1224	22	380	many	many	ADJ
ajlm-1224	22	381	tissues	tissue	NOUN
ajlm-1224	22	382	including	include	VERB
ajlm-1224	22	383	the	the	DET
ajlm-1224	22	384	liver	liver	NOUN
ajlm-1224	22	385	,	,	PUNCT
ajlm-1224	22	386	the	the	DET
ajlm-1224	22	387	heart	heart	NOUN
ajlm-1224	22	388	and	and	CCONJ
ajlm-1224	22	389	the	the	DET
ajlm-1224	22	390	hematopoietic	hematopoietic	ADJ
ajlm-1224	22	391	tissues.3	tissues.3	PROPN
ajlm-1224	22	392	however	however	ADV
ajlm-1224	22	393	,	,	PUNCT
ajlm-1224	22	394	a	a	DET
ajlm-1224	22	395	total	total	ADJ
ajlm-1224	22	396	absence	absence	NOUN
ajlm-1224	22	397	of	of	ADP
ajlm-1224	22	398	expression	expression	NOUN
ajlm-1224	22	399	of	of	ADP
ajlm-1224	22	400	the	the	DET
ajlm-1224	22	401	cd95	cd95	PROPN
ajlm-1224	22	402	protein	protein	NOUN
ajlm-1224	22	403	in	in	ADP
ajlm-1224	22	404	humans	human	NOUN
ajlm-1224	22	405	has	have	VERB
ajlm-1224	22	406	no	no	DET
ajlm-1224	22	407	direct	direct	ADJ
ajlm-1224	22	408	repercussions	repercussion	NOUN
ajlm-1224	22	409	on	on	ADP
ajlm-1224	22	410	the	the	DET
ajlm-1224	22	411	lymphoid	lymphoid	ADJ
ajlm-1224	22	412	system.4	system.4	NOUN
ajlm-1224	22	413	cd95	cd95	PROPN
ajlm-1224	22	414	is	be	AUX
ajlm-1224	22	415	expressed	express	VERB
ajlm-1224	22	416	on	on	ADP
ajlm-1224	22	417	the	the	DET
ajlm-1224	22	418	surface	surface	NOUN
ajlm-1224	22	419	membrane	membrane	NOUN
ajlm-1224	22	420	of	of	ADP
ajlm-1224	22	421	activated	activate	VERB
ajlm-1224	22	422	t	t	PROPN
ajlm-1224	22	423	-	-	PUNCT
ajlm-1224	22	424	lymphocytes	lymphocyte	NOUN
ajlm-1224	22	425	or	or	CCONJ
ajlm-1224	22	426	b	b	NOUN
ajlm-1224	22	427	-	-	PUNCT
ajlm-1224	22	428	lymphocytes	lymphocyte	NOUN
ajlm-1224	22	429	,	,	PUNCT
ajlm-1224	22	430	during	during	ADP
ajlm-1224	22	431	the	the	DET
ajlm-1224	22	432	first	first	ADJ
ajlm-1224	22	433	activation.5	activation.5	NOUN
ajlm-1224	22	434	after	after	ADP
ajlm-1224	22	435	a	a	DET
ajlm-1224	22	436	second	second	ADJ
ajlm-1224	22	437	activation	activation	NOUN
ajlm-1224	22	438	,	,	PUNCT
ajlm-1224	22	439	the	the	DET
ajlm-1224	22	440	t	t	PROPN
ajlm-1224	22	441	-	-	PUNCT
ajlm-1224	22	442	lymphocyte	lymphocyte	NOUN
ajlm-1224	22	443	expresses	express	VERB
ajlm-1224	22	444	cd95l	cd95l	NOUN
ajlm-1224	22	445	and	and	CCONJ
ajlm-1224	22	446	kills	kill	VERB
ajlm-1224	22	447	the	the	DET
ajlm-1224	22	448	activated	activate	VERB
ajlm-1224	22	449	lymphocytes	lymphocyte	NOUN
ajlm-1224	22	450	(	(	PUNCT
ajlm-1224	22	451	death	death	NOUN
ajlm-1224	22	452	in	in	ADP
ajlm-1224	22	453	‘	'	PUNCT
ajlm-1224	22	454	trans	tran	NOUN
ajlm-1224	22	455	’	'	PUNCT
ajlm-1224	22	456	)	)	PUNCT
ajlm-1224	22	457	,	,	PUNCT
ajlm-1224	22	458	including	include	VERB
ajlm-1224	22	459	itself	itself	PRON
ajlm-1224	22	460	(	(	PUNCT
ajlm-1224	22	461	death	death	NOUN
ajlm-1224	22	462	in	in	ADP
ajlm-1224	22	463	‘	'	PUNCT
ajlm-1224	22	464	cis	cis	NOUN
ajlm-1224	22	465	’	'	PUNCT
ajlm-1224	22	466	)	)	PUNCT
ajlm-1224	22	467	,	,	PUNCT
ajlm-1224	22	468	which	which	PRON
ajlm-1224	22	469	is	be	AUX
ajlm-1224	22	470	called	call	VERB
ajlm-1224	22	471	‘	'	PUNCT
ajlm-1224	22	472	activation	activation	NOUN
ajlm-1224	22	473	-	-	PUNCT
ajlm-1224	22	474	induced	induce	VERB
ajlm-1224	22	475	cell	cell	NOUN
ajlm-1224	22	476	death	death	NOUN
ajlm-1224	22	477	’	'	PUNCT
ajlm-1224	22	478	(	(	PUNCT
ajlm-1224	22	479	aicd).5	aicd).5	PROPN
ajlm-1224	22	480	the	the	DET
ajlm-1224	22	481	cd95	cd95	PROPN
ajlm-1224	22	482	-	-	PUNCT
ajlm-1224	22	483	cd95l	cd95l	NOUN
ajlm-1224	22	484	interaction	interaction	NOUN
ajlm-1224	22	485	,	,	PUNCT
ajlm-1224	22	486	therefore	therefore	ADV
ajlm-1224	22	487	,	,	PUNCT
ajlm-1224	22	488	represents	represent	VERB
ajlm-1224	22	489	a	a	DET
ajlm-1224	22	490	route	route	NOUN
ajlm-1224	22	491	of	of	ADP
ajlm-1224	22	492	control	control	NOUN
ajlm-1224	22	493	of	of	ADP
ajlm-1224	22	494	the	the	DET
ajlm-1224	22	495	immune	immune	ADJ
ajlm-1224	22	496	response	response	NOUN
ajlm-1224	22	497	,	,	PUNCT
ajlm-1224	22	498	and	and	CCONJ
ajlm-1224	22	499	the	the	DET
ajlm-1224	22	500	regulation	regulation	NOUN
ajlm-1224	22	501	of	of	ADP
ajlm-1224	22	502	autoimmune	autoimmune	ADJ
ajlm-1224	22	503	proliferations.5	proliferations.5	PROPN
ajlm-1224	22	504	cd95	cd95	PROPN
ajlm-1224	22	505	-	-	PUNCT
ajlm-1224	22	506	mediated	mediate	VERB
ajlm-1224	22	507	t	t	NOUN
ajlm-1224	22	508	-	-	PUNCT
ajlm-1224	22	509	cell	cell	NOUN
ajlm-1224	22	510	apoptosis	apoptosis	NOUN
ajlm-1224	22	511	is	be	AUX
ajlm-1224	22	512	a	a	DET
ajlm-1224	22	513	well	well	ADV
ajlm-1224	22	514	-	-	PUNCT
ajlm-1224	22	515	known	know	VERB
ajlm-1224	22	516	mechanism	mechanism	NOUN
ajlm-1224	22	517	for	for	ADP
ajlm-1224	22	518	the	the	DET
ajlm-1224	22	519	prevention	prevention	NOUN
ajlm-1224	22	520	of	of	ADP
ajlm-1224	22	521	immunopathogenesis	immunopathogenesis	NOUN
ajlm-1224	22	522	and	and	CCONJ
ajlm-1224	22	523	the	the	DET
ajlm-1224	22	524	maintenance	maintenance	NOUN
ajlm-1224	22	525	of	of	ADP
ajlm-1224	22	526	immune	immune	ADJ
ajlm-1224	22	527	tolerance	tolerance	NOUN
ajlm-1224	22	528	through	through	ADP
ajlm-1224	22	529	the	the	DET
ajlm-1224	22	530	contraction	contraction	NOUN
ajlm-1224	22	531	of	of	ADP
ajlm-1224	22	532	t	t	PROPN
ajlm-1224	22	533	-	-	PUNCT
ajlm-1224	22	534	cell	cell	NOUN
ajlm-1224	22	535	responses	response	NOUN
ajlm-1224	22	536	.	.	PUNCT
ajlm-1224	23	1	this	this	PRON
ajlm-1224	23	2	is	be	AUX
ajlm-1224	23	3	described	describe	VERB
ajlm-1224	23	4	as	as	ADP
ajlm-1224	23	5	an	an	DET
ajlm-1224	23	6	immune	immune	ADJ
ajlm-1224	23	7	checkpoint	checkpoint	NOUN
ajlm-1224	23	8	mechanism.5	mechanism.5	PROPN
ajlm-1224	23	9	three	three	NUM
ajlm-1224	23	10	mechanisms	mechanism	NOUN
ajlm-1224	23	11	maintain	maintain	VERB
ajlm-1224	23	12	peripheral	peripheral	ADJ
ajlm-1224	23	13	t	t	NOUN
ajlm-1224	23	14	-	-	PUNCT
ajlm-1224	23	15	cells	cell	NOUN
ajlm-1224	23	16	homeostasis	homeostasis	NOUN
ajlm-1224	23	17	:	:	PUNCT
ajlm-1224	23	18	t	t	NOUN
ajlm-1224	23	19	-	-	PUNCT
ajlm-1224	23	20	cells	cell	NOUN
ajlm-1224	23	21	anergy	anergy	NOUN
ajlm-1224	23	22	,	,	PUNCT
ajlm-1224	23	23	suppression	suppression	NOUN
ajlm-1224	23	24	by	by	ADP
ajlm-1224	23	25	regulatory	regulatory	ADJ
ajlm-1224	23	26	t	t	PROPN
ajlm-1224	23	27	-	-	PUNCT
ajlm-1224	23	28	cells	cell	NOUN
ajlm-1224	23	29	and	and	CCONJ
ajlm-1224	23	30	aicd.6	aicd.6	VERB
ajlm-1224	23	31	the	the	DET
ajlm-1224	23	32	population	population	NOUN
ajlm-1224	23	33	of	of	ADP
ajlm-1224	23	34	effector	effector	PROPN
ajlm-1224	23	35	t	t	PROPN
ajlm-1224	23	36	-	-	PUNCT
ajlm-1224	23	37	cells	cell	NOUN
ajlm-1224	23	38	is	be	AUX
ajlm-1224	23	39	controlled	control	VERB
ajlm-1224	23	40	by	by	ADP
ajlm-1224	23	41	aicd	aicd	NOUN
ajlm-1224	23	42	,	,	PUNCT
ajlm-1224	23	43	which	which	PRON
ajlm-1224	23	44	is	be	AUX
ajlm-1224	23	45	initiated	initiate	VERB
ajlm-1224	23	46	by	by	ADP
ajlm-1224	23	47	repeated	repeat	VERB
ajlm-1224	23	48	stimulation	stimulation	NOUN
ajlm-1224	23	49	of	of	ADP
ajlm-1224	23	50	the	the	DET
ajlm-1224	23	51	t	t	NOUN
ajlm-1224	23	52	-	-	PUNCT
ajlm-1224	23	53	cell	cell	NOUN
ajlm-1224	23	54	receptor	receptor	NOUN
ajlm-1224	23	55	via	via	ADP
ajlm-1224	23	56	apoptosis	apoptosis	NOUN
ajlm-1224	23	57	mediated	mediate	VERB
ajlm-1224	23	58	by	by	ADP
ajlm-1224	23	59	cd95.7	cd95.7	PROPN
ajlm-1224	23	60	thus	thus	ADV
ajlm-1224	23	61	,	,	PUNCT
ajlm-1224	23	62	aicd	aicd	NOUN
ajlm-1224	23	63	mediated	mediate	VERB
ajlm-1224	23	64	by	by	ADP
ajlm-1224	23	65	cd95	cd95	PROPN
ajlm-1224	23	66	plays	play	VERB
ajlm-1224	23	67	a	a	DET
ajlm-1224	23	68	very	very	ADV
ajlm-1224	23	69	important	important	ADJ
ajlm-1224	23	70	role	role	NOUN
ajlm-1224	23	71	within	within	ADP
ajlm-1224	23	72	the	the	DET
ajlm-1224	23	73	peripheral	peripheral	ADJ
ajlm-1224	23	74	immune	immune	NOUN
ajlm-1224	23	75	system.6	system.6	NOUN
ajlm-1224	23	76	the	the	DET
ajlm-1224	23	77	mechanisms	mechanism	NOUN
ajlm-1224	23	78	of	of	ADP
ajlm-1224	23	79	the	the	DET
ajlm-1224	23	80	cd95	cd95	PROPN
ajlm-1224	23	81	-	-	PUNCT
ajlm-1224	23	82	cd95l	cd95l	NOUN
ajlm-1224	23	83	apoptotic	apoptotic	ADJ
ajlm-1224	23	84	signalling	signal	VERB
ajlm-1224	23	85	pathway	pathway	NOUN
ajlm-1224	23	86	during	during	ADP
ajlm-1224	23	87	chronic	chronic	ADJ
ajlm-1224	23	88	hbv	hbv	NOUN
ajlm-1224	23	89	remains	remain	VERB
ajlm-1224	23	90	to	to	PART
ajlm-1224	23	91	be	be	AUX
ajlm-1224	23	92	elucidated.6	elucidated.6	VERB
ajlm-1224	23	93	our	our	PRON
ajlm-1224	23	94	objective	objective	NOUN
ajlm-1224	23	95	was	be	AUX
ajlm-1224	23	96	to	to	PART
ajlm-1224	23	97	evaluate	evaluate	VERB
ajlm-1224	23	98	the	the	DET
ajlm-1224	23	99	involvement	involvement	NOUN
ajlm-1224	23	100	of	of	ADP
ajlm-1224	23	101	cd95	cd95	PROPN
ajlm-1224	23	102	-	-	PUNCT
ajlm-1224	23	103	cd95l	cd95l	NOUN
ajlm-1224	23	104	receptor	receptor	NOUN
ajlm-1224	23	105	-	-	PUNCT
ajlm-1224	23	106	ligands	ligand	NOUN
ajlm-1224	23	107	in	in	ADP
ajlm-1224	23	108	t	t	NOUN
ajlm-1224	23	109	-	-	PUNCT
ajlm-1224	23	110	cell	cell	NOUN
ajlm-1224	23	111	depletion	depletion	NOUN
ajlm-1224	23	112	and	and	CCONJ
ajlm-1224	23	113	hepatic	hepatic	ADJ
ajlm-1224	23	114	cytolysis	cytolysis	NOUN
ajlm-1224	23	115	in	in	ADP
ajlm-1224	23	116	patients	patient	NOUN
ajlm-1224	23	117	with	with	ADP
ajlm-1224	23	118	chronic	chronic	ADJ
ajlm-1224	23	119	hbv	hbv	NOUN
ajlm-1224	23	120	.	.	PUNCT
ajlm-1224	24	1	methods	method	NOUN
ajlm-1224	24	2	ethical	ethical	ADJ
ajlm-1224	24	3	considerations	consideration	NOUN
ajlm-1224	24	4	ethical	ethical	ADJ
ajlm-1224	24	5	approval	approval	NOUN
ajlm-1224	24	6	to	to	PART
ajlm-1224	24	7	conduct	conduct	VERB
ajlm-1224	24	8	the	the	DET
ajlm-1224	24	9	study	study	NOUN
ajlm-1224	24	10	was	be	AUX
ajlm-1224	24	11	obtained	obtain	VERB
ajlm-1224	24	12	from	from	ADP
ajlm-1224	24	13	the	the	DET
ajlm-1224	24	14	institutional	institutional	ADJ
ajlm-1224	24	15	ethics	ethic	NOUN
ajlm-1224	24	16	and	and	CCONJ
ajlm-1224	24	17	research	research	NOUN
ajlm-1224	24	18	committee	committee	NOUN
ajlm-1224	24	19	for	for	ADP
ajlm-1224	24	20	human	human	ADJ
ajlm-1224	24	21	health	health	NOUN
ajlm-1224	24	22	,	,	PUNCT
ajlm-1224	24	23	of	of	ADP
ajlm-1224	24	24	the	the	DET
ajlm-1224	24	25	catholic	catholic	PROPN
ajlm-1224	24	26	university	university	PROPN
ajlm-1224	24	27	of	of	ADP
ajlm-1224	24	28	central	central	PROPN
ajlm-1224	24	29	africa	africa	PROPN
ajlm-1224	24	30	(	(	PUNCT
ajlm-1224	24	31	no	no	INTJ
ajlm-1224	24	32	.	.	NOUN
ajlm-1224	24	33	2019/0803	2019/0803	NUM
ajlm-1224	24	34	/	/	SYM
ajlm-1224	24	35	ceirsh	ceirsh	ADJ
ajlm-1224	24	36	/	/	SYM
ajlm-1224	24	37	ess	ess	NOUN
ajlm-1224	24	38	/	/	SYM
ajlm-1224	24	39	mim	mim	PROPN
ajlm-1224	24	40	)	)	PUNCT
ajlm-1224	24	41	.	.	PUNCT
ajlm-1224	25	1	written	write	VERB
ajlm-1224	25	2	and	and	CCONJ
ajlm-1224	25	3	verbal	verbal	ADJ
ajlm-1224	25	4	informed	inform	VERB
ajlm-1224	25	5	consent	consent	NOUN
ajlm-1224	25	6	was	be	AUX
ajlm-1224	25	7	given	give	VERB
ajlm-1224	25	8	by	by	ADP
ajlm-1224	25	9	all	all	DET
ajlm-1224	25	10	participants	participant	NOUN
ajlm-1224	25	11	.	.	PUNCT
ajlm-1224	26	1	the	the	DET
ajlm-1224	26	2	study	study	NOUN
ajlm-1224	26	3	was	be	AUX
ajlm-1224	26	4	conducted	conduct	VERB
ajlm-1224	26	5	according	accord	VERB
ajlm-1224	26	6	to	to	ADP
ajlm-1224	26	7	the	the	DET
ajlm-1224	26	8	ethical	ethical	ADJ
ajlm-1224	26	9	principles	principle	NOUN
ajlm-1224	26	10	and	and	CCONJ
ajlm-1224	26	11	guidelines	guideline	NOUN
ajlm-1224	26	12	of	of	ADP
ajlm-1224	26	13	the	the	DET
ajlm-1224	26	14	international	international	ADJ
ajlm-1224	26	15	declaration	declaration	NOUN
ajlm-1224	26	16	of	of	ADP
ajlm-1224	26	17	helsinki	helsinki	PROPN
ajlm-1224	26	18	2013	2013	NUM
ajlm-1224	26	19	.	.	PUNCT
ajlm-1224	27	1	all	all	DET
ajlm-1224	27	2	procedures	procedure	NOUN
ajlm-1224	27	3	were	be	AUX
ajlm-1224	27	4	standard	standard	ADJ
ajlm-1224	27	5	and	and	CCONJ
ajlm-1224	27	6	presented	present	VERB
ajlm-1224	27	7	a	a	DET
ajlm-1224	27	8	minimal	minimal	ADJ
ajlm-1224	27	9	risk	risk	NOUN
ajlm-1224	27	10	to	to	ADP
ajlm-1224	27	11	participants	participant	NOUN
ajlm-1224	27	12	.	.	PUNCT
ajlm-1224	28	1	the	the	DET
ajlm-1224	28	2	names	name	NOUN
ajlm-1224	28	3	of	of	ADP
ajlm-1224	28	4	the	the	DET
ajlm-1224	28	5	participants	participant	NOUN
ajlm-1224	28	6	were	be	AUX
ajlm-1224	28	7	replaced	replace	VERB
ajlm-1224	28	8	by	by	ADP
ajlm-1224	28	9	alphanumeric	alphanumeric	ADJ
ajlm-1224	28	10	codes	code	NOUN
ajlm-1224	28	11	and	and	CCONJ
ajlm-1224	28	12	kept	keep	VERB
ajlm-1224	28	13	in	in	ADP
ajlm-1224	28	14	a	a	DET
ajlm-1224	28	15	safe	safe	ADJ
ajlm-1224	28	16	place	place	NOUN
ajlm-1224	28	17	,	,	PUNCT
ajlm-1224	28	18	accessible	accessible	ADJ
ajlm-1224	28	19	only	only	ADV
ajlm-1224	28	20	by	by	ADP
ajlm-1224	28	21	the	the	DET
ajlm-1224	28	22	principal	principal	ADJ
ajlm-1224	28	23	investigator	investigator	NOUN
ajlm-1224	28	24	.	.	PUNCT
ajlm-1224	29	1	the	the	DET
ajlm-1224	29	2	physical	physical	ADJ
ajlm-1224	29	3	documents	document	NOUN
ajlm-1224	29	4	were	be	AUX
ajlm-1224	29	5	kept	keep	VERB
ajlm-1224	29	6	in	in	ADP
ajlm-1224	29	7	secure	secure	ADJ
ajlm-1224	29	8	locked	lock	VERB
ajlm-1224	29	9	drawers	drawer	NOUN
ajlm-1224	29	10	within	within	ADP
ajlm-1224	29	11	the	the	DET
ajlm-1224	29	12	processing	processing	NOUN
ajlm-1224	29	13	site	site	NOUN
ajlm-1224	29	14	.	.	PUNCT
ajlm-1224	30	1	the	the	DET
ajlm-1224	30	2	digital	digital	ADJ
ajlm-1224	30	3	documents	document	NOUN
ajlm-1224	30	4	were	be	AUX
ajlm-1224	30	5	encrypted	encrypt	VERB
ajlm-1224	30	6	and	and	CCONJ
ajlm-1224	30	7	secured	secure	VERB
ajlm-1224	30	8	by	by	ADP
ajlm-1224	30	9	passwords	password	NOUN
ajlm-1224	30	10	and	and	CCONJ
ajlm-1224	30	11	stored	store	VERB
ajlm-1224	30	12	on	on	ADP
ajlm-1224	30	13	secure	secure	ADJ
ajlm-1224	30	14	hard	hard	ADJ
ajlm-1224	30	15	disks	disk	NOUN
ajlm-1224	30	16	.	.	PUNCT
ajlm-1224	31	1	study	study	NOUN
ajlm-1224	31	2	design	design	NOUN
ajlm-1224	31	3	we	we	PRON
ajlm-1224	31	4	performed	perform	VERB
ajlm-1224	31	5	a	a	DET
ajlm-1224	31	6	cross	cross	ADJ
ajlm-1224	31	7	-	-	ADJ
ajlm-1224	31	8	sectional	sectional	ADJ
ajlm-1224	31	9	study	study	NOUN
ajlm-1224	31	10	from	from	ADP
ajlm-1224	31	11	september	september	PROPN
ajlm-1224	31	12	to	to	ADP
ajlm-1224	31	13	december	december	PROPN
ajlm-1224	31	14	2018	2018	NUM
ajlm-1224	31	15	of	of	ADP
ajlm-1224	31	16	patients	patient	NOUN
ajlm-1224	31	17	with	with	ADP
ajlm-1224	31	18	chronic	chronic	ADJ
ajlm-1224	31	19	hbv	hbv	NOUN
ajlm-1224	31	20	infection	infection	NOUN
ajlm-1224	31	21	.	.	PUNCT
ajlm-1224	32	1	participants	participant	NOUN
ajlm-1224	32	2	received	receive	VERB
ajlm-1224	32	3	consultation	consultation	NOUN
ajlm-1224	32	4	at	at	ADP
ajlm-1224	32	5	the	the	DET
ajlm-1224	32	6	hepato	hepato	NOUN
ajlm-1224	32	7	-	-	PUNCT
ajlm-1224	32	8	gastroenterology	gastroenterology	NOUN
ajlm-1224	32	9	department	department	NOUN
ajlm-1224	32	10	of	of	ADP
ajlm-1224	32	11	the	the	DET
ajlm-1224	32	12	yaoundé	yaoundé	PROPN
ajlm-1224	32	13	general	general	ADJ
ajlm-1224	32	14	hospital	hospital	NOUN
ajlm-1224	32	15	,	,	PUNCT
ajlm-1224	32	16	cameroon	cameroon	NOUN
ajlm-1224	32	17	.	.	PUNCT
ajlm-1224	33	1	patient	patient	ADJ
ajlm-1224	33	2	recruitment	recruitment	NOUN
ajlm-1224	33	3	was	be	AUX
ajlm-1224	33	4	consecutive	consecutive	ADJ
ajlm-1224	33	5	and	and	CCONJ
ajlm-1224	33	6	non	non	ADJ
ajlm-1224	33	7	-	-	ADJ
ajlm-1224	33	8	probabilistic	probabilistic	ADJ
ajlm-1224	33	9	.	.	PUNCT
ajlm-1224	34	1	the	the	DET
ajlm-1224	34	2	results	result	NOUN
ajlm-1224	34	3	of	of	ADP
ajlm-1224	34	4	the	the	DET
ajlm-1224	34	5	biological	biological	ADJ
ajlm-1224	34	6	analysis	analysis	NOUN
ajlm-1224	34	7	were	be	AUX
ajlm-1224	34	8	returned	return	VERB
ajlm-1224	34	9	to	to	ADP
ajlm-1224	34	10	the	the	DET
ajlm-1224	34	11	patients	patient	NOUN
ajlm-1224	34	12	and	and	CCONJ
ajlm-1224	34	13	incorporated	incorporate	VERB
ajlm-1224	34	14	into	into	ADP
ajlm-1224	34	15	their	their	PRON
ajlm-1224	34	16	medical	medical	ADJ
ajlm-1224	34	17	records	record	NOUN
ajlm-1224	34	18	.	.	PUNCT
ajlm-1224	35	1	study	study	NOUN
ajlm-1224	35	2	population	population	NOUN
ajlm-1224	35	3	from	from	ADP
ajlm-1224	35	4	the	the	DET
ajlm-1224	35	5	fibro	fibro	PROPN
ajlm-1224	35	6	test	test	NOUN
ajlm-1224	35	7	examination	examination	NOUN
ajlm-1224	35	8	,	,	PUNCT
ajlm-1224	35	9	patients	patient	NOUN
ajlm-1224	35	10	were	be	AUX
ajlm-1224	35	11	divided	divide	VERB
ajlm-1224	35	12	based	base	VERB
ajlm-1224	35	13	on	on	ADP
ajlm-1224	35	14	their	their	PRON
ajlm-1224	35	15	metavir	metavir	PROPN
ajlm-1224	35	16	fibrosis	fibrosis	NOUN
ajlm-1224	35	17	score	score	NOUN
ajlm-1224	35	18	into	into	ADP
ajlm-1224	35	19	cirrhotic	cirrhotic	ADJ
ajlm-1224	35	20	and	and	CCONJ
ajlm-1224	35	21	non	non	ADJ
ajlm-1224	35	22	-	-	ADJ
ajlm-1224	35	23	cirrhotic	cirrhotic	ADJ
ajlm-1224	35	24	hbv	hbv	NOUN
ajlm-1224	35	25	-	-	PUNCT
ajlm-1224	35	26	infected	infect	VERB
ajlm-1224	35	27	patients	patient	NOUN
ajlm-1224	35	28	.	.	PUNCT
ajlm-1224	36	1	recruited	recruit	VERB
ajlm-1224	36	2	patients	patient	NOUN
ajlm-1224	36	3	were	be	AUX
ajlm-1224	36	4	between	between	ADP
ajlm-1224	36	5	18	18	NUM
ajlm-1224	36	6	and	and	CCONJ
ajlm-1224	36	7	60	60	NUM
ajlm-1224	36	8	years	year	NOUN
ajlm-1224	36	9	of	of	ADP
ajlm-1224	36	10	age	age	NOUN
ajlm-1224	36	11	.	.	PUNCT
ajlm-1224	37	1	patients	patient	NOUN
ajlm-1224	37	2	with	with	ADP
ajlm-1224	37	3	liver	liver	NOUN
ajlm-1224	37	4	diseases	disease	NOUN
ajlm-1224	37	5	of	of	ADP
ajlm-1224	37	6	other	other	ADJ
ajlm-1224	37	7	aetiologies	aetiology	NOUN
ajlm-1224	37	8	or	or	CCONJ
ajlm-1224	37	9	those	those	PRON
ajlm-1224	37	10	having	have	VERB
ajlm-1224	37	11	hbv	hbv	NOUN
ajlm-1224	37	12	infection	infection	NOUN
ajlm-1224	37	13	and	and	CCONJ
ajlm-1224	37	14	a	a	DET
ajlm-1224	37	15	history	history	NOUN
ajlm-1224	37	16	of	of	ADP
ajlm-1224	37	17	autoimmunity	autoimmunity	NOUN
ajlm-1224	37	18	,	,	PUNCT
ajlm-1224	37	19	drug	drug	NOUN
ajlm-1224	37	20	-	-	PUNCT
ajlm-1224	37	21	dependence	dependence	NOUN
ajlm-1224	37	22	or	or	CCONJ
ajlm-1224	37	23	co	co	NOUN
ajlm-1224	37	24	-	-	NOUN
ajlm-1224	37	25	infection	infection	NOUN
ajlm-1224	37	26	with	with	ADP
ajlm-1224	37	27	other	other	ADJ
ajlm-1224	37	28	viruses	virus	NOUN
ajlm-1224	37	29	,	,	PUNCT
ajlm-1224	37	30	including	include	VERB
ajlm-1224	37	31	hepatitis	hepatitis	PROPN
ajlm-1224	37	32	c	c	PROPN
ajlm-1224	37	33	virus	virus	NOUN
ajlm-1224	37	34	(	(	PUNCT
ajlm-1224	37	35	hcv	hcv	PROPN
ajlm-1224	37	36	)	)	PUNCT
ajlm-1224	37	37	,	,	PUNCT
ajlm-1224	37	38	hepatitis	hepatitis	NOUN
ajlm-1224	37	39	d	d	PROPN
ajlm-1224	37	40	virus	virus	NOUN
ajlm-1224	37	41	(	(	PUNCT
ajlm-1224	37	42	hdv	hdv	PROPN
ajlm-1224	37	43	)	)	PUNCT
ajlm-1224	37	44	,	,	PUNCT
ajlm-1224	37	45	hiv	hiv	PROPN
ajlm-1224	37	46	and	and	CCONJ
ajlm-1224	37	47	human	human	PROPN
ajlm-1224	37	48	t	t	PROPN
ajlm-1224	37	49	-	-	PUNCT
ajlm-1224	37	50	cell	cell	NOUN
ajlm-1224	37	51	leukemia	leukemia	NOUN
ajlm-1224	37	52	virus	virus	NOUN
ajlm-1224	37	53	type	type	NOUN
ajlm-1224	37	54	1	1	NUM
ajlm-1224	37	55	,	,	PUNCT
ajlm-1224	37	56	were	be	AUX
ajlm-1224	37	57	excluded	exclude	VERB
ajlm-1224	37	58	from	from	ADP
ajlm-1224	37	59	the	the	DET
ajlm-1224	37	60	study	study	NOUN
ajlm-1224	37	61	.	.	PUNCT
ajlm-1224	38	1	the	the	DET
ajlm-1224	38	2	selection	selection	NOUN
ajlm-1224	38	3	criteria	criterion	NOUN
ajlm-1224	38	4	for	for	ADP
ajlm-1224	38	5	the	the	DET
ajlm-1224	38	6	control	control	NOUN
ajlm-1224	38	7	participants	participant	NOUN
ajlm-1224	38	8	were	be	AUX
ajlm-1224	38	9	:	:	PUNCT
ajlm-1224	38	10	not	not	PART
ajlm-1224	38	11	having	have	VERB
ajlm-1224	38	12	a	a	DET
ajlm-1224	38	13	medical	medical	ADJ
ajlm-1224	38	14	history	history	NOUN
ajlm-1224	38	15	of	of	ADP
ajlm-1224	38	16	hbv	hbv	NOUN
ajlm-1224	38	17	,	,	PUNCT
ajlm-1224	38	18	hcv	hcv	PROPN
ajlm-1224	38	19	,	,	PUNCT
ajlm-1224	38	20	hdv	hdv	PROPN
ajlm-1224	38	21	,	,	PUNCT
ajlm-1224	38	22	human	human	PROPN
ajlm-1224	38	23	t	t	PROPN
ajlm-1224	38	24	-	-	PUNCT
ajlm-1224	38	25	cell	cell	NOUN
ajlm-1224	38	26	leukemia	leukemia	NOUN
ajlm-1224	38	27	virus	virus	NOUN
ajlm-1224	38	28	type	type	NOUN
ajlm-1224	38	29	1	1	NUM
ajlm-1224	38	30	or	or	CCONJ
ajlm-1224	38	31	hiv	hiv	PROPN
ajlm-1224	38	32	infection	infection	NOUN
ajlm-1224	38	33	,	,	PUNCT
ajlm-1224	38	34	autoimmunity	autoimmunity	NOUN
ajlm-1224	38	35	and	and	CCONJ
ajlm-1224	38	36	not	not	PART
ajlm-1224	38	37	having	having	AUX
ajlm-1224	38	38	consumed	consume	VERB
ajlm-1224	38	39	alcohol	alcohol	NOUN
ajlm-1224	38	40	in	in	ADP
ajlm-1224	38	41	the	the	DET
ajlm-1224	38	42	past	past	ADJ
ajlm-1224	38	43	7	7	NUM
ajlm-1224	38	44	years	year	NOUN
ajlm-1224	38	45	.	.	PUNCT
ajlm-1224	39	1	these	these	DET
ajlm-1224	39	2	control	control	NOUN
ajlm-1224	39	3	participants	participant	NOUN
ajlm-1224	39	4	were	be	AUX
ajlm-1224	39	5	selected	select	VERB
ajlm-1224	39	6	from	from	ADP
ajlm-1224	39	7	a	a	DET
ajlm-1224	39	8	population	population	NOUN
ajlm-1224	39	9	of	of	ADP
ajlm-1224	39	10	blood	blood	NOUN
ajlm-1224	39	11	donors	donor	NOUN
ajlm-1224	39	12	at	at	ADP
ajlm-1224	39	13	the	the	DET
ajlm-1224	39	14	yaoundé	yaoundé	PROPN
ajlm-1224	39	15	general	general	ADJ
ajlm-1224	39	16	hospital	hospital	NOUN
ajlm-1224	39	17	and	and	CCONJ
ajlm-1224	39	18	screened	screen	VERB
ajlm-1224	39	19	for	for	ADP
ajlm-1224	39	20	these	these	DET
ajlm-1224	39	21	viral	viral	ADJ
ajlm-1224	39	22	infections	infection	NOUN
ajlm-1224	39	23	and	and	CCONJ
ajlm-1224	39	24	diseases	disease	NOUN
ajlm-1224	39	25	.	.	PUNCT
ajlm-1224	40	1	social	social	ADJ
ajlm-1224	40	2	characteristics	characteristic	NOUN
ajlm-1224	40	3	(	(	PUNCT
ajlm-1224	40	4	age	age	NOUN
ajlm-1224	40	5	and	and	CCONJ
ajlm-1224	40	6	sex	sex	NOUN
ajlm-1224	40	7	)	)	PUNCT
ajlm-1224	40	8	and	and	CCONJ
ajlm-1224	40	9	clinical	clinical	ADJ
ajlm-1224	40	10	information	information	NOUN
ajlm-1224	40	11	(	(	PUNCT
ajlm-1224	40	12	cirrhosis	cirrhosis	NOUN
ajlm-1224	40	13	statute	statute	NOUN
ajlm-1224	40	14	,	,	PUNCT
ajlm-1224	40	15	levels	level	NOUN
ajlm-1224	40	16	of	of	ADP
ajlm-1224	40	17	cd95	cd95	PROPN
ajlm-1224	40	18	and	and	CCONJ
ajlm-1224	40	19	cd95l	cd95l	NOUN
ajlm-1224	40	20	,	,	PUNCT
ajlm-1224	40	21	counts	count	NOUN
ajlm-1224	40	22	of	of	ADP
ajlm-1224	40	23	cd4	cd4	PROPN
ajlm-1224	40	24	+	+	PROPN
ajlm-1224	40	25	t	t	PROPN
ajlm-1224	40	26	-	-	PUNCT
ajlm-1224	40	27	cells	cell	NOUN
ajlm-1224	40	28	,	,	PUNCT
ajlm-1224	40	29	cd8	cd8	PROPN
ajlm-1224	40	30	+	+	PROPN
ajlm-1224	40	31	t	t	PROPN
ajlm-1224	40	32	-	-	PUNCT
ajlm-1224	40	33	cells	cell	NOUN
ajlm-1224	40	34	and	and	CCONJ
ajlm-1224	40	35	cd4	cd4	PROPN
ajlm-1224	40	36	/	/	SYM
ajlm-1224	40	37	cd8	cd8	PROPN
ajlm-1224	40	38	ratio	ratio	PROPN
ajlm-1224	40	39	)	)	PUNCT
ajlm-1224	40	40	were	be	AUX
ajlm-1224	40	41	collected	collect	VERB
ajlm-1224	40	42	for	for	ADP
ajlm-1224	40	43	each	each	DET
ajlm-1224	40	44	participant	participant	NOUN
ajlm-1224	40	45	using	use	VERB
ajlm-1224	40	46	a	a	DET
ajlm-1224	40	47	standard	standard	ADJ
ajlm-1224	40	48	questionnaire	questionnaire	NOUN
ajlm-1224	40	49	.	.	PUNCT
ajlm-1224	41	1	sample	sample	NOUN
ajlm-1224	41	2	collection	collection	NOUN
ajlm-1224	41	3	and	and	CCONJ
ajlm-1224	41	4	analysis	analysis	NOUN
ajlm-1224	41	5	site	site	NOUN
ajlm-1224	41	6	four	four	NUM
ajlm-1224	41	7	millilitres	millilitre	NOUN
ajlm-1224	41	8	of	of	ADP
ajlm-1224	41	9	whole	whole	ADJ
ajlm-1224	41	10	blood	blood	NOUN
ajlm-1224	41	11	was	be	AUX
ajlm-1224	41	12	collected	collect	VERB
ajlm-1224	41	13	into	into	ADP
ajlm-1224	41	14	ethylene	ethylene	NOUN
ajlm-1224	41	15	diamine	diamine	NOUN
ajlm-1224	41	16	tetra	tetra	NOUN
ajlm-1224	41	17	acetate	acetate	NOUN
ajlm-1224	41	18	acid	acid	PROPN
ajlm-1224	41	19	anticoagulant	anticoagulant	PROPN
ajlm-1224	41	20	tubes	tube	NOUN
ajlm-1224	41	21	(	(	PUNCT
ajlm-1224	41	22	greiner	greiner	PROPN
ajlm-1224	41	23	bio	bio	PROPN
ajlm-1224	41	24	-	-	ADJ
ajlm-1224	41	25	one	one	NUM
ajlm-1224	41	26	international	international	ADJ
ajlm-1224	41	27	gmbh	gmbh	NOUN
ajlm-1224	41	28	,	,	PUNCT
ajlm-1224	41	29	kremsmünster	kremsmünster	NOUN
ajlm-1224	41	30	,	,	PUNCT
ajlm-1224	41	31	austria	austria	PROPN
ajlm-1224	41	32	)	)	PUNCT
ajlm-1224	41	33	,	,	PUNCT
ajlm-1224	41	34	and	and	CCONJ
ajlm-1224	41	35	transported	transport	VERB
ajlm-1224	41	36	at	at	ADP
ajlm-1224	41	37	room	room	NOUN
ajlm-1224	41	38	temperature	temperature	NOUN
ajlm-1224	41	39	to	to	ADP
ajlm-1224	41	40	the	the	DET
ajlm-1224	41	41	immuno	immuno	ADJ
ajlm-1224	41	42	-	-	PUNCT
ajlm-1224	41	43	virology	virology	NOUN
ajlm-1224	41	44	laboratory	laboratory	NOUN
ajlm-1224	41	45	of	of	ADP
ajlm-1224	41	46	the	the	DET
ajlm-1224	41	47	center	center	NOUN
ajlm-1224	41	48	for	for	ADP
ajlm-1224	41	49	the	the	DET
ajlm-1224	41	50	study	study	NOUN
ajlm-1224	41	51	and	and	CCONJ
ajlm-1224	41	52	control	control	NOUN
ajlm-1224	41	53	of	of	ADP
ajlm-1224	41	54	communicable	communicable	NOUN
ajlm-1224	41	55	diseases	disease	NOUN
ajlm-1224	41	56	of	of	ADP
ajlm-1224	41	57	the	the	DET
ajlm-1224	41	58	faculty	faculty	NOUN
ajlm-1224	41	59	of	of	ADP
ajlm-1224	41	60	medicine	medicine	NOUN
ajlm-1224	41	61	and	and	CCONJ
ajlm-1224	41	62	biomedical	biomedical	ADJ
ajlm-1224	41	63	sciences	science	NOUN
ajlm-1224	41	64	of	of	ADP
ajlm-1224	41	65	the	the	DET
ajlm-1224	41	66	university	university	NOUN
ajlm-1224	41	67	of	of	ADP
ajlm-1224	41	68	yaoundé	yaoundé	NOUN
ajlm-1224	41	69	1	1	NUM
ajlm-1224	41	70	.	.	PUNCT
ajlm-1224	42	1	these	these	DET
ajlm-1224	42	2	samples	sample	NOUN
ajlm-1224	42	3	were	be	AUX
ajlm-1224	42	4	analysed	analyse	VERB
ajlm-1224	42	5	within	within	ADP
ajlm-1224	42	6	24	24	NUM
ajlm-1224	42	7	h	h	NOUN
ajlm-1224	42	8	for	for	ADP
ajlm-1224	42	9	cd4	cd4	PROPN
ajlm-1224	42	10	+	+	PROPN
ajlm-1224	42	11	t	t	PROPN
ajlm-1224	42	12	-	-	PUNCT
ajlm-1224	42	13	cells	cell	NOUN
ajlm-1224	42	14	,	,	PUNCT
ajlm-1224	42	15	cd8	cd8	PROPN
ajlm-1224	42	16	+	+	PROPN
ajlm-1224	42	17	t	t	PROPN
ajlm-1224	42	18	-	-	PUNCT
ajlm-1224	42	19	cells	cell	NOUN
ajlm-1224	42	20	and	and	CCONJ
ajlm-1224	42	21	the	the	DET
ajlm-1224	42	22	cd4	cd4	PROPN
ajlm-1224	42	23	/	/	SYM
ajlm-1224	42	24	cd8	cd8	PROPN
ajlm-1224	42	25	ratio	ratio	NOUN
ajlm-1224	42	26	.	.	PUNCT
ajlm-1224	43	1	plasma	plasma	PROPN
ajlm-1224	43	2	was	be	AUX
ajlm-1224	43	3	obtained	obtain	VERB
ajlm-1224	43	4	by	by	ADP
ajlm-1224	43	5	centrifugation	centrifugation	NOUN
ajlm-1224	43	6	of	of	ADP
ajlm-1224	43	7	whole	whole	ADJ
ajlm-1224	43	8	blood	blood	NOUN
ajlm-1224	43	9	at	at	ADP
ajlm-1224	43	10	a	a	DET
ajlm-1224	43	11	speed	speed	NOUN
ajlm-1224	43	12	of	of	ADP
ajlm-1224	43	13	5000	5000	NUM
ajlm-1224	43	14	revolutions	revolution	NOUN
ajlm-1224	43	15	per	per	ADP
ajlm-1224	43	16	minute	minute	NOUN
ajlm-1224	43	17	for	for	ADP
ajlm-1224	43	18	5	5	NUM
ajlm-1224	43	19	min	min	NOUN
ajlm-1224	43	20	and	and	CCONJ
ajlm-1224	43	21	aliquoted	aliquote	VERB
ajlm-1224	43	22	in	in	ADP
ajlm-1224	43	23	cryovials	cryovial	NOUN
ajlm-1224	43	24	.	.	PUNCT
ajlm-1224	44	1	plasma	plasma	NOUN
ajlm-1224	44	2	samples	sample	NOUN
ajlm-1224	44	3	were	be	AUX
ajlm-1224	44	4	frozen	freeze	VERB
ajlm-1224	44	5	at	at	ADP
ajlm-1224	44	6	−20	−20	PROPN
ajlm-1224	44	7	°	°	ADP
ajlm-1224	44	8	c	c	NOUN
ajlm-1224	44	9	,	,	PUNCT
ajlm-1224	44	10	for	for	ADP
ajlm-1224	44	11	the	the	DET
ajlm-1224	44	12	subsequent	subsequent	ADJ
ajlm-1224	44	13	determination	determination	NOUN
ajlm-1224	44	14	of	of	ADP
ajlm-1224	44	15	cd95	cd95	PROPN
ajlm-1224	44	16	and	and	CCONJ
ajlm-1224	44	17	cd95l	cd95l	NOUN
ajlm-1224	44	18	levels	level	NOUN
ajlm-1224	44	19	.	.	PUNCT
ajlm-1224	45	1	metavir	metavir	PROPN
ajlm-1224	45	2	scores	score	NOUN
ajlm-1224	45	3	of	of	ADP
ajlm-1224	45	4	fibrosis	fibrosis	NOUN
ajlm-1224	45	5	were	be	AUX
ajlm-1224	45	6	collected	collect	VERB
ajlm-1224	45	7	from	from	ADP
ajlm-1224	45	8	patients	patient	NOUN
ajlm-1224	45	9	’	'	PUNCT
ajlm-1224	45	10	medical	medical	ADJ
ajlm-1224	45	11	records	record	NOUN
ajlm-1224	45	12	.	.	PUNCT
ajlm-1224	46	1	determination	determination	NOUN
ajlm-1224	46	2	of	of	ADP
ajlm-1224	46	3	cd4	cd4	PROPN
ajlm-1224	46	4	+	+	PROPN
ajlm-1224	46	5	t	t	PROPN
ajlm-1224	46	6	-	-	PUNCT
ajlm-1224	46	7	cell	cell	NOUN
ajlm-1224	46	8	and	and	CCONJ
ajlm-1224	46	9	cd8	cd8	PROPN
ajlm-1224	46	10	+	+	PROPN
ajlm-1224	46	11	t	t	PROPN
ajlm-1224	46	12	-	-	PUNCT
ajlm-1224	46	13	cell	cell	NOUN
ajlm-1224	46	14	count	count	NOUN
ajlm-1224	46	15	and	and	CCONJ
ajlm-1224	46	16	the	the	DET
ajlm-1224	46	17	cd4	cd4	PROPN
ajlm-1224	46	18	/	/	SYM
ajlm-1224	46	19	cd8	cd8	PROPN
ajlm-1224	46	20	ratio	ratio	NOUN
ajlm-1224	46	21	we	we	PRON
ajlm-1224	46	22	used	use	VERB
ajlm-1224	46	23	the	the	DET
ajlm-1224	46	24	whole	whole	ADJ
ajlm-1224	46	25	blood	blood	NOUN
ajlm-1224	46	26	collected	collect	VERB
ajlm-1224	46	27	for	for	ADP
ajlm-1224	46	28	the	the	DET
ajlm-1224	46	29	determination	determination	NOUN
ajlm-1224	46	30	of	of	ADP
ajlm-1224	46	31	cd4	cd4	PROPN
ajlm-1224	46	32	+	+	PROPN
ajlm-1224	46	33	t	t	PROPN
ajlm-1224	46	34	-	-	PUNCT
ajlm-1224	46	35	cells	cell	NOUN
ajlm-1224	46	36	,	,	PUNCT
ajlm-1224	46	37	cd8	cd8	PROPN
ajlm-1224	46	38	+	+	PROPN
ajlm-1224	46	39	t	t	PROPN
ajlm-1224	46	40	-	-	PUNCT
ajlm-1224	46	41	cells	cell	NOUN
ajlm-1224	46	42	and	and	CCONJ
ajlm-1224	46	43	the	the	DET
ajlm-1224	46	44	cd4	cd4	PROPN
ajlm-1224	46	45	/	/	SYM
ajlm-1224	46	46	cd8	cd8	PROPN
ajlm-1224	46	47	ratio	ratio	NOUN
ajlm-1224	46	48	.	.	PUNCT
ajlm-1224	47	1	this	this	PRON
ajlm-1224	47	2	was	be	AUX
ajlm-1224	47	3	performed	perform	VERB
ajlm-1224	47	4	by	by	ADP
ajlm-1224	47	5	flow	flow	NOUN
ajlm-1224	47	6	cytometry	cytometry	NOUN
ajlm-1224	47	7	,	,	PUNCT
ajlm-1224	47	8	which	which	PRON
ajlm-1224	47	9	is	be	AUX
ajlm-1224	47	10	a	a	DET
ajlm-1224	47	11	technology	technology	NOUN
ajlm-1224	47	12	that	that	PRON
ajlm-1224	47	13	provides	provide	VERB
ajlm-1224	47	14	rapid	rapid	ADJ
ajlm-1224	47	15	multi	multi	ADJ
ajlm-1224	47	16	-	-	ADJ
ajlm-1224	47	17	parametric	parametric	ADJ
ajlm-1224	47	18	analysis	analysis	NOUN
ajlm-1224	47	19	of	of	ADP
ajlm-1224	47	20	single	single	ADJ
ajlm-1224	47	21	cells	cell	NOUN
ajlm-1224	47	22	in	in	ADP
ajlm-1224	47	23	solution	solution	NOUN
ajlm-1224	47	24	,	,	PUNCT
ajlm-1224	47	25	with	with	ADP
ajlm-1224	47	26	specific	specific	ADJ
ajlm-1224	47	27	fluorochrome	fluorochrome	NOUN
ajlm-1224	47	28	-	-	PUNCT
ajlm-1224	47	29	conjugated	conjugate	VERB
ajlm-1224	47	30	antibodies	antibody	NOUN
ajlm-1224	47	31	,	,	PUNCT
ajlm-1224	47	32	using	use	VERB
ajlm-1224	47	33	the	the	DET
ajlm-1224	47	34	becton	becton	PROPN
ajlm-1224	47	35	dickenson	dickenson	PROPN
ajlm-1224	47	36	fluorescent	fluorescent	VERB
ajlm-1224	47	37	activated	activate	VERB
ajlm-1224	47	38	cells	cell	NOUN
ajlm-1224	47	39	sorting	sort	VERB
ajlm-1224	47	40	system	system	NOUN
ajlm-1224	47	41	(	(	PUNCT
ajlm-1224	47	42	biosource	biosource	NOUN
ajlm-1224	47	43	,	,	PUNCT
ajlm-1224	47	44	san	san	PROPN
ajlm-1224	47	45	jose	jose	PROPN
ajlm-1224	47	46	,	,	PUNCT
ajlm-1224	47	47	california	california	PROPN
ajlm-1224	47	48	,	,	PUNCT
ajlm-1224	47	49	united	united	PROPN
ajlm-1224	47	50	states	states	PROPN
ajlm-1224	47	51	)	)	PUNCT
ajlm-1224	47	52	.	.	PUNCT
ajlm-1224	48	1	results	result	NOUN
ajlm-1224	48	2	were	be	AUX
ajlm-1224	48	3	obtained	obtain	VERB
ajlm-1224	48	4	automatically	automatically	ADV
ajlm-1224	48	5	for	for	ADP
ajlm-1224	48	6	the	the	DET
ajlm-1224	48	7	absolute	absolute	PROPN
ajlm-1224	48	8	cd4	cd4	PROPN
ajlm-1224	48	9	+	+	PROPN
ajlm-1224	48	10	t	t	PROPN
ajlm-1224	48	11	-	-	PUNCT
ajlm-1224	48	12	cells	cell	NOUN
ajlm-1224	48	13	and	and	CCONJ
ajlm-1224	48	14	cd8	cd8	PROPN
ajlm-1224	48	15	+	+	PROPN
ajlm-1224	48	16	t	t	PROPN
ajlm-1224	48	17	-	-	PUNCT
ajlm-1224	48	18	cells	cell	NOUN
ajlm-1224	48	19	count	count	NOUN
ajlm-1224	48	20	,	,	PUNCT
ajlm-1224	48	21	including	include	VERB
ajlm-1224	48	22	the	the	DET
ajlm-1224	48	23	cd4	cd4	PROPN
ajlm-1224	48	24	/	/	SYM
ajlm-1224	48	25	cd8	cd8	PROPN
ajlm-1224	48	26	ratio	ratio	NOUN
ajlm-1224	48	27	.	.	PUNCT
ajlm-1224	49	1	this	this	PRON
ajlm-1224	49	2	was	be	AUX
ajlm-1224	49	3	done	do	VERB
ajlm-1224	49	4	according	accord	VERB
ajlm-1224	49	5	to	to	ADP
ajlm-1224	49	6	the	the	DET
ajlm-1224	49	7	manufacturer	manufacturer	NOUN
ajlm-1224	49	8	’s	’s	PART
ajlm-1224	49	9	recommendations	recommendation	NOUN
ajlm-1224	49	10	.	.	PUNCT
ajlm-1224	50	1	determination	determination	NOUN
ajlm-1224	50	2	of	of	ADP
ajlm-1224	50	3	cd95	cd95	PROPN
ajlm-1224	50	4	and	and	CCONJ
ajlm-1224	50	5	cd95l	cd95l	NOUN
ajlm-1224	50	6	plasma	plasma	NOUN
ajlm-1224	50	7	level	level	NOUN
ajlm-1224	50	8	the	the	DET
ajlm-1224	50	9	determination	determination	NOUN
ajlm-1224	50	10	of	of	ADP
ajlm-1224	50	11	the	the	DET
ajlm-1224	50	12	cd95	cd95	PROPN
ajlm-1224	50	13	and	and	CCONJ
ajlm-1224	50	14	cd95l	cd95l	NOUN
ajlm-1224	50	15	plasma	plasma	NOUN
ajlm-1224	50	16	levels	level	NOUN
ajlm-1224	50	17	were	be	AUX
ajlm-1224	50	18	performed	perform	VERB
ajlm-1224	50	19	by	by	ADP
ajlm-1224	50	20	the	the	DET
ajlm-1224	50	21	sandwich	sandwich	NOUN
ajlm-1224	50	22	enzyme	enzyme	NOUN
ajlm-1224	50	23	-	-	PUNCT
ajlm-1224	50	24	linked	link	VERB
ajlm-1224	50	25	immunosorbent	immunosorbent	NOUN
ajlm-1224	50	26	assay	assay	PROPN
ajlm-1224	50	27	(	(	PUNCT
ajlm-1224	50	28	elisa	elisa	NOUN
ajlm-1224	50	29	)	)	PUNCT
ajlm-1224	50	30	technique	technique	NOUN
ajlm-1224	50	31	(	(	PUNCT
ajlm-1224	50	32	quantikine	quantikine	NOUN
ajlm-1224	50	33	®	®	NOUN
ajlm-1224	50	34	,	,	PUNCT
ajlm-1224	50	35	r&d	r&d	NOUN
ajlm-1224	50	36	systems	system	NOUN
ajlm-1224	50	37	,	,	PUNCT
ajlm-1224	50	38	abingdon	abingdon	PROPN
ajlm-1224	50	39	,	,	PUNCT
ajlm-1224	50	40	united	united	ADJ
ajlm-1224	50	41	kingdom	kingdom	PROPN
ajlm-1224	50	42	)	)	PUNCT
ajlm-1224	50	43	,	,	PUNCT
ajlm-1224	50	44	following	follow	VERB
ajlm-1224	50	45	the	the	DET
ajlm-1224	50	46	manufacturer	manufacturer	NOUN
ajlm-1224	50	47	’s	’s	PART
ajlm-1224	50	48	instruction	instruction	NOUN
ajlm-1224	50	49	.	.	PUNCT
ajlm-1224	51	1	optical	optical	ADJ
ajlm-1224	51	2	densities	density	NOUN
ajlm-1224	51	3	were	be	AUX
ajlm-1224	51	4	measured	measure	VERB
ajlm-1224	51	5	at	at	ADP
ajlm-1224	51	6	450	450	NUM
ajlm-1224	51	7	nm	nm	NOUN
ajlm-1224	51	8	using	use	VERB
ajlm-1224	51	9	an	an	DET
ajlm-1224	51	10	elisa	elisa	NOUN
ajlm-1224	51	11	reader	reader	NOUN
ajlm-1224	51	12	(	(	PUNCT
ajlm-1224	51	13	sunrise	sunrise	PROPN
ajlm-1224	51	14	tecan	tecan	NUM
ajlm-1224	51	15	,	,	PUNCT
ajlm-1224	51	16	tecan	tecan	NUM
ajlm-1224	51	17	gmbh	gmbh	NOUN
ajlm-1224	51	18	,	,	PUNCT
ajlm-1224	51	19	grödig	grödig	PROPN
ajlm-1224	51	20	/	/	SYM
ajlm-1224	51	21	salzburg	salzburg	PROPN
ajlm-1224	51	22	,	,	PUNCT
ajlm-1224	51	23	austria	austria	PROPN
ajlm-1224	51	24	)	)	PUNCT
ajlm-1224	51	25	,	,	PUNCT
ajlm-1224	51	26	and	and	CCONJ
ajlm-1224	51	27	all	all	DET
ajlm-1224	51	28	samples	sample	NOUN
ajlm-1224	51	29	were	be	AUX
ajlm-1224	51	30	assayed	assayed	ADJ
ajlm-1224	51	31	in	in	ADP
ajlm-1224	51	32	duplicate	duplicate	NOUN
ajlm-1224	51	33	.	.	PUNCT
ajlm-1224	52	1	the	the	DET
ajlm-1224	52	2	cd95	cd95	PROPN
ajlm-1224	52	3	and	and	CCONJ
ajlm-1224	52	4	cd95l	cd95l	NOUN
ajlm-1224	52	5	levels	level	NOUN
ajlm-1224	52	6	in	in	ADP
ajlm-1224	52	7	the	the	DET
ajlm-1224	52	8	samples	sample	NOUN
ajlm-1224	52	9	were	be	AUX
ajlm-1224	52	10	determined	determine	VERB
ajlm-1224	52	11	by	by	ADP
ajlm-1224	52	12	extrapolating	extrapolate	VERB
ajlm-1224	52	13	the	the	DET
ajlm-1224	52	14	results	result	NOUN
ajlm-1224	52	15	from	from	ADP
ajlm-1224	52	16	a	a	DET
ajlm-1224	52	17	standard	standard	ADJ
ajlm-1224	52	18	curve	curve	NOUN
ajlm-1224	52	19	.	.	PUNCT
ajlm-1224	53	1	statistical	statistical	ADJ
ajlm-1224	53	2	analysis	analysis	NOUN
ajlm-1224	53	3	data	datum	NOUN
ajlm-1224	53	4	from	from	ADP
ajlm-1224	53	5	this	this	DET
ajlm-1224	53	6	study	study	NOUN
ajlm-1224	53	7	were	be	AUX
ajlm-1224	53	8	recorded	record	VERB
ajlm-1224	53	9	in	in	ADP
ajlm-1224	53	10	microsoft	microsoft	PROPN
ajlm-1224	53	11	office	office	PROPN
ajlm-1224	53	12	excel	excel	VERB
ajlm-1224	53	13	2016	2016	NUM
ajlm-1224	53	14	,	,	PUNCT
ajlm-1224	53	15	and	and	CCONJ
ajlm-1224	53	16	statistical	statistical	ADJ
ajlm-1224	53	17	analysis	analysis	NOUN
ajlm-1224	53	18	was	be	AUX
ajlm-1224	53	19	performed	perform	VERB
ajlm-1224	53	20	using	use	VERB
ajlm-1224	53	21	epiinfo	epiinfo	NOUN
ajlm-1224	53	22	®	®	NOUN
ajlm-1224	53	23	7.0	7.0	NUM
ajlm-1224	53	24	(	(	PUNCT
ajlm-1224	53	25	division	division	NOUN
ajlm-1224	53	26	of	of	ADP
ajlm-1224	53	27	public	public	ADJ
ajlm-1224	53	28	health	health	NOUN
ajlm-1224	53	29	surveillance	surveillance	NOUN
ajlm-1224	53	30	and	and	CCONJ
ajlm-1224	53	31	informatics	informatics	PROPN
ajlm-1224	53	32	epidemiology	epidemiology	NOUN
ajlm-1224	53	33	program	program	NOUN
ajlm-1224	53	34	office	office	NOUN
ajlm-1224	53	35	,	,	PUNCT
ajlm-1224	53	36	ms	ms	PROPN
ajlm-1224	53	37	k74	k74	NOUN
ajlm-1224	53	38	centers	center	NOUN
ajlm-1224	53	39	for	for	ADP
ajlm-1224	53	40	disease	disease	NOUN
ajlm-1224	53	41	control	control	NOUN
ajlm-1224	53	42	and	and	CCONJ
ajlm-1224	53	43	prevention	prevention	NOUN
ajlm-1224	53	44	,	,	PUNCT
ajlm-1224	53	45	atlanta	atlanta	PROPN
ajlm-1224	53	46	,	,	PUNCT
ajlm-1224	53	47	georgia	georgia	PROPN
ajlm-1224	53	48	,	,	PUNCT
ajlm-1224	53	49	united	united	PROPN
ajlm-1224	53	50	states	states	PROPN
ajlm-1224	53	51	)	)	PUNCT
ajlm-1224	53	52	and	and	CCONJ
ajlm-1224	53	53	graph	graph	NOUN
ajlm-1224	53	54	pad	pad	NOUN
ajlm-1224	53	55	prism	prism	NOUN
ajlm-1224	53	56	5.0	5.0	NUM
ajlm-1224	53	57	(	(	PUNCT
ajlm-1224	53	58	graph	graph	NOUN
ajlm-1224	53	59	pad	pad	PROPN
ajlm-1224	53	60	software	software	PROPN
ajlm-1224	53	61	inc	inc	PROPN
ajlm-1224	53	62	.	.	PROPN
ajlm-1224	53	63	,	,	PUNCT
ajlm-1224	53	64	la	la	PROPN
ajlm-1224	53	65	jolla	jolla	PROPN
ajlm-1224	53	66	,	,	PUNCT
ajlm-1224	53	67	california	california	PROPN
ajlm-1224	53	68	,	,	PUNCT
ajlm-1224	53	69	united	united	PROPN
ajlm-1224	53	70	states	states	PROPN
ajlm-1224	53	71	)	)	PUNCT
ajlm-1224	53	72	.	.	PUNCT
ajlm-1224	54	1	comparisons	comparison	NOUN
ajlm-1224	54	2	between	between	ADP
ajlm-1224	54	3	cd4	cd4	PROPN
ajlm-1224	54	4	+	+	PROPN
ajlm-1224	54	5	t	t	PROPN
ajlm-1224	54	6	-	-	PUNCT
ajlm-1224	54	7	cells	cell	NOUN
ajlm-1224	54	8	,	,	PUNCT
ajlm-1224	54	9	cd8	cd8	PROPN
ajlm-1224	54	10	+	+	PROPN
ajlm-1224	54	11	t	t	PROPN
ajlm-1224	54	12	-	-	PUNCT
ajlm-1224	54	13	cells	cell	NOUN
ajlm-1224	54	14	,	,	PUNCT
ajlm-1224	54	15	cd4	cd4	PROPN
ajlm-1224	54	16	/	/	SYM
ajlm-1224	54	17	cd8	cd8	PROPN
ajlm-1224	54	18	ratio	ratio	NOUN
ajlm-1224	54	19	,	,	PUNCT
ajlm-1224	54	20	cd95	cd95	PROPN
ajlm-1224	54	21	and	and	CCONJ
ajlm-1224	54	22	cd95l	cd95l	NOUN
ajlm-1224	54	23	between	between	ADP
ajlm-1224	54	24	different	different	ADJ
ajlm-1224	54	25	groups	group	NOUN
ajlm-1224	54	26	were	be	AUX
ajlm-1224	54	27	performed	perform	VERB
ajlm-1224	54	28	using	use	VERB
ajlm-1224	54	29	the	the	DET
ajlm-1224	54	30	non	non	ADJ
ajlm-1224	54	31	-	-	ADJ
ajlm-1224	54	32	parametric	parametric	ADJ
ajlm-1224	54	33	test	test	NOUN
ajlm-1224	54	34	of	of	ADP
ajlm-1224	54	35	mann	mann	PROPN
ajlm-1224	54	36	-	-	PUNCT
ajlm-1224	54	37	whitney	whitney	PROPN
ajlm-1224	54	38	and	and	CCONJ
ajlm-1224	54	39	kruskal	kruskal	PROPN
ajlm-1224	54	40	-	-	PUNCT
ajlm-1224	54	41	wallis	wallis	PROPN
ajlm-1224	54	42	.	.	PUNCT
ajlm-1224	55	1	the	the	DET
ajlm-1224	55	2	correlations	correlation	NOUN
ajlm-1224	55	3	between	between	ADP
ajlm-1224	55	4	cd95	cd95	PROPN
ajlm-1224	55	5	,	,	PUNCT
ajlm-1224	55	6	cd95l	cd95l	NOUN
ajlm-1224	55	7	,	,	PUNCT
ajlm-1224	55	8	cd4	cd4	PROPN
ajlm-1224	55	9	+	+	PROPN
ajlm-1224	55	10	t	t	PROPN
ajlm-1224	55	11	-	-	PUNCT
ajlm-1224	55	12	cells	cell	NOUN
ajlm-1224	55	13	,	,	PUNCT
ajlm-1224	55	14	cd8	cd8	PROPN
ajlm-1224	55	15	+	+	PROPN
ajlm-1224	55	16	t	t	PROPN
ajlm-1224	55	17	-	-	PUNCT
ajlm-1224	55	18	cells	cell	NOUN
ajlm-1224	55	19	,	,	PUNCT
ajlm-1224	55	20	cd4	cd4	PROPN
ajlm-1224	55	21	/	/	SYM
ajlm-1224	55	22	cd8	cd8	PROPN
ajlm-1224	55	23	ratio	ratio	NOUN
ajlm-1224	55	24	and	and	CCONJ
ajlm-1224	55	25	fibrosis	fibrosis	NOUN
ajlm-1224	55	26	score	score	NOUN
ajlm-1224	55	27	were	be	AUX
ajlm-1224	55	28	established	establish	VERB
ajlm-1224	55	29	using	use	VERB
ajlm-1224	55	30	the	the	DET
ajlm-1224	55	31	spearman	spearman	NOUN
ajlm-1224	55	32	’s	’s	PART
ajlm-1224	55	33	correlation	correlation	NOUN
ajlm-1224	55	34	coefficient	coefficient	NOUN
ajlm-1224	55	35	(	(	PUNCT
ajlm-1224	55	36	r	r	NOUN
ajlm-1224	55	37	)	)	PUNCT
ajlm-1224	55	38	.	.	PUNCT
ajlm-1224	56	1	all	all	DET
ajlm-1224	56	2	values	value	NOUN
ajlm-1224	56	3	of	of	ADP
ajlm-1224	56	4	p	p	NOUN
ajlm-1224	56	5	under	under	ADP
ajlm-1224	56	6	0.05	0.05	NUM
ajlm-1224	56	7	were	be	AUX
ajlm-1224	56	8	considered	consider	VERB
ajlm-1224	56	9	statistically	statistically	ADV
ajlm-1224	56	10	significant	significant	ADJ
ajlm-1224	56	11	at	at	ADP
ajlm-1224	56	12	a	a	DET
ajlm-1224	56	13	confidence	confidence	NOUN
ajlm-1224	56	14	interval	interval	NOUN
ajlm-1224	56	15	of	of	ADP
ajlm-1224	56	16	95	95	NUM
ajlm-1224	56	17	%	%	NOUN
ajlm-1224	56	18	.	.	PUNCT
ajlm-1224	57	1	results	result	NOUN
ajlm-1224	57	2	for	for	SCONJ
ajlm-1224	57	3	190	190	NUM
ajlm-1224	57	4	patients	patient	NOUN
ajlm-1224	57	5	recruited	recruit	VERB
ajlm-1224	57	6	,	,	PUNCT
ajlm-1224	57	7	130	130	NUM
ajlm-1224	57	8	(	(	PUNCT
ajlm-1224	57	9	68.42	68.42	NUM
ajlm-1224	57	10	%	%	NOUN
ajlm-1224	57	11	)	)	PUNCT
ajlm-1224	57	12	were	be	AUX
ajlm-1224	57	13	hbv	hbv	NOUN
ajlm-1224	57	14	-	-	PUNCT
ajlm-1224	57	15	infected	infect	VERB
ajlm-1224	57	16	patients	patient	NOUN
ajlm-1224	57	17	,	,	PUNCT
ajlm-1224	57	18	and	and	CCONJ
ajlm-1224	57	19	60	60	NUM
ajlm-1224	57	20	(	(	PUNCT
ajlm-1224	57	21	31.58	31.58	NUM
ajlm-1224	57	22	%	%	NOUN
ajlm-1224	57	23	)	)	PUNCT
ajlm-1224	57	24	were	be	AUX
ajlm-1224	57	25	control	control	NOUN
ajlm-1224	57	26	participants	participant	NOUN
ajlm-1224	57	27	.	.	PUNCT
ajlm-1224	58	1	among	among	ADP
ajlm-1224	58	2	the	the	DET
ajlm-1224	58	3	control	control	NOUN
ajlm-1224	58	4	participants	participant	NOUN
ajlm-1224	58	5	,	,	PUNCT
ajlm-1224	58	6	36	36	NUM
ajlm-1224	58	7	(	(	PUNCT
ajlm-1224	58	8	60.00	60.00	NUM
ajlm-1224	58	9	%	%	NOUN
ajlm-1224	58	10	)	)	PUNCT
ajlm-1224	58	11	were	be	AUX
ajlm-1224	58	12	male	male	ADJ
ajlm-1224	58	13	and	and	CCONJ
ajlm-1224	58	14	24	24	NUM
ajlm-1224	58	15	(	(	PUNCT
ajlm-1224	58	16	40.00	40.00	NUM
ajlm-1224	58	17	%	%	NOUN
ajlm-1224	58	18	)	)	PUNCT
ajlm-1224	58	19	were	be	AUX
ajlm-1224	58	20	female	female	ADJ
ajlm-1224	58	21	,	,	PUNCT
ajlm-1224	58	22	with	with	ADP
ajlm-1224	58	23	an	an	DET
ajlm-1224	58	24	average	average	ADJ
ajlm-1224	58	25	age	age	NOUN
ajlm-1224	58	26	of	of	ADP
ajlm-1224	58	27	35	35	NUM
ajlm-1224	58	28	±	±	NUM
ajlm-1224	58	29	13	13	NUM
ajlm-1224	58	30	years	year	NOUN
ajlm-1224	58	31	.	.	PUNCT
ajlm-1224	59	1	of	of	ADP
ajlm-1224	59	2	the	the	DET
ajlm-1224	59	3	130	130	NUM
ajlm-1224	59	4	hbv	hbv	NOUN
ajlm-1224	59	5	-	-	PUNCT
ajlm-1224	59	6	infected	infect	VERB
ajlm-1224	59	7	patients	patient	NOUN
ajlm-1224	59	8	,	,	PUNCT
ajlm-1224	59	9	36	36	NUM
ajlm-1224	59	10	(	(	PUNCT
ajlm-1224	59	11	27.70	27.70	NUM
ajlm-1224	59	12	%	%	NOUN
ajlm-1224	59	13	)	)	PUNCT
ajlm-1224	59	14	were	be	AUX
ajlm-1224	59	15	cirrhotic	cirrhotic	ADJ
ajlm-1224	59	16	and	and	CCONJ
ajlm-1224	59	17	94	94	NUM
ajlm-1224	59	18	(	(	PUNCT
ajlm-1224	59	19	72.30	72.30	NUM
ajlm-1224	59	20	%	%	NOUN
ajlm-1224	59	21	)	)	PUNCT
ajlm-1224	59	22	were	be	AUX
ajlm-1224	59	23	non	non	ADJ
ajlm-1224	59	24	-	-	ADJ
ajlm-1224	59	25	cirrhotic	cirrhotic	ADJ
ajlm-1224	59	26	.	.	PUNCT
ajlm-1224	60	1	among	among	ADP
ajlm-1224	60	2	the	the	DET
ajlm-1224	60	3	cirrhotic	cirrhotic	ADJ
ajlm-1224	60	4	patients	patient	NOUN
ajlm-1224	60	5	,	,	PUNCT
ajlm-1224	60	6	23	23	NUM
ajlm-1224	60	7	(	(	PUNCT
ajlm-1224	60	8	64.00	64.00	NUM
ajlm-1224	60	9	%	%	NOUN
ajlm-1224	60	10	)	)	PUNCT
ajlm-1224	60	11	were	be	AUX
ajlm-1224	60	12	male	male	ADJ
ajlm-1224	60	13	and	and	CCONJ
ajlm-1224	60	14	13	13	NUM
ajlm-1224	60	15	(	(	PUNCT
ajlm-1224	60	16	36.00	36.00	NUM
ajlm-1224	60	17	%	%	NOUN
ajlm-1224	60	18	)	)	PUNCT
ajlm-1224	60	19	were	be	AUX
ajlm-1224	60	20	female	female	ADJ
ajlm-1224	60	21	,	,	PUNCT
ajlm-1224	60	22	with	with	ADP
ajlm-1224	60	23	an	an	DET
ajlm-1224	60	24	average	average	ADJ
ajlm-1224	60	25	age	age	NOUN
ajlm-1224	60	26	of	of	ADP
ajlm-1224	60	27	38	38	NUM
ajlm-1224	60	28	±	±	NUM
ajlm-1224	60	29	16	16	NUM
ajlm-1224	60	30	years	year	NOUN
ajlm-1224	60	31	.	.	PUNCT
ajlm-1224	61	1	among	among	ADP
ajlm-1224	61	2	non	non	ADJ
ajlm-1224	61	3	-	-	ADJ
ajlm-1224	61	4	cirrhotic	cirrhotic	ADJ
ajlm-1224	61	5	patients	patient	NOUN
ajlm-1224	61	6	,	,	PUNCT
ajlm-1224	61	7	52	52	NUM
ajlm-1224	61	8	(	(	PUNCT
ajlm-1224	61	9	55.3	55.3	NUM
ajlm-1224	61	10	%	%	NOUN
ajlm-1224	61	11	)	)	PUNCT
ajlm-1224	61	12	were	be	AUX
ajlm-1224	61	13	male	male	ADJ
ajlm-1224	61	14	and	and	CCONJ
ajlm-1224	61	15	42	42	NUM
ajlm-1224	61	16	(	(	PUNCT
ajlm-1224	61	17	44.70	44.70	NUM
ajlm-1224	61	18	%	%	NOUN
ajlm-1224	61	19	)	)	PUNCT
ajlm-1224	61	20	were	be	AUX
ajlm-1224	61	21	female	female	ADJ
ajlm-1224	61	22	,	,	PUNCT
ajlm-1224	61	23	with	with	ADP
ajlm-1224	61	24	an	an	DET
ajlm-1224	61	25	average	average	ADJ
ajlm-1224	61	26	age	age	NOUN
ajlm-1224	61	27	of	of	ADP
ajlm-1224	61	28	31.54	31.54	NUM
ajlm-1224	61	29	±	±	NUM
ajlm-1224	61	30	9	9	NUM
ajlm-1224	61	31	years	year	NOUN
ajlm-1224	61	32	(	(	PUNCT
ajlm-1224	61	33	table	table	NOUN
ajlm-1224	61	34	1	1	NUM
ajlm-1224	61	35	)	)	PUNCT
ajlm-1224	61	36	.	.	PUNCT
ajlm-1224	62	1	table	table	NOUN
ajlm-1224	62	2	1	1	NUM
ajlm-1224	62	3	:	:	PUNCT
ajlm-1224	62	4	 	 	SPACE
ajlm-1224	62	5	social	social	ADJ
ajlm-1224	62	6	and	and	CCONJ
ajlm-1224	62	7	clinical	clinical	ADJ
ajlm-1224	62	8	characteristics	characteristic	NOUN
ajlm-1224	62	9	of	of	ADP
ajlm-1224	62	10	hepatitis	hepatitis	PROPN
ajlm-1224	62	11	b	b	PROPN
ajlm-1224	62	12	virus	virus	NOUN
ajlm-1224	62	13	-	-	PUNCT
ajlm-1224	62	14	positive	positive	ADJ
ajlm-1224	62	15	patients	patient	NOUN
ajlm-1224	62	16	at	at	ADP
ajlm-1224	62	17	yaoundé	yaoundé	PROPN
ajlm-1224	62	18	general	general	ADJ
ajlm-1224	62	19	hospital	hospital	PROPN
ajlm-1224	62	20	,	,	PUNCT
ajlm-1224	62	21	cameroon	cameroon	PROPN
ajlm-1224	62	22	,	,	PUNCT
ajlm-1224	62	23	september	september	PROPN
ajlm-1224	62	24	–	–	PUNCT
ajlm-1224	62	25	december	december	PROPN
ajlm-1224	62	26	2018	2018	NUM
ajlm-1224	62	27	.	.	PUNCT
ajlm-1224	63	1	the	the	DET
ajlm-1224	63	2	level	level	NOUN
ajlm-1224	63	3	of	of	ADP
ajlm-1224	63	4	cd95	cd95	PROPN
ajlm-1224	63	5	in	in	ADP
ajlm-1224	63	6	cirrhotic	cirrhotic	ADJ
ajlm-1224	63	7	patients	patient	NOUN
ajlm-1224	63	8	ranged	range	VERB
ajlm-1224	63	9	from	from	ADP
ajlm-1224	63	10	0.6	0.6	NUM
ajlm-1224	63	11	picograms	picogram	NOUN
ajlm-1224	63	12	per	per	ADP
ajlm-1224	63	13	millilitre	millilitre	NOUN
ajlm-1224	63	14	(	(	PUNCT
ajlm-1224	63	15	pg	pg	NOUN
ajlm-1224	63	16	/	/	SYM
ajlm-1224	63	17	ml	ml	NOUN
ajlm-1224	63	18	)	)	PUNCT
ajlm-1224	63	19	to	to	ADP
ajlm-1224	63	20	6.5	6.5	NUM
ajlm-1224	63	21	pg	pg	NOUN
ajlm-1224	63	22	/	/	SYM
ajlm-1224	63	23	ml	ml	ADP
ajlm-1224	63	24	,	,	PUNCT
ajlm-1224	63	25	with	with	ADP
ajlm-1224	63	26	a	a	DET
ajlm-1224	63	27	median	median	NOUN
ajlm-1224	63	28	of	of	ADP
ajlm-1224	63	29	5.3	5.3	NUM
ajlm-1224	63	30	pg	pg	NOUN
ajlm-1224	63	31	/	/	SYM
ajlm-1224	63	32	ml	ml	ADP
ajlm-1224	63	33	.	.	PUNCT
ajlm-1224	64	1	the	the	DET
ajlm-1224	64	2	level	level	NOUN
ajlm-1224	64	3	of	of	ADP
ajlm-1224	64	4	cd95	cd95	PROPN
ajlm-1224	64	5	in	in	ADP
ajlm-1224	64	6	non	non	ADJ
ajlm-1224	64	7	-	-	ADJ
ajlm-1224	64	8	cirrhotic	cirrhotic	ADJ
ajlm-1224	64	9	patients	patient	NOUN
ajlm-1224	64	10	ranged	range	VERB
ajlm-1224	64	11	from	from	ADP
ajlm-1224	64	12	0.7	0.7	NUM
ajlm-1224	64	13	pg	pg	NOUN
ajlm-1224	64	14	/	/	SYM
ajlm-1224	64	15	ml	ml	X
ajlm-1224	64	16	to	to	ADP
ajlm-1224	64	17	6.3	6.3	NUM
ajlm-1224	64	18	pg	pg	NOUN
ajlm-1224	64	19	/	/	SYM
ajlm-1224	64	20	ml	ml	ADP
ajlm-1224	64	21	,	,	PUNCT
ajlm-1224	64	22	with	with	ADP
ajlm-1224	64	23	a	a	DET
ajlm-1224	64	24	median	median	NOUN
ajlm-1224	64	25	of	of	ADP
ajlm-1224	64	26	3.2	3.2	NUM
ajlm-1224	64	27	pg	pg	NOUN
ajlm-1224	64	28	/	/	SYM
ajlm-1224	64	29	ml	ml	NOUN
ajlm-1224	64	30	.	.	PUNCT
ajlm-1224	65	1	the	the	DET
ajlm-1224	65	2	difference	difference	NOUN
ajlm-1224	65	3	between	between	ADP
ajlm-1224	65	4	the	the	DET
ajlm-1224	65	5	cd95	cd95	PROPN
ajlm-1224	65	6	levels	level	NOUN
ajlm-1224	65	7	of	of	ADP
ajlm-1224	65	8	the	the	DET
ajlm-1224	65	9	cirrhotic	cirrhotic	ADJ
ajlm-1224	65	10	and	and	CCONJ
ajlm-1224	65	11	non	non	ADJ
ajlm-1224	65	12	-	-	ADJ
ajlm-1224	65	13	cirrhotic	cirrhotic	ADJ
ajlm-1224	65	14	patients	patient	NOUN
ajlm-1224	65	15	was	be	AUX
ajlm-1224	65	16	statistically	statistically	ADV
ajlm-1224	65	17	significant	significant	ADJ
ajlm-1224	65	18	,	,	PUNCT
ajlm-1224	65	19	with	with	ADP
ajlm-1224	65	20	a	a	DET
ajlm-1224	65	21	p	p	NOUN
ajlm-1224	65	22	-	-	PUNCT
ajlm-1224	65	23	value	value	NOUN
ajlm-1224	65	24	of	of	ADP
ajlm-1224	65	25	less	less	ADJ
ajlm-1224	65	26	than	than	ADP
ajlm-1224	65	27	0.001	0.001	NUM
ajlm-1224	65	28	(	(	PUNCT
ajlm-1224	65	29	figure	figure	NOUN
ajlm-1224	65	30	1a	1a	NOUN
ajlm-1224	65	31	)	)	PUNCT
ajlm-1224	65	32	.	.	PUNCT
ajlm-1224	66	1	the	the	DET
ajlm-1224	66	2	level	level	NOUN
ajlm-1224	66	3	of	of	ADP
ajlm-1224	66	4	cd95l	cd95l	NOUN
ajlm-1224	66	5	in	in	ADP
ajlm-1224	66	6	cirrhotic	cirrhotic	ADJ
ajlm-1224	66	7	patients	patient	NOUN
ajlm-1224	66	8	ranged	range	VERB
ajlm-1224	66	9	from	from	ADP
ajlm-1224	66	10	1.8	1.8	NUM
ajlm-1224	66	11	pg	pg	NOUN
ajlm-1224	66	12	/	/	SYM
ajlm-1224	66	13	ml	ml	NOUN
ajlm-1224	66	14	to	to	ADP
ajlm-1224	66	15	5.9	5.9	NUM
ajlm-1224	66	16	pg	pg	NOUN
ajlm-1224	66	17	/	/	SYM
ajlm-1224	66	18	ml	ml	ADP
ajlm-1224	66	19	,	,	PUNCT
ajlm-1224	66	20	with	with	ADP
ajlm-1224	66	21	a	a	DET
ajlm-1224	66	22	median	median	NOUN
ajlm-1224	66	23	of	of	ADP
ajlm-1224	66	24	4.2	4.2	NUM
ajlm-1224	66	25	pg	pg	NOUN
ajlm-1224	66	26	/	/	SYM
ajlm-1224	66	27	ml	ml	NOUN
ajlm-1224	66	28	.	.	PUNCT
ajlm-1224	67	1	the	the	DET
ajlm-1224	67	2	level	level	NOUN
ajlm-1224	67	3	of	of	ADP
ajlm-1224	67	4	cd95l	cd95l	NOUN
ajlm-1224	67	5	in	in	ADP
ajlm-1224	67	6	non	non	ADJ
ajlm-1224	67	7	-	-	ADJ
ajlm-1224	67	8	cirrhotic	cirrhotic	ADJ
ajlm-1224	67	9	patients	patient	NOUN
ajlm-1224	67	10	ranged	range	VERB
ajlm-1224	67	11	from	from	ADP
ajlm-1224	67	12	1.3	1.3	NUM
ajlm-1224	67	13	pg	pg	NOUN
ajlm-1224	67	14	/	/	SYM
ajlm-1224	67	15	ml	ml	NOUN
ajlm-1224	67	16	to	to	ADP
ajlm-1224	67	17	5.3	5.3	NUM
ajlm-1224	67	18	pg	pg	NOUN
ajlm-1224	67	19	/	/	SYM
ajlm-1224	67	20	ml	ml	ADP
ajlm-1224	67	21	,	,	PUNCT
ajlm-1224	67	22	with	with	ADP
ajlm-1224	67	23	a	a	DET
ajlm-1224	67	24	median	median	NOUN
ajlm-1224	67	25	of	of	ADP
ajlm-1224	67	26	3.6	3.6	NUM
ajlm-1224	67	27	pg	pg	NOUN
ajlm-1224	67	28	/	/	SYM
ajlm-1224	67	29	ml	ml	PROPN
ajlm-1224	67	30	.	.	PUNCT
ajlm-1224	68	1	the	the	DET
ajlm-1224	68	2	difference	difference	NOUN
ajlm-1224	68	3	between	between	ADP
ajlm-1224	68	4	the	the	DET
ajlm-1224	68	5	cd95l	cd95l	NOUN
ajlm-1224	68	6	levels	level	NOUN
ajlm-1224	68	7	of	of	ADP
ajlm-1224	68	8	the	the	DET
ajlm-1224	68	9	cirrhotic	cirrhotic	ADJ
ajlm-1224	68	10	and	and	CCONJ
ajlm-1224	68	11	non	non	ADJ
ajlm-1224	68	12	-	-	ADJ
ajlm-1224	68	13	cirrhotic	cirrhotic	ADJ
ajlm-1224	68	14	patients	patient	NOUN
ajlm-1224	68	15	was	be	AUX
ajlm-1224	68	16	statistically	statistically	ADV
ajlm-1224	68	17	significant	significant	ADJ
ajlm-1224	68	18	,	,	PUNCT
ajlm-1224	68	19	with	with	ADP
ajlm-1224	68	20	a	a	DET
ajlm-1224	68	21	p	p	NOUN
ajlm-1224	68	22	-	-	PUNCT
ajlm-1224	68	23	value	value	NOUN
ajlm-1224	68	24	of	of	ADP
ajlm-1224	68	25	0.001	0.001	NUM
ajlm-1224	68	26	(	(	PUNCT
ajlm-1224	68	27	figure	figure	NOUN
ajlm-1224	68	28	1b	1b	NUM
ajlm-1224	68	29	)	)	PUNCT
ajlm-1224	68	30	.	.	PUNCT
ajlm-1224	69	1	figure	figure	VERB
ajlm-1224	69	2	1	1	NUM
ajlm-1224	69	3	:	:	PUNCT
ajlm-1224	69	4	level	level	NOUN
ajlm-1224	69	5	of	of	ADP
ajlm-1224	69	6	cd95	cd95	PROPN
ajlm-1224	69	7	and	and	CCONJ
ajlm-1224	69	8	cd95l	cd95l	NOUN
ajlm-1224	69	9	in	in	ADP
ajlm-1224	69	10	cirrhotic	cirrhotic	ADJ
ajlm-1224	69	11	and	and	CCONJ
ajlm-1224	69	12	non	non	ADJ
ajlm-1224	69	13	-	-	ADJ
ajlm-1224	69	14	cirrhotic	cirrhotic	ADJ
ajlm-1224	69	15	hepatitis	hepatitis	PROPN
ajlm-1224	69	16	b	b	PROPN
ajlm-1224	69	17	virus	virus	NOUN
ajlm-1224	69	18	-	-	PUNCT
ajlm-1224	69	19	positive	positive	ADJ
ajlm-1224	69	20	patients	patient	NOUN
ajlm-1224	69	21	at	at	ADP
ajlm-1224	69	22	yaoundé	yaoundé	PROPN
ajlm-1224	69	23	general	general	ADJ
ajlm-1224	69	24	hospital	hospital	PROPN
ajlm-1224	69	25	,	,	PUNCT
ajlm-1224	69	26	cameroon	cameroon	PROPN
ajlm-1224	69	27	,	,	PUNCT
ajlm-1224	69	28	september	september	PROPN
ajlm-1224	69	29	–	–	PUNCT
ajlm-1224	69	30	december	december	PROPN
ajlm-1224	69	31	2018	2018	NUM
ajlm-1224	69	32	.	.	PUNCT
ajlm-1224	70	1	the	the	DET
ajlm-1224	70	2	cd4	cd4	PROPN
ajlm-1224	70	3	+	+	PROPN
ajlm-1224	70	4	t	t	PROPN
ajlm-1224	70	5	-	-	PUNCT
ajlm-1224	70	6	cell	cell	NOUN
ajlm-1224	70	7	values	value	NOUN
ajlm-1224	70	8	in	in	ADP
ajlm-1224	70	9	cirrhotic	cirrhotic	ADJ
ajlm-1224	70	10	patients	patient	NOUN
ajlm-1224	70	11	ranged	range	VERB
ajlm-1224	70	12	from	from	ADP
ajlm-1224	70	13	608	608	NUM
ajlm-1224	70	14	cells/µl	cells/µl	NOUN
ajlm-1224	70	15	to	to	ADP
ajlm-1224	70	16	1024	1024	NUM
ajlm-1224	70	17	cells/µl	cells/µl	NOUN
ajlm-1224	70	18	,	,	PUNCT
ajlm-1224	70	19	with	with	ADP
ajlm-1224	70	20	a	a	DET
ajlm-1224	70	21	median	median	NOUN
ajlm-1224	70	22	of	of	ADP
ajlm-1224	70	23	784.5	784.5	NUM
ajlm-1224	70	24	cells/µl	cells/µl	NOUN
ajlm-1224	70	25	.	.	PUNCT
ajlm-1224	71	1	the	the	DET
ajlm-1224	71	2	cd4	cd4	PROPN
ajlm-1224	71	3	+	+	PROPN
ajlm-1224	71	4	t	t	PROPN
ajlm-1224	71	5	-	-	PUNCT
ajlm-1224	71	6	cell	cell	NOUN
ajlm-1224	71	7	values	value	NOUN
ajlm-1224	71	8	in	in	ADP
ajlm-1224	71	9	non	non	ADJ
ajlm-1224	71	10	-	-	ADJ
ajlm-1224	71	11	cirrhotic	cirrhotic	ADJ
ajlm-1224	71	12	patients	patient	NOUN
ajlm-1224	71	13	ranged	range	VERB
ajlm-1224	71	14	from	from	ADP
ajlm-1224	71	15	688	688	NUM
ajlm-1224	71	16	to	to	PART
ajlm-1224	71	17	1116	1116	NUM
ajlm-1224	71	18	cells/µl	cells/µl	NOUN
ajlm-1224	71	19	,	,	PUNCT
ajlm-1224	71	20	with	with	ADP
ajlm-1224	71	21	a	a	DET
ajlm-1224	71	22	median	median	NOUN
ajlm-1224	71	23	of	of	ADP
ajlm-1224	71	24	901.3	901.3	NUM
ajlm-1224	71	25	cells/µl	cells/µl	NOUN
ajlm-1224	71	26	.	.	PUNCT
ajlm-1224	72	1	the	the	DET
ajlm-1224	72	2	difference	difference	NOUN
ajlm-1224	72	3	between	between	ADP
ajlm-1224	72	4	the	the	DET
ajlm-1224	72	5	cd4	cd4	PROPN
ajlm-1224	72	6	+	+	PROPN
ajlm-1224	72	7	t	t	PROPN
ajlm-1224	72	8	-	-	PUNCT
ajlm-1224	72	9	cell	cell	NOUN
ajlm-1224	72	10	values	value	NOUN
ajlm-1224	72	11	of	of	ADP
ajlm-1224	72	12	the	the	DET
ajlm-1224	72	13	cirrhotic	cirrhotic	ADJ
ajlm-1224	72	14	and	and	CCONJ
ajlm-1224	72	15	non	non	ADJ
ajlm-1224	72	16	-	-	ADJ
ajlm-1224	72	17	cirrhotic	cirrhotic	ADJ
ajlm-1224	72	18	patients	patient	NOUN
ajlm-1224	72	19	was	be	AUX
ajlm-1224	72	20	statistically	statistically	ADV
ajlm-1224	72	21	significant	significant	ADJ
ajlm-1224	72	22	,	,	PUNCT
ajlm-1224	72	23	with	with	ADP
ajlm-1224	72	24	a	a	DET
ajlm-1224	72	25	p	p	NOUN
ajlm-1224	72	26	-	-	PUNCT
ajlm-1224	72	27	value	value	NOUN
ajlm-1224	72	28	of	of	ADP
ajlm-1224	72	29	0.003	0.003	NUM
ajlm-1224	72	30	(	(	PUNCT
ajlm-1224	72	31	figure	figure	NOUN
ajlm-1224	72	32	2a	2a	NUM
ajlm-1224	72	33	)	)	PUNCT
ajlm-1224	72	34	.	.	PUNCT
ajlm-1224	73	1	figure	figure	VERB
ajlm-1224	73	2	2	2	NUM
ajlm-1224	73	3	:	:	PUNCT
ajlm-1224	73	4	value	value	NOUN
ajlm-1224	73	5	of	of	ADP
ajlm-1224	73	6	cd4	cd4	PROPN
ajlm-1224	73	7	+	+	PROPN
ajlm-1224	73	8	t	t	PROPN
ajlm-1224	73	9	-	-	PUNCT
ajlm-1224	73	10	cells	cell	NOUN
ajlm-1224	73	11	,	,	PUNCT
ajlm-1224	73	12	cd8	cd8	PROPN
ajlm-1224	73	13	+	+	PROPN
ajlm-1224	73	14	t	t	PROPN
ajlm-1224	73	15	-	-	PUNCT
ajlm-1224	73	16	cells	cell	NOUN
ajlm-1224	73	17	and	and	CCONJ
ajlm-1224	73	18	the	the	DET
ajlm-1224	73	19	cd4	cd4	PROPN
ajlm-1224	73	20	/	/	SYM
ajlm-1224	73	21	cd8	cd8	PROPN
ajlm-1224	73	22	ratio	ratio	NOUN
ajlm-1224	73	23	in	in	ADP
ajlm-1224	73	24	cirrhotic	cirrhotic	ADJ
ajlm-1224	73	25	and	and	CCONJ
ajlm-1224	73	26	non	non	ADJ
ajlm-1224	73	27	-	-	ADJ
ajlm-1224	73	28	cirrhotic	cirrhotic	ADJ
ajlm-1224	73	29	hepatitis	hepatitis	PROPN
ajlm-1224	73	30	b	b	PROPN
ajlm-1224	73	31	virus	virus	NOUN
ajlm-1224	73	32	-	-	PUNCT
ajlm-1224	73	33	positive	positive	ADJ
ajlm-1224	73	34	patients	patient	NOUN
ajlm-1224	73	35	at	at	ADP
ajlm-1224	73	36	yaoundé	yaoundé	PROPN
ajlm-1224	73	37	general	general	ADJ
ajlm-1224	73	38	hospital	hospital	PROPN
ajlm-1224	73	39	,	,	PUNCT
ajlm-1224	73	40	cameroon	cameroon	PROPN
ajlm-1224	73	41	,	,	PUNCT
ajlm-1224	73	42	september	september	PROPN
ajlm-1224	73	43	–	–	PUNCT
ajlm-1224	73	44	december	december	PROPN
ajlm-1224	73	45	2018	2018	NUM
ajlm-1224	73	46	.	.	PUNCT
ajlm-1224	74	1	the	the	DET
ajlm-1224	74	2	cd8	cd8	PROPN
ajlm-1224	74	3	+	+	PROPN
ajlm-1224	74	4	t	t	PROPN
ajlm-1224	74	5	-	-	PUNCT
ajlm-1224	74	6	cell	cell	NOUN
ajlm-1224	74	7	values	value	NOUN
ajlm-1224	74	8	in	in	ADP
ajlm-1224	74	9	cirrhotic	cirrhotic	ADJ
ajlm-1224	74	10	patients	patient	NOUN
ajlm-1224	74	11	ranged	range	VERB
ajlm-1224	74	12	from	from	ADP
ajlm-1224	74	13	508	508	NUM
ajlm-1224	74	14	cells/µl	cells/µl	NOUN
ajlm-1224	74	15	to	to	ADP
ajlm-1224	74	16	1003	1003	NUM
ajlm-1224	74	17	cells/µl	cells/µl	NOUN
ajlm-1224	74	18	,	,	PUNCT
ajlm-1224	74	19	with	with	ADP
ajlm-1224	74	20	a	a	DET
ajlm-1224	74	21	median	median	NOUN
ajlm-1224	74	22	of	of	ADP
ajlm-1224	74	23	774.5	774.5	NUM
ajlm-1224	74	24	cells/µl	cells/µl	NOUN
ajlm-1224	74	25	.	.	PUNCT
ajlm-1224	75	1	the	the	DET
ajlm-1224	75	2	cd8	cd8	PROPN
ajlm-1224	75	3	+	+	PROPN
ajlm-1224	75	4	t	t	PROPN
ajlm-1224	75	5	-	-	PUNCT
ajlm-1224	75	6	cell	cell	NOUN
ajlm-1224	75	7	values	value	NOUN
ajlm-1224	75	8	in	in	ADP
ajlm-1224	75	9	non	non	ADJ
ajlm-1224	75	10	-	-	ADJ
ajlm-1224	75	11	cirrhotic	cirrhotic	ADJ
ajlm-1224	75	12	patients	patient	NOUN
ajlm-1224	75	13	ranged	range	VERB
ajlm-1224	75	14	from	from	ADP
ajlm-1224	75	15	585	585	NUM
ajlm-1224	75	16	cells/µl	cells/µl	NOUN
ajlm-1224	75	17	to	to	ADP
ajlm-1224	75	18	1013	1013	NUM
ajlm-1224	75	19	cells/µl	cells/µl	NOUN
ajlm-1224	75	20	,	,	PUNCT
ajlm-1224	75	21	with	with	ADP
ajlm-1224	75	22	a	a	DET
ajlm-1224	75	23	median	median	NOUN
ajlm-1224	75	24	of	of	ADP
ajlm-1224	75	25	786	786	NUM
ajlm-1224	75	26	cells/µl	cells/µl	NOUN
ajlm-1224	75	27	.	.	PUNCT
ajlm-1224	76	1	the	the	DET
ajlm-1224	76	2	difference	difference	NOUN
ajlm-1224	76	3	between	between	ADP
ajlm-1224	76	4	the	the	DET
ajlm-1224	76	5	cd8	cd8	PROPN
ajlm-1224	76	6	+	+	PROPN
ajlm-1224	76	7	t	t	PROPN
ajlm-1224	76	8	-	-	PUNCT
ajlm-1224	76	9	cell	cell	NOUN
ajlm-1224	76	10	values	value	NOUN
ajlm-1224	76	11	of	of	ADP
ajlm-1224	76	12	the	the	DET
ajlm-1224	76	13	cirrhotic	cirrhotic	ADJ
ajlm-1224	76	14	and	and	CCONJ
ajlm-1224	76	15	non	non	ADJ
ajlm-1224	76	16	-	-	ADJ
ajlm-1224	76	17	cirrhotic	cirrhotic	ADJ
ajlm-1224	76	18	patients	patient	NOUN
ajlm-1224	76	19	was	be	AUX
ajlm-1224	76	20	not	not	PART
ajlm-1224	76	21	statistically	statistically	ADV
ajlm-1224	76	22	significant	significant	ADJ
ajlm-1224	76	23	,	,	PUNCT
ajlm-1224	76	24	with	with	ADP
ajlm-1224	76	25	a	a	DET
ajlm-1224	76	26	p	p	NOUN
ajlm-1224	76	27	-	-	PUNCT
ajlm-1224	76	28	value	value	NOUN
ajlm-1224	76	29	of	of	ADP
ajlm-1224	76	30	0.417	0.417	NUM
ajlm-1224	76	31	(	(	PUNCT
ajlm-1224	76	32	figure	figure	NOUN
ajlm-1224	76	33	2b	2b	NOUN
ajlm-1224	76	34	)	)	PUNCT
ajlm-1224	76	35	.	.	PUNCT
ajlm-1224	77	1	the	the	DET
ajlm-1224	77	2	cd4	cd4	PROPN
ajlm-1224	77	3	/	/	SYM
ajlm-1224	77	4	cd8	cd8	PROPN
ajlm-1224	77	5	ratio	ratio	NOUN
ajlm-1224	77	6	in	in	ADP
ajlm-1224	77	7	cirrhotic	cirrhotic	ADJ
ajlm-1224	77	8	patients	patient	NOUN
ajlm-1224	77	9	ranged	range	VERB
ajlm-1224	77	10	from	from	ADP
ajlm-1224	77	11	1.0	1.0	NUM
ajlm-1224	77	12	to	to	ADP
ajlm-1224	77	13	1.2	1.2	NUM
ajlm-1224	77	14	,	,	PUNCT
ajlm-1224	77	15	with	with	ADP
ajlm-1224	77	16	a	a	DET
ajlm-1224	77	17	median	median	NOUN
ajlm-1224	77	18	of	of	ADP
ajlm-1224	77	19	1.0	1.0	NUM
ajlm-1224	77	20	.	.	PUNCT
ajlm-1224	78	1	the	the	DET
ajlm-1224	78	2	cd4	cd4	PROPN
ajlm-1224	78	3	/	/	SYM
ajlm-1224	78	4	cd8	cd8	PROPN
ajlm-1224	78	5	ratio	ratio	NOUN
ajlm-1224	78	6	in	in	ADP
ajlm-1224	78	7	non	non	ADJ
ajlm-1224	78	8	-	-	ADJ
ajlm-1224	78	9	cirrhotic	cirrhotic	ADJ
ajlm-1224	78	10	patients	patient	NOUN
ajlm-1224	78	11	ranged	range	VERB
ajlm-1224	78	12	from	from	ADP
ajlm-1224	78	13	1.0	1.0	NUM
ajlm-1224	78	14	to	to	PART
ajlm-1224	78	15	1.4	1.4	NUM
ajlm-1224	78	16	with	with	ADP
ajlm-1224	78	17	a	a	DET
ajlm-1224	78	18	median	median	NOUN
ajlm-1224	78	19	of	of	ADP
ajlm-1224	78	20	1.2	1.2	NUM
ajlm-1224	78	21	.	.	PUNCT
ajlm-1224	79	1	the	the	DET
ajlm-1224	79	2	difference	difference	NOUN
ajlm-1224	79	3	between	between	ADP
ajlm-1224	79	4	the	the	DET
ajlm-1224	79	5	cd4	cd4	PROPN
ajlm-1224	79	6	/	/	SYM
ajlm-1224	79	7	cd8	cd8	PROPN
ajlm-1224	79	8	ratios	ratio	NOUN
ajlm-1224	79	9	of	of	ADP
ajlm-1224	79	10	the	the	DET
ajlm-1224	79	11	cirrhotic	cirrhotic	ADJ
ajlm-1224	79	12	and	and	CCONJ
ajlm-1224	79	13	non	non	ADJ
ajlm-1224	79	14	-	-	ADJ
ajlm-1224	79	15	cirrhotic	cirrhotic	ADJ
ajlm-1224	79	16	patients	patient	NOUN
ajlm-1224	79	17	was	be	AUX
ajlm-1224	79	18	statistically	statistically	ADV
ajlm-1224	79	19	significant	significant	ADJ
ajlm-1224	79	20	,	,	PUNCT
ajlm-1224	79	21	with	with	ADP
ajlm-1224	79	22	a	a	DET
ajlm-1224	79	23	p	p	NOUN
ajlm-1224	79	24	-	-	PUNCT
ajlm-1224	79	25	value	value	NOUN
ajlm-1224	79	26	of	of	ADP
ajlm-1224	79	27	less	less	ADJ
ajlm-1224	79	28	than	than	ADP
ajlm-1224	79	29	0.001	0.001	NUM
ajlm-1224	79	30	(	(	PUNCT
ajlm-1224	79	31	figure	figure	NOUN
ajlm-1224	79	32	2c	2c	NUM
ajlm-1224	79	33	)	)	PUNCT
ajlm-1224	79	34	.	.	PUNCT
ajlm-1224	80	1	within	within	ADP
ajlm-1224	80	2	the	the	DET
ajlm-1224	80	3	group	group	NOUN
ajlm-1224	80	4	of	of	ADP
ajlm-1224	80	5	non	non	ADJ
ajlm-1224	80	6	-	-	ADJ
ajlm-1224	80	7	cirrhotic	cirrhotic	ADJ
ajlm-1224	80	8	and	and	CCONJ
ajlm-1224	80	9	cirrhotic	cirrhotic	ADJ
ajlm-1224	80	10	patients	patient	NOUN
ajlm-1224	80	11	infected	infect	VERB
ajlm-1224	80	12	with	with	ADP
ajlm-1224	80	13	hbv	hbv	NOUN
ajlm-1224	80	14	,	,	PUNCT
ajlm-1224	80	15	there	there	PRON
ajlm-1224	80	16	was	be	VERB
ajlm-1224	80	17	a	a	DET
ajlm-1224	80	18	statistically	statistically	ADV
ajlm-1224	80	19	significant	significant	ADJ
ajlm-1224	80	20	direct	direct	ADJ
ajlm-1224	80	21	correlation	correlation	NOUN
ajlm-1224	80	22	between	between	ADP
ajlm-1224	80	23	cd95	cd95	PROPN
ajlm-1224	80	24	and	and	CCONJ
ajlm-1224	80	25	cd4	cd4	PROPN
ajlm-1224	80	26	+	+	PROPN
ajlm-1224	80	27	t	t	PROPN
ajlm-1224	80	28	-	-	PUNCT
ajlm-1224	80	29	cells	cell	NOUN
ajlm-1224	80	30	(	(	PUNCT
ajlm-1224	80	31	r	r	NOUN
ajlm-1224	80	32	=	=	NOUN
ajlm-1224	80	33	0.042	0.042	NUM
ajlm-1224	80	34	,	,	PUNCT
ajlm-1224	80	35	p	p	NOUN
ajlm-1224	80	36	=	=	NOUN
ajlm-1224	80	37	0.016	0.016	NUM
ajlm-1224	80	38	)	)	PUNCT
ajlm-1224	80	39	,	,	PUNCT
ajlm-1224	80	40	and	and	CCONJ
ajlm-1224	80	41	between	between	ADP
ajlm-1224	80	42	cd95	cd95	PROPN
ajlm-1224	80	43	and	and	CCONJ
ajlm-1224	80	44	the	the	DET
ajlm-1224	80	45	cd4	cd4	PROPN
ajlm-1224	80	46	/	/	SYM
ajlm-1224	80	47	cd8	cd8	PROPN
ajlm-1224	80	48	ratio	ratio	NOUN
ajlm-1224	80	49	(	(	PUNCT
ajlm-1224	80	50	r	r	NOUN
ajlm-1224	80	51	=	=	SYM
ajlm-1224	80	52	0.123	0.123	NUM
ajlm-1224	80	53	,	,	PUNCT
ajlm-1224	80	54	p	p	X
ajlm-1224	80	55	=	=	NOUN
ajlm-1224	80	56	0.01	0.01	NUM
ajlm-1224	80	57	)	)	PUNCT
ajlm-1224	80	58	.	.	PUNCT
ajlm-1224	81	1	within	within	ADP
ajlm-1224	81	2	the	the	DET
ajlm-1224	81	3	group	group	NOUN
ajlm-1224	81	4	of	of	ADP
ajlm-1224	81	5	cirrhotic	cirrhotic	ADJ
ajlm-1224	81	6	patients	patient	NOUN
ajlm-1224	81	7	infected	infect	VERB
ajlm-1224	81	8	with	with	ADP
ajlm-1224	81	9	hbv	hbv	NOUN
ajlm-1224	81	10	,	,	PUNCT
ajlm-1224	81	11	there	there	PRON
ajlm-1224	81	12	was	be	VERB
ajlm-1224	81	13	a	a	DET
ajlm-1224	81	14	statistically	statistically	ADV
ajlm-1224	81	15	significant	significant	ADJ
ajlm-1224	81	16	direct	direct	ADJ
ajlm-1224	81	17	correlation	correlation	NOUN
ajlm-1224	81	18	between	between	ADP
ajlm-1224	81	19	cd95	cd95	PROPN
ajlm-1224	81	20	and	and	CCONJ
ajlm-1224	81	21	fibrosis	fibrosis	NOUN
ajlm-1224	81	22	score	score	NOUN
ajlm-1224	81	23	(	(	PUNCT
ajlm-1224	81	24	r	r	NOUN
ajlm-1224	81	25	=	=	SYM
ajlm-1224	81	26	0.021	0.021	NUM
ajlm-1224	81	27	,	,	PUNCT
ajlm-1224	81	28	p	p	X
ajlm-1224	81	29	=	=	NOUN
ajlm-1224	81	30	0.003	0.003	NUM
ajlm-1224	81	31	)	)	PUNCT
ajlm-1224	81	32	.	.	PUNCT
ajlm-1224	82	1	in	in	ADP
ajlm-1224	82	2	this	this	DET
ajlm-1224	82	3	same	same	ADJ
ajlm-1224	82	4	group	group	NOUN
ajlm-1224	82	5	,	,	PUNCT
ajlm-1224	82	6	there	there	PRON
ajlm-1224	82	7	was	be	VERB
ajlm-1224	82	8	a	a	DET
ajlm-1224	82	9	statistically	statistically	ADV
ajlm-1224	82	10	significant	significant	ADJ
ajlm-1224	82	11	inverse	inverse	NOUN
ajlm-1224	82	12	correlation	correlation	NOUN
ajlm-1224	82	13	between	between	ADP
ajlm-1224	82	14	cd95	cd95	PROPN
ajlm-1224	82	15	and	and	CCONJ
ajlm-1224	82	16	cd8	cd8	PROPN
ajlm-1224	82	17	+	+	PROPN
ajlm-1224	82	18	t	t	PROPN
ajlm-1224	82	19	-	-	PUNCT
ajlm-1224	82	20	cells	cell	NOUN
ajlm-1224	82	21	(	(	PUNCT
ajlm-1224	82	22	r	r	NOUN
ajlm-1224	82	23	=	=	SYM
ajlm-1224	82	24	−0.029	−0.029	NOUN
ajlm-1224	82	25	,	,	PUNCT
ajlm-1224	82	26	p	p	X
ajlm-1224	82	27	=	=	NOUN
ajlm-1224	82	28	0.016	0.016	NUM
ajlm-1224	82	29	)	)	PUNCT
ajlm-1224	82	30	(	(	PUNCT
ajlm-1224	82	31	table	table	NOUN
ajlm-1224	82	32	2	2	NUM
ajlm-1224	82	33	)	)	PUNCT
ajlm-1224	82	34	.	.	PUNCT
ajlm-1224	83	1	we	we	PRON
ajlm-1224	83	2	also	also	ADV
ajlm-1224	83	3	found	find	VERB
ajlm-1224	83	4	,	,	PUNCT
ajlm-1224	83	5	within	within	ADP
ajlm-1224	83	6	this	this	DET
ajlm-1224	83	7	same	same	ADJ
ajlm-1224	83	8	group	group	NOUN
ajlm-1224	83	9	,	,	PUNCT
ajlm-1224	83	10	a	a	DET
ajlm-1224	83	11	statistically	statistically	ADV
ajlm-1224	83	12	significant	significant	ADJ
ajlm-1224	83	13	direct	direct	ADJ
ajlm-1224	83	14	correlation	correlation	NOUN
ajlm-1224	83	15	between	between	ADP
ajlm-1224	83	16	cd95l	cd95l	NOUN
ajlm-1224	83	17	and	and	CCONJ
ajlm-1224	83	18	the	the	DET
ajlm-1224	83	19	fibrosis	fibrosis	NOUN
ajlm-1224	83	20	score	score	NOUN
ajlm-1224	83	21	(	(	PUNCT
ajlm-1224	83	22	r	r	NOUN
ajlm-1224	83	23	=	=	SYM
ajlm-1224	83	24	0.099	0.099	NUM
ajlm-1224	83	25	,	,	PUNCT
ajlm-1224	83	26	p	p	X
ajlm-1224	83	27	=	=	NOUN
ajlm-1224	83	28	0.003	0.003	NUM
ajlm-1224	83	29	)	)	PUNCT
ajlm-1224	83	30	.	.	PUNCT
ajlm-1224	84	1	there	there	PRON
ajlm-1224	84	2	were	be	VERB
ajlm-1224	84	3	statistically	statistically	ADV
ajlm-1224	84	4	significant	significant	ADJ
ajlm-1224	84	5	inverse	inverse	NOUN
ajlm-1224	84	6	correlations	correlation	NOUN
ajlm-1224	84	7	between	between	ADP
ajlm-1224	84	8	the	the	DET
ajlm-1224	84	9	fibrosis	fibrosis	NOUN
ajlm-1224	84	10	score	score	NOUN
ajlm-1224	84	11	and	and	CCONJ
ajlm-1224	84	12	the	the	DET
ajlm-1224	84	13	cd4	cd4	PROPN
ajlm-1224	84	14	+	+	PROPN
ajlm-1224	84	15	t	t	PROPN
ajlm-1224	84	16	-	-	PUNCT
ajlm-1224	84	17	cells	cell	NOUN
ajlm-1224	84	18	(	(	PUNCT
ajlm-1224	84	19	r	r	NOUN
ajlm-1224	84	20	=	=	SYM
ajlm-1224	84	21	−0.280	−0.280	NOUN
ajlm-1224	84	22	,	,	PUNCT
ajlm-1224	84	23	p	p	X
ajlm-1224	84	24	<	<	X
ajlm-1224	84	25	0.001	0.001	NUM
ajlm-1224	84	26	)	)	PUNCT
ajlm-1224	84	27	,	,	PUNCT
ajlm-1224	84	28	and	and	CCONJ
ajlm-1224	84	29	between	between	ADP
ajlm-1224	84	30	the	the	DET
ajlm-1224	84	31	fibrosis	fibrosis	NOUN
ajlm-1224	84	32	score	score	NOUN
ajlm-1224	84	33	and	and	CCONJ
ajlm-1224	84	34	cd4	cd4	PROPN
ajlm-1224	84	35	/	/	SYM
ajlm-1224	84	36	cd8	cd8	PROPN
ajlm-1224	84	37	ratio	ratio	NOUN
ajlm-1224	84	38	(	(	PUNCT
ajlm-1224	84	39	r	r	NOUN
ajlm-1224	84	40	=	=	SYM
ajlm-1224	84	41	−0.455	−0.455	NUM
ajlm-1224	84	42	,	,	PUNCT
ajlm-1224	84	43	p	p	X
ajlm-1224	84	44	<	<	X
ajlm-1224	84	45	0.001	0.001	NUM
ajlm-1224	84	46	)	)	PUNCT
ajlm-1224	84	47	within	within	ADP
ajlm-1224	84	48	the	the	DET
ajlm-1224	84	49	group	group	NOUN
ajlm-1224	84	50	of	of	ADP
ajlm-1224	84	51	cirrhotic	cirrhotic	ADJ
ajlm-1224	84	52	patients	patient	NOUN
ajlm-1224	84	53	infected	infect	VERB
ajlm-1224	84	54	with	with	ADP
ajlm-1224	84	55	hbv	hbv	NOUN
ajlm-1224	84	56	(	(	PUNCT
ajlm-1224	84	57	table	table	NOUN
ajlm-1224	84	58	2	2	NUM
ajlm-1224	84	59	)	)	PUNCT
ajlm-1224	84	60	.	.	PUNCT
ajlm-1224	85	1	table	table	NOUN
ajlm-1224	85	2	2	2	NUM
ajlm-1224	85	3	:	:	PUNCT
ajlm-1224	85	4	 	 	SPACE
ajlm-1224	85	5	correlation	correlation	NOUN
ajlm-1224	85	6	between	between	ADP
ajlm-1224	85	7	cd95	cd95	PROPN
ajlm-1224	85	8	,	,	PUNCT
ajlm-1224	85	9	cd95l	cd95l	NOUN
ajlm-1224	85	10	,	,	PUNCT
ajlm-1224	85	11	fibrosis	fibrosis	NOUN
ajlm-1224	85	12	score	score	NOUN
ajlm-1224	85	13	,	,	PUNCT
ajlm-1224	85	14	cd4	cd4	PROPN
ajlm-1224	85	15	+	+	PROPN
ajlm-1224	85	16	t	t	PROPN
ajlm-1224	85	17	-	-	PUNCT
ajlm-1224	85	18	cells	cell	NOUN
ajlm-1224	85	19	,	,	PUNCT
ajlm-1224	85	20	cd8	cd8	PROPN
ajlm-1224	85	21	+	+	PROPN
ajlm-1224	85	22	t	t	PROPN
ajlm-1224	85	23	-	-	PUNCT
ajlm-1224	85	24	cells	cell	NOUN
ajlm-1224	85	25	and	and	CCONJ
ajlm-1224	85	26	cd4	cd4	PROPN
ajlm-1224	85	27	/	/	SYM
ajlm-1224	85	28	cd8	cd8	PROPN
ajlm-1224	85	29	ratio	ratio	NOUN
ajlm-1224	85	30	of	of	ADP
ajlm-1224	85	31	hepatitis	hepatitis	PROPN
ajlm-1224	85	32	b	b	PROPN
ajlm-1224	85	33	virus	virus	NOUN
ajlm-1224	85	34	-	-	PUNCT
ajlm-1224	85	35	positive	positive	ADJ
ajlm-1224	85	36	patients	patient	NOUN
ajlm-1224	85	37	at	at	ADP
ajlm-1224	85	38	yaoundé	yaoundé	PROPN
ajlm-1224	85	39	general	general	ADJ
ajlm-1224	85	40	hospital	hospital	PROPN
ajlm-1224	85	41	,	,	PUNCT
ajlm-1224	85	42	cameroon	cameroon	PROPN
ajlm-1224	85	43	,	,	PUNCT
ajlm-1224	85	44	september	september	PROPN
ajlm-1224	85	45	–	–	PUNCT
ajlm-1224	85	46	december	december	PROPN
ajlm-1224	85	47	2018	2018	NUM
ajlm-1224	85	48	.	.	PUNCT
ajlm-1224	86	1	discussion	discussion	NOUN
ajlm-1224	86	2	we	we	PRON
ajlm-1224	86	3	sought	seek	VERB
ajlm-1224	86	4	to	to	PART
ajlm-1224	86	5	assess	assess	VERB
ajlm-1224	86	6	the	the	DET
ajlm-1224	86	7	implications	implication	NOUN
ajlm-1224	86	8	of	of	ADP
ajlm-1224	86	9	cd95	cd95	PROPN
ajlm-1224	86	10	-	-	PUNCT
ajlm-1224	86	11	cd95l	cd95l	NOUN
ajlm-1224	86	12	receptor	receptor	NOUN
ajlm-1224	86	13	-	-	PUNCT
ajlm-1224	86	14	ligands	ligand	NOUN
ajlm-1224	86	15	in	in	ADP
ajlm-1224	86	16	t	t	NOUN
ajlm-1224	86	17	-	-	PUNCT
ajlm-1224	86	18	cell	cell	NOUN
ajlm-1224	86	19	depletion	depletion	NOUN
ajlm-1224	86	20	and	and	CCONJ
ajlm-1224	86	21	hepatic	hepatic	NOUN
ajlm-1224	86	22	cytolysis	cytolysis	NOUN
ajlm-1224	86	23	,	,	PUNCT
ajlm-1224	86	24	in	in	ADP
ajlm-1224	86	25	patients	patient	NOUN
ajlm-1224	86	26	with	with	ADP
ajlm-1224	86	27	chronic	chronic	ADJ
ajlm-1224	86	28	hbv	hbv	NOUN
ajlm-1224	86	29	.	.	PUNCT
ajlm-1224	87	1	we	we	PRON
ajlm-1224	87	2	found	find	VERB
ajlm-1224	87	3	that	that	SCONJ
ajlm-1224	87	4	the	the	DET
ajlm-1224	87	5	plasma	plasma	NOUN
ajlm-1224	87	6	levels	level	NOUN
ajlm-1224	87	7	of	of	ADP
ajlm-1224	87	8	cd95	cd95	PROPN
ajlm-1224	87	9	and	and	CCONJ
ajlm-1224	87	10	cd95l	cd95l	NOUN
ajlm-1224	87	11	were	be	AUX
ajlm-1224	87	12	significantly	significantly	ADV
ajlm-1224	87	13	elevated	elevate	VERB
ajlm-1224	87	14	in	in	ADP
ajlm-1224	87	15	cirrhotic	cirrhotic	ADJ
ajlm-1224	87	16	patients	patient	NOUN
ajlm-1224	87	17	,	,	PUNCT
ajlm-1224	87	18	compared	compare	VERB
ajlm-1224	87	19	to	to	ADP
ajlm-1224	87	20	non	non	ADJ
ajlm-1224	87	21	-	-	ADJ
ajlm-1224	87	22	cirrhotic	cirrhotic	ADJ
ajlm-1224	87	23	patients	patient	NOUN
ajlm-1224	87	24	.	.	PUNCT
ajlm-1224	88	1	the	the	DET
ajlm-1224	88	2	cd4	cd4	PROPN
ajlm-1224	88	3	/	/	SYM
ajlm-1224	88	4	cd8	cd8	PROPN
ajlm-1224	88	5	ratios	ratio	NOUN
ajlm-1224	88	6	were	be	AUX
ajlm-1224	88	7	lower	low	ADJ
ajlm-1224	88	8	in	in	ADP
ajlm-1224	88	9	cirrhotic	cirrhotic	ADJ
ajlm-1224	88	10	patients	patient	NOUN
ajlm-1224	88	11	,	,	PUNCT
ajlm-1224	88	12	compared	compare	VERB
ajlm-1224	88	13	to	to	ADP
ajlm-1224	88	14	non	non	ADJ
ajlm-1224	88	15	-	-	ADJ
ajlm-1224	88	16	cirrhotic	cirrhotic	ADJ
ajlm-1224	88	17	patients	patient	NOUN
ajlm-1224	88	18	.	.	PUNCT
ajlm-1224	89	1	there	there	PRON
ajlm-1224	89	2	were	be	VERB
ajlm-1224	89	3	statistically	statistically	ADV
ajlm-1224	89	4	significant	significant	ADJ
ajlm-1224	89	5	correlations	correlation	NOUN
ajlm-1224	89	6	between	between	ADP
ajlm-1224	89	7	the	the	DET
ajlm-1224	89	8	cd95	cd95	PROPN
ajlm-1224	89	9	level	level	NOUN
ajlm-1224	89	10	and	and	CCONJ
ajlm-1224	89	11	cd4	cd4	PROPN
ajlm-1224	89	12	+	+	PROPN
ajlm-1224	89	13	t	t	PROPN
ajlm-1224	89	14	-	-	PUNCT
ajlm-1224	89	15	cell	cell	NOUN
ajlm-1224	89	16	count	count	NOUN
ajlm-1224	89	17	,	,	PUNCT
ajlm-1224	89	18	between	between	ADP
ajlm-1224	89	19	the	the	DET
ajlm-1224	89	20	cd95	cd95	PROPN
ajlm-1224	89	21	level	level	NOUN
ajlm-1224	89	22	and	and	CCONJ
ajlm-1224	89	23	the	the	DET
ajlm-1224	89	24	cd8	cd8	PROPN
ajlm-1224	89	25	+	+	PROPN
ajlm-1224	89	26	t	t	PROPN
ajlm-1224	89	27	-	-	PUNCT
ajlm-1224	89	28	cell	cell	NOUN
ajlm-1224	89	29	count	count	NOUN
ajlm-1224	89	30	,	,	PUNCT
ajlm-1224	89	31	between	between	ADP
ajlm-1224	89	32	the	the	DET
ajlm-1224	89	33	cd95	cd95	PROPN
ajlm-1224	89	34	level	level	NOUN
ajlm-1224	89	35	and	and	CCONJ
ajlm-1224	89	36	cd4	cd4	PROPN
ajlm-1224	89	37	/	/	SYM
ajlm-1224	89	38	cd8	cd8	PROPN
ajlm-1224	89	39	ratio	ratio	NOUN
ajlm-1224	89	40	,	,	PUNCT
ajlm-1224	89	41	between	between	ADP
ajlm-1224	89	42	the	the	DET
ajlm-1224	89	43	cd95	cd95	PROPN
ajlm-1224	89	44	level	level	NOUN
ajlm-1224	89	45	and	and	CCONJ
ajlm-1224	89	46	fibrosis	fibrosis	NOUN
ajlm-1224	89	47	score	score	NOUN
ajlm-1224	89	48	,	,	PUNCT
ajlm-1224	89	49	and	and	CCONJ
ajlm-1224	89	50	between	between	ADP
ajlm-1224	89	51	the	the	DET
ajlm-1224	89	52	cd95l	cd95l	NOUN
ajlm-1224	89	53	level	level	NOUN
ajlm-1224	89	54	and	and	CCONJ
ajlm-1224	89	55	fibrosis	fibrosis	NOUN
ajlm-1224	89	56	score	score	NOUN
ajlm-1224	89	57	.	.	PUNCT
ajlm-1224	90	1	the	the	DET
ajlm-1224	90	2	concentrations	concentration	NOUN
ajlm-1224	90	3	of	of	ADP
ajlm-1224	90	4	cd95	cd95	PROPN
ajlm-1224	90	5	and	and	CCONJ
ajlm-1224	90	6	cd95l	cd95l	NOUN
ajlm-1224	90	7	were	be	AUX
ajlm-1224	90	8	higher	high	ADJ
ajlm-1224	90	9	in	in	ADP
ajlm-1224	90	10	cirrhotic	cirrhotic	ADJ
ajlm-1224	90	11	patients	patient	NOUN
ajlm-1224	90	12	than	than	ADP
ajlm-1224	90	13	in	in	ADP
ajlm-1224	90	14	non	non	ADJ
ajlm-1224	90	15	-	-	ADJ
ajlm-1224	90	16	cirrhotic	cirrhotic	ADJ
ajlm-1224	90	17	patients	patient	NOUN
ajlm-1224	90	18	,	,	PUNCT
ajlm-1224	90	19	with	with	ADP
ajlm-1224	90	20	a	a	DET
ajlm-1224	90	21	statistically	statistically	ADV
ajlm-1224	90	22	significant	significant	ADJ
ajlm-1224	90	23	difference	difference	NOUN
ajlm-1224	90	24	between	between	ADP
ajlm-1224	90	25	the	the	DET
ajlm-1224	90	26	two	two	NUM
ajlm-1224	90	27	groups	group	NOUN
ajlm-1224	90	28	.	.	PUNCT
ajlm-1224	91	1	these	these	DET
ajlm-1224	91	2	results	result	NOUN
ajlm-1224	91	3	corroborate	corroborate	VERB
ajlm-1224	91	4	those	those	PRON
ajlm-1224	91	5	of	of	ADP
ajlm-1224	91	6	peter	peter	PROPN
ajlm-1224	91	7	et	et	PROPN
ajlm-1224	91	8	al	al	PROPN
ajlm-1224	91	9	.	.	PROPN
ajlm-1224	91	10	:	:	PUNCT
ajlm-1224	92	1	they	they	PRON
ajlm-1224	92	2	observed	observe	VERB
ajlm-1224	92	3	low	low	ADJ
ajlm-1224	92	4	constitutive	constitutive	ADJ
ajlm-1224	92	5	expression	expression	NOUN
ajlm-1224	92	6	of	of	ADP
ajlm-1224	92	7	cd95	cd95	PROPN
ajlm-1224	92	8	in	in	ADP
ajlm-1224	92	9	non	non	ADJ
ajlm-1224	92	10	-	-	ADJ
ajlm-1224	92	11	cirrhotic	cirrhotic	ADJ
ajlm-1224	92	12	patients	patient	NOUN
ajlm-1224	92	13	with	with	ADP
ajlm-1224	92	14	chronic	chronic	ADJ
ajlm-1224	92	15	hbv	hbv	NOUN
ajlm-1224	92	16	,	,	PUNCT
ajlm-1224	92	17	compared	compare	VERB
ajlm-1224	92	18	to	to	ADP
ajlm-1224	92	19	patients	patient	NOUN
ajlm-1224	92	20	with	with	ADP
ajlm-1224	92	21	cirrhosis	cirrhosis	NOUN
ajlm-1224	92	22	related	relate	VERB
ajlm-1224	92	23	to	to	ADP
ajlm-1224	92	24	hbv.8	hbv.8	PROPN
ajlm-1224	92	25	the	the	DET
ajlm-1224	92	26	results	result	NOUN
ajlm-1224	92	27	obtained	obtain	VERB
ajlm-1224	92	28	in	in	ADP
ajlm-1224	92	29	this	this	DET
ajlm-1224	92	30	study	study	NOUN
ajlm-1224	92	31	agree	agree	VERB
ajlm-1224	92	32	with	with	ADP
ajlm-1224	92	33	literature	literature	NOUN
ajlm-1224	92	34	that	that	SCONJ
ajlm-1224	92	35	cd95	cd95	PROPN
ajlm-1224	92	36	is	be	AUX
ajlm-1224	92	37	overexpressed	overexpresse	VERB
ajlm-1224	92	38	during	during	ADP
ajlm-1224	92	39	hbv	hbv	NOUN
ajlm-1224	92	40	infection.9	infection.9	ADP
ajlm-1224	92	41	the	the	DET
ajlm-1224	92	42	expression	expression	NOUN
ajlm-1224	92	43	of	of	ADP
ajlm-1224	92	44	cd95	cd95	PROPN
ajlm-1224	92	45	increases	increase	VERB
ajlm-1224	92	46	in	in	ADP
ajlm-1224	92	47	response	response	NOUN
ajlm-1224	92	48	to	to	ADP
ajlm-1224	92	49	a	a	DET
ajlm-1224	92	50	primary	primary	ADJ
ajlm-1224	92	51	stimulus	stimulus	NOUN
ajlm-1224	92	52	and	and	CCONJ
ajlm-1224	92	53	this	this	PRON
ajlm-1224	92	54	makes	make	VERB
ajlm-1224	92	55	hepatocytes	hepatocyte	NOUN
ajlm-1224	92	56	more	more	ADV
ajlm-1224	92	57	susceptible	susceptible	ADJ
ajlm-1224	92	58	to	to	ADP
ajlm-1224	92	59	stimulation	stimulation	NOUN
ajlm-1224	92	60	by	by	ADP
ajlm-1224	92	61	cd95l	cd95l	NOUN
ajlm-1224	92	62	.	.	PUNCT
ajlm-1224	93	1	this	this	DET
ajlm-1224	93	2	hypothesis	hypothesis	NOUN
ajlm-1224	93	3	is	be	AUX
ajlm-1224	93	4	supported	support	VERB
ajlm-1224	93	5	by	by	ADP
ajlm-1224	93	6	the	the	DET
ajlm-1224	93	7	observation	observation	NOUN
ajlm-1224	93	8	that	that	SCONJ
ajlm-1224	93	9	induction	induction	NOUN
ajlm-1224	93	10	of	of	ADP
ajlm-1224	93	11	cd95	cd95	PROPN
ajlm-1224	93	12	expression	expression	NOUN
ajlm-1224	93	13	occurs	occur	VERB
ajlm-1224	93	14	following	follow	VERB
ajlm-1224	93	15	chronic	chronic	ADJ
ajlm-1224	93	16	lymphatic	lymphatic	ADJ
ajlm-1224	93	17	histiocytic	histiocytic	ADJ
ajlm-1224	93	18	inflammation	inflammation	NOUN
ajlm-1224	93	19	in	in	ADP
ajlm-1224	93	20	different	different	ADJ
ajlm-1224	93	21	epithelial	epithelial	ADJ
ajlm-1224	93	22	cells.6	cells.6	NOUN
ajlm-1224	93	23	these	these	DET
ajlm-1224	93	24	results	result	NOUN
ajlm-1224	93	25	suggest	suggest	VERB
ajlm-1224	93	26	that	that	SCONJ
ajlm-1224	93	27	liver	liver	NOUN
ajlm-1224	93	28	damage	damage	NOUN
ajlm-1224	93	29	in	in	ADP
ajlm-1224	93	30	hbv	hbv	NOUN
ajlm-1224	93	31	-	-	PUNCT
ajlm-1224	93	32	infected	infect	VERB
ajlm-1224	93	33	patients	patient	NOUN
ajlm-1224	93	34	may	may	AUX
ajlm-1224	93	35	primarily	primarily	ADV
ajlm-1224	93	36	involve	involve	VERB
ajlm-1224	93	37	the	the	DET
ajlm-1224	93	38	destruction	destruction	NOUN
ajlm-1224	93	39	of	of	ADP
ajlm-1224	93	40	hepatocytes	hepatocyte	NOUN
ajlm-1224	93	41	by	by	ADP
ajlm-1224	93	42	t	t	PROPN
ajlm-1224	93	43	-	-	PUNCT
ajlm-1224	93	44	cells	cell	NOUN
ajlm-1224	93	45	using	use	VERB
ajlm-1224	93	46	the	the	DET
ajlm-1224	93	47	cd95	cd95	PROPN
ajlm-1224	93	48	-	-	PUNCT
ajlm-1224	93	49	cd95l	cd95l	NOUN
ajlm-1224	93	50	receptor	receptor	NOUN
ajlm-1224	93	51	-	-	PUNCT
ajlm-1224	93	52	ligand	ligand	NOUN
ajlm-1224	93	53	system	system	NOUN
ajlm-1224	93	54	.	.	PUNCT
ajlm-1224	94	1	immune	immune	ADJ
ajlm-1224	94	2	system	system	NOUN
ajlm-1224	94	3	abnormalities	abnormality	NOUN
ajlm-1224	94	4	are	be	AUX
ajlm-1224	94	5	associated	associate	VERB
ajlm-1224	94	6	with	with	ADP
ajlm-1224	94	7	t	t	NOUN
ajlm-1224	94	8	-	-	PUNCT
ajlm-1224	94	9	cell	cell	NOUN
ajlm-1224	94	10	depletion.10	depletion.10	NOUN
ajlm-1224	94	11	we	we	PRON
ajlm-1224	94	12	found	find	VERB
ajlm-1224	94	13	statistically	statistically	ADV
ajlm-1224	94	14	significant	significant	ADJ
ajlm-1224	94	15	differences	difference	NOUN
ajlm-1224	94	16	in	in	ADP
ajlm-1224	94	17	cd4	cd4	PROPN
ajlm-1224	94	18	+	+	PROPN
ajlm-1224	94	19	t	t	PROPN
ajlm-1224	94	20	-	-	PUNCT
ajlm-1224	94	21	cell	cell	NOUN
ajlm-1224	94	22	values	value	NOUN
ajlm-1224	94	23	between	between	ADP
ajlm-1224	94	24	cirrhotic	cirrhotic	ADJ
ajlm-1224	94	25	and	and	CCONJ
ajlm-1224	94	26	non	non	ADJ
ajlm-1224	94	27	-	-	ADJ
ajlm-1224	94	28	cirrhotic	cirrhotic	ADJ
ajlm-1224	94	29	patients	patient	NOUN
ajlm-1224	94	30	.	.	PUNCT
ajlm-1224	95	1	mean	mean	VERB
ajlm-1224	95	2	values	value	NOUN
ajlm-1224	95	3	of	of	ADP
ajlm-1224	95	4	cd4	cd4	PROPN
ajlm-1224	95	5	+	+	PROPN
ajlm-1224	95	6	t	t	PROPN
ajlm-1224	95	7	-	-	PUNCT
ajlm-1224	95	8	cells	cell	NOUN
ajlm-1224	95	9	in	in	ADP
ajlm-1224	95	10	cirrhotic	cirrhotic	ADJ
ajlm-1224	95	11	patients	patient	NOUN
ajlm-1224	95	12	were	be	AUX
ajlm-1224	95	13	lower	low	ADJ
ajlm-1224	95	14	than	than	ADP
ajlm-1224	95	15	those	those	PRON
ajlm-1224	95	16	observed	observe	VERB
ajlm-1224	95	17	in	in	ADP
ajlm-1224	95	18	non	non	ADJ
ajlm-1224	95	19	-	-	ADJ
ajlm-1224	95	20	cirrhotic	cirrhotic	ADJ
ajlm-1224	95	21	patients	patient	NOUN
ajlm-1224	95	22	.	.	PUNCT
ajlm-1224	96	1	also	also	ADV
ajlm-1224	96	2	,	,	PUNCT
ajlm-1224	96	3	the	the	DET
ajlm-1224	96	4	mean	mean	ADJ
ajlm-1224	96	5	values	value	NOUN
ajlm-1224	96	6	of	of	ADP
ajlm-1224	96	7	cd8	cd8	PROPN
ajlm-1224	96	8	+	+	PROPN
ajlm-1224	96	9	t	t	PROPN
ajlm-1224	96	10	-	-	PUNCT
ajlm-1224	96	11	cells	cell	NOUN
ajlm-1224	96	12	in	in	ADP
ajlm-1224	96	13	cirrhotic	cirrhotic	ADJ
ajlm-1224	96	14	patients	patient	NOUN
ajlm-1224	96	15	were	be	AUX
ajlm-1224	96	16	higher	high	ADJ
ajlm-1224	96	17	than	than	ADP
ajlm-1224	96	18	in	in	ADP
ajlm-1224	96	19	non	non	ADJ
ajlm-1224	96	20	-	-	ADJ
ajlm-1224	96	21	cirrhotic	cirrhotic	ADJ
ajlm-1224	96	22	patients	patient	NOUN
ajlm-1224	96	23	.	.	PUNCT
ajlm-1224	97	1	these	these	DET
ajlm-1224	97	2	abnormalities	abnormality	NOUN
ajlm-1224	97	3	can	can	AUX
ajlm-1224	97	4	be	be	AUX
ajlm-1224	97	5	caused	cause	VERB
ajlm-1224	97	6	by	by	ADP
ajlm-1224	97	7	abnormal	abnormal	ADJ
ajlm-1224	97	8	regulation	regulation	NOUN
ajlm-1224	97	9	of	of	ADP
ajlm-1224	97	10	the	the	DET
ajlm-1224	97	11	activation	activation	NOUN
ajlm-1224	97	12	gene	gene	NOUN
ajlm-1224	97	13	for	for	ADP
ajlm-1224	97	14	the	the	DET
ajlm-1224	97	15	antigen	antigen	NOUN
ajlm-1224	97	16	4	4	NUM
ajlm-1224	97	17	of	of	ADP
ajlm-1224	97	18	cytotoxic	cytotoxic	ADJ
ajlm-1224	97	19	t	t	PROPN
ajlm-1224	97	20	-	-	PUNCT
ajlm-1224	97	21	cells	cell	NOUN
ajlm-1224	97	22	,	,	PUNCT
ajlm-1224	97	23	the	the	DET
ajlm-1224	97	24	lymphocytes	lymphocyte	NOUN
ajlm-1224	97	25	3	3	NUM
ajlm-1224	97	26	,	,	PUNCT
ajlm-1224	97	27	the	the	DET
ajlm-1224	97	28	immunoglobulin	immunoglobulin	NOUN
ajlm-1224	97	29	t	t	PROPN
ajlm-1224	97	30	domain	domain	NOUN
ajlm-1224	97	31	and	and	CCONJ
ajlm-1224	97	32	the	the	DET
ajlm-1224	97	33	mucin	mucin	NOUN
ajlm-1224	97	34	3	3	NUM
ajlm-1224	97	35	domain	domain	NOUN
ajlm-1224	97	36	,	,	PUNCT
ajlm-1224	97	37	the	the	DET
ajlm-1224	97	38	cell	cell	NOUN
ajlm-1224	97	39	death	death	NOUN
ajlm-1224	97	40	receptor	receptor	NOUN
ajlm-1224	97	41	1	1	NUM
ajlm-1224	97	42	,	,	PUNCT
ajlm-1224	97	43	the	the	DET
ajlm-1224	97	44	cd244/2b4	cd244/2b4	PROPN
ajlm-1224	97	45	,	,	PUNCT
ajlm-1224	97	46	the	the	DET
ajlm-1224	97	47	cd160	cd160	NOUN
ajlm-1224	97	48	and	and	CCONJ
ajlm-1224	97	49	by	by	ADP
ajlm-1224	97	50	the	the	DET
ajlm-1224	97	51	t	t	PROPN
ajlm-1224	97	52	-	-	PUNCT
ajlm-1224	97	53	cells	cell	NOUN
ajlm-1224	97	54	immunoreceptor	immunoreceptor	NOUN
ajlm-1224	97	55	with	with	ADP
ajlm-1224	97	56	immunoglobulin	immunoglobulin	NOUN
ajlm-1224	97	57	and	and	CCONJ
ajlm-1224	97	58	immunoreceptor	immunoreceptor	NOUN
ajlm-1224	97	59	tyrosine	tyrosine	NOUN
ajlm-1224	97	60	-	-	PUNCT
ajlm-1224	97	61	based	base	VERB
ajlm-1224	97	62	inhibition	inhibition	NOUN
ajlm-1224	97	63	motif	motif	NOUN
ajlm-1224	97	64	domains.11,12	domains.11,12	VERB
ajlm-1224	97	65	the	the	DET
ajlm-1224	97	66	average	average	ADJ
ajlm-1224	97	67	cd4	cd4	PROPN
ajlm-1224	97	68	/	/	SYM
ajlm-1224	97	69	cd8	cd8	PROPN
ajlm-1224	97	70	ratio	ratio	NOUN
ajlm-1224	97	71	in	in	ADP
ajlm-1224	97	72	cirrhotic	cirrhotic	ADJ
ajlm-1224	97	73	patients	patient	NOUN
ajlm-1224	97	74	was	be	AUX
ajlm-1224	97	75	similar	similar	ADJ
ajlm-1224	97	76	to	to	ADP
ajlm-1224	97	77	that	that	PRON
ajlm-1224	97	78	found	find	VERB
ajlm-1224	97	79	in	in	ADP
ajlm-1224	97	80	2016	2016	NUM
ajlm-1224	97	81	by	by	ADP
ajlm-1224	97	82	yang	yang	PROPN
ajlm-1224	97	83	et	et	PROPN
ajlm-1224	97	84	al.13	al.13	PROPN
ajlm-1224	97	85	the	the	DET
ajlm-1224	97	86	cd4	cd4	PROPN
ajlm-1224	97	87	/	/	SYM
ajlm-1224	97	88	cd8	cd8	PROPN
ajlm-1224	97	89	mean	mean	PROPN
ajlm-1224	97	90	ratio	ratio	NOUN
ajlm-1224	97	91	,	,	PUNCT
ajlm-1224	97	92	however	however	ADV
ajlm-1224	97	93	,	,	PUNCT
ajlm-1224	97	94	was	be	AUX
ajlm-1224	97	95	lower	low	ADJ
ajlm-1224	97	96	than	than	ADP
ajlm-1224	97	97	that	that	PRON
ajlm-1224	97	98	found	find	VERB
ajlm-1224	97	99	in	in	ADP
ajlm-1224	97	100	non	non	ADJ
ajlm-1224	97	101	-	-	ADJ
ajlm-1224	97	102	cirrhotic	cirrhotic	ADJ
ajlm-1224	97	103	patients	patient	NOUN
ajlm-1224	97	104	.	.	PUNCT
ajlm-1224	98	1	this	this	PRON
ajlm-1224	98	2	could	could	AUX
ajlm-1224	98	3	reflect	reflect	VERB
ajlm-1224	98	4	a	a	DET
ajlm-1224	98	5	possible	possible	ADJ
ajlm-1224	98	6	increased	increase	VERB
ajlm-1224	98	7	immune	immune	ADJ
ajlm-1224	98	8	depletion	depletion	NOUN
ajlm-1224	98	9	in	in	ADP
ajlm-1224	98	10	cirrhotic	cirrhotic	ADJ
ajlm-1224	98	11	patients	patient	NOUN
ajlm-1224	98	12	,	,	PUNCT
ajlm-1224	98	13	compared	compare	VERB
ajlm-1224	98	14	to	to	ADP
ajlm-1224	98	15	non	non	ADJ
ajlm-1224	98	16	-	-	ADJ
ajlm-1224	98	17	cirrhotic	cirrhotic	ADJ
ajlm-1224	98	18	patients	patient	NOUN
ajlm-1224	98	19	.	.	PUNCT
ajlm-1224	99	1	we	we	PRON
ajlm-1224	99	2	highlighted	highlight	VERB
ajlm-1224	99	3	the	the	DET
ajlm-1224	99	4	existence	existence	NOUN
ajlm-1224	99	5	of	of	ADP
ajlm-1224	99	6	a	a	DET
ajlm-1224	99	7	statistically	statistically	ADV
ajlm-1224	99	8	significant	significant	ADJ
ajlm-1224	99	9	direct	direct	ADJ
ajlm-1224	99	10	correlation	correlation	NOUN
ajlm-1224	99	11	between	between	ADP
ajlm-1224	99	12	cd95	cd95	PROPN
ajlm-1224	99	13	and	and	CCONJ
ajlm-1224	99	14	cd4	cd4	PROPN
ajlm-1224	99	15	+	+	PROPN
ajlm-1224	99	16	t	t	PROPN
ajlm-1224	99	17	-	-	PUNCT
ajlm-1224	99	18	cells	cell	NOUN
ajlm-1224	99	19	in	in	ADP
ajlm-1224	99	20	hbv	hbv	NOUN
ajlm-1224	99	21	-	-	PUNCT
ajlm-1224	99	22	infected	infect	VERB
ajlm-1224	99	23	patients	patient	NOUN
ajlm-1224	99	24	,	,	PUNCT
ajlm-1224	99	25	cirrhotic	cirrhotic	ADJ
ajlm-1224	99	26	and	and	CCONJ
ajlm-1224	99	27	non	non	ADJ
ajlm-1224	99	28	-	-	ADJ
ajlm-1224	99	29	cirrhotic	cirrhotic	ADJ
ajlm-1224	99	30	.	.	PUNCT
ajlm-1224	100	1	at	at	ADP
ajlm-1224	100	2	the	the	DET
ajlm-1224	100	3	same	same	ADJ
ajlm-1224	100	4	time	time	NOUN
ajlm-1224	100	5	,	,	PUNCT
ajlm-1224	100	6	there	there	PRON
ajlm-1224	100	7	was	be	VERB
ajlm-1224	100	8	a	a	DET
ajlm-1224	100	9	statistically	statistically	ADV
ajlm-1224	100	10	significant	significant	ADJ
ajlm-1224	100	11	,	,	PUNCT
ajlm-1224	100	12	but	but	CCONJ
ajlm-1224	100	13	inverse	inverse	NOUN
ajlm-1224	100	14	,	,	PUNCT
ajlm-1224	100	15	correlation	correlation	NOUN
ajlm-1224	100	16	between	between	ADP
ajlm-1224	100	17	cd95	cd95	PROPN
ajlm-1224	100	18	and	and	CCONJ
ajlm-1224	100	19	cd8	cd8	PROPN
ajlm-1224	100	20	.	.	PUNCT
ajlm-1224	101	1	these	these	DET
ajlm-1224	101	2	results	result	NOUN
ajlm-1224	101	3	could	could	AUX
ajlm-1224	101	4	be	be	AUX
ajlm-1224	101	5	explained	explain	VERB
ajlm-1224	101	6	by	by	ADP
ajlm-1224	101	7	the	the	DET
ajlm-1224	101	8	fact	fact	NOUN
ajlm-1224	101	9	that	that	SCONJ
ajlm-1224	101	10	the	the	DET
ajlm-1224	101	11	increase	increase	NOUN
ajlm-1224	101	12	in	in	ADP
ajlm-1224	101	13	activated	activate	VERB
ajlm-1224	101	14	cd8	cd8	PROPN
ajlm-1224	101	15	t	t	PROPN
ajlm-1224	101	16	-	-	PUNCT
ajlm-1224	101	17	cells	cell	NOUN
ajlm-1224	101	18	is	be	AUX
ajlm-1224	101	19	followed	follow	VERB
ajlm-1224	101	20	by	by	ADP
ajlm-1224	101	21	their	their	PRON
ajlm-1224	101	22	differentiation	differentiation	NOUN
ajlm-1224	101	23	into	into	ADP
ajlm-1224	101	24	cytotoxic	cytotoxic	ADJ
ajlm-1224	101	25	t	t	PROPN
ajlm-1224	101	26	-	-	PUNCT
ajlm-1224	101	27	cells	cell	NOUN
ajlm-1224	101	28	.	.	PUNCT
ajlm-1224	102	1	cytotoxic	cytotoxic	ADJ
ajlm-1224	102	2	t	t	PROPN
ajlm-1224	102	3	-	-	PUNCT
ajlm-1224	102	4	cells	cell	NOUN
ajlm-1224	102	5	are	be	AUX
ajlm-1224	102	6	effector	effector	NOUN
ajlm-1224	102	7	lymphocytes	lymphocyte	NOUN
ajlm-1224	102	8	that	that	PRON
ajlm-1224	102	9	cause	cause	VERB
ajlm-1224	102	10	the	the	DET
ajlm-1224	102	11	destruction	destruction	NOUN
ajlm-1224	102	12	of	of	ADP
ajlm-1224	102	13	neighbouring	neighbouring	NOUN
ajlm-1224	102	14	cells	cell	NOUN
ajlm-1224	102	15	having	have	VERB
ajlm-1224	102	16	cd98	cd98	PROPN
ajlm-1224	102	17	receptors	receptor	NOUN
ajlm-1224	102	18	on	on	ADP
ajlm-1224	102	19	their	their	PRON
ajlm-1224	102	20	surfaces	surface	NOUN
ajlm-1224	102	21	,	,	PUNCT
ajlm-1224	102	22	thus	thus	ADV
ajlm-1224	102	23	causing	cause	VERB
ajlm-1224	102	24	a	a	DET
ajlm-1224	102	25	decrease	decrease	NOUN
ajlm-1224	102	26	in	in	ADP
ajlm-1224	102	27	the	the	DET
ajlm-1224	102	28	cd98	cd98	PROPN
ajlm-1224	102	29	receptor	receptor	NOUN
ajlm-1224	102	30	.	.	PUNCT
ajlm-1224	103	1	the	the	DET
ajlm-1224	103	2	statistically	statistically	ADV
ajlm-1224	103	3	significant	significant	ADJ
ajlm-1224	103	4	direct	direct	ADJ
ajlm-1224	103	5	correlation	correlation	NOUN
ajlm-1224	103	6	between	between	ADP
ajlm-1224	103	7	cd95	cd95	PROPN
ajlm-1224	103	8	and	and	CCONJ
ajlm-1224	103	9	the	the	DET
ajlm-1224	103	10	cd4	cd4	PROPN
ajlm-1224	103	11	/	/	SYM
ajlm-1224	103	12	cd8	cd8	PROPN
ajlm-1224	103	13	ratio	ratio	NOUN
ajlm-1224	103	14	observed	observe	VERB
ajlm-1224	103	15	in	in	ADP
ajlm-1224	103	16	cirrhotic	cirrhotic	ADJ
ajlm-1224	103	17	hbv	hbv	NOUN
ajlm-1224	103	18	-	-	PUNCT
ajlm-1224	103	19	infected	infect	VERB
ajlm-1224	103	20	individuals	individual	NOUN
ajlm-1224	103	21	could	could	AUX
ajlm-1224	103	22	be	be	AUX
ajlm-1224	103	23	due	due	ADJ
ajlm-1224	103	24	to	to	ADP
ajlm-1224	103	25	the	the	DET
ajlm-1224	103	26	influence	influence	NOUN
ajlm-1224	103	27	of	of	ADP
ajlm-1224	103	28	the	the	DET
ajlm-1224	103	29	number	number	NOUN
ajlm-1224	103	30	of	of	ADP
ajlm-1224	103	31	activated	activate	VERB
ajlm-1224	103	32	cd4	cd4	PROPN
ajlm-1224	103	33	+	+	PROPN
ajlm-1224	103	34	t	t	PROPN
ajlm-1224	103	35	-	-	PUNCT
ajlm-1224	103	36	cells	cell	NOUN
ajlm-1224	103	37	carrying	carry	VERB
ajlm-1224	103	38	cd95	cd95	PROPN
ajlm-1224	103	39	receptors	receptor	NOUN
ajlm-1224	103	40	,	,	PUNCT
ajlm-1224	103	41	in	in	ADP
ajlm-1224	103	42	the	the	DET
ajlm-1224	103	43	cd4	cd4	PROPN
ajlm-1224	103	44	/	/	SYM
ajlm-1224	103	45	cd8	cd8	PROPN
ajlm-1224	103	46	ratios	ratio	NOUN
ajlm-1224	103	47	.	.	PUNCT
ajlm-1224	104	1	the	the	DET
ajlm-1224	104	2	increase	increase	NOUN
ajlm-1224	104	3	in	in	ADP
ajlm-1224	104	4	the	the	DET
ajlm-1224	104	5	number	number	NOUN
ajlm-1224	104	6	of	of	ADP
ajlm-1224	104	7	activated	activate	VERB
ajlm-1224	104	8	cd4	cd4	PROPN
ajlm-1224	104	9	+	+	PROPN
ajlm-1224	104	10	t	t	PROPN
ajlm-1224	104	11	-	-	PUNCT
ajlm-1224	104	12	cells	cell	NOUN
ajlm-1224	104	13	directly	directly	ADV
ajlm-1224	104	14	involves	involve	VERB
ajlm-1224	104	15	an	an	DET
ajlm-1224	104	16	increase	increase	NOUN
ajlm-1224	104	17	in	in	ADP
ajlm-1224	104	18	the	the	DET
ajlm-1224	104	19	production	production	NOUN
ajlm-1224	104	20	of	of	ADP
ajlm-1224	104	21	cd95	cd95	PROPN
ajlm-1224	104	22	receptors	receptor	NOUN
ajlm-1224	104	23	,	,	PUNCT
ajlm-1224	104	24	which	which	PRON
ajlm-1224	104	25	in	in	ADP
ajlm-1224	104	26	turn	turn	NOUN
ajlm-1224	104	27	increases	increase	VERB
ajlm-1224	104	28	the	the	DET
ajlm-1224	104	29	plasma	plasma	NOUN
ajlm-1224	104	30	concentration	concentration	NOUN
ajlm-1224	104	31	of	of	ADP
ajlm-1224	104	32	cd95	cd95	PROPN
ajlm-1224	104	33	receptors	receptor	NOUN
ajlm-1224	104	34	.	.	PUNCT
ajlm-1224	105	1	although	although	SCONJ
ajlm-1224	105	2	the	the	DET
ajlm-1224	105	3	correlation	correlation	NOUN
ajlm-1224	105	4	observed	observe	VERB
ajlm-1224	105	5	between	between	ADP
ajlm-1224	105	6	cd95l	cd95l	NOUN
ajlm-1224	105	7	and	and	CCONJ
ajlm-1224	105	8	cd4	cd4	PROPN
ajlm-1224	105	9	+	+	PROPN
ajlm-1224	105	10	t	t	PROPN
ajlm-1224	105	11	-	-	PUNCT
ajlm-1224	105	12	cells	cell	NOUN
ajlm-1224	105	13	and	and	CCONJ
ajlm-1224	105	14	between	between	ADP
ajlm-1224	105	15	cd8	cd8	PROPN
ajlm-1224	105	16	+	+	PROPN
ajlm-1224	105	17	t	t	PROPN
ajlm-1224	105	18	-	-	PUNCT
ajlm-1224	105	19	cells	cell	NOUN
ajlm-1224	105	20	and	and	CCONJ
ajlm-1224	105	21	the	the	DET
ajlm-1224	105	22	cd4	cd4	PROPN
ajlm-1224	105	23	/	/	SYM
ajlm-1224	105	24	cd8	cd8	PROPN
ajlm-1224	105	25	ratio	ratio	NOUN
ajlm-1224	105	26	was	be	AUX
ajlm-1224	105	27	not	not	PART
ajlm-1224	105	28	statistically	statistically	ADV
ajlm-1224	105	29	significant	significant	ADJ
ajlm-1224	105	30	,	,	PUNCT
ajlm-1224	105	31	both	both	PRON
ajlm-1224	105	32	had	have	VERB
ajlm-1224	105	33	inverse	inverse	ADJ
ajlm-1224	105	34	relationships	relationship	NOUN
ajlm-1224	105	35	in	in	ADP
ajlm-1224	105	36	cirrhotic	cirrhotic	ADJ
ajlm-1224	105	37	hbv	hbv	NOUN
ajlm-1224	105	38	-	-	PUNCT
ajlm-1224	105	39	infected	infect	VERB
ajlm-1224	105	40	individuals	individual	NOUN
ajlm-1224	105	41	.	.	PUNCT
ajlm-1224	106	1	the	the	DET
ajlm-1224	106	2	cd95l	cd95l	NOUN
ajlm-1224	106	3	level	level	NOUN
ajlm-1224	106	4	evolved	evolve	VERB
ajlm-1224	106	5	in	in	ADP
ajlm-1224	106	6	the	the	DET
ajlm-1224	106	7	opposite	opposite	ADJ
ajlm-1224	106	8	direction	direction	NOUN
ajlm-1224	106	9	to	to	ADP
ajlm-1224	106	10	the	the	DET
ajlm-1224	106	11	cd4	cd4	PROPN
ajlm-1224	106	12	+	+	PROPN
ajlm-1224	106	13	t	t	PROPN
ajlm-1224	106	14	-	-	PUNCT
ajlm-1224	106	15	cells	cell	NOUN
ajlm-1224	106	16	,	,	PUNCT
ajlm-1224	106	17	cd8	cd8	PROPN
ajlm-1224	106	18	+	+	PROPN
ajlm-1224	106	19	t	t	PROPN
ajlm-1224	106	20	-	-	PUNCT
ajlm-1224	106	21	cells	cell	NOUN
ajlm-1224	106	22	and	and	CCONJ
ajlm-1224	106	23	the	the	DET
ajlm-1224	106	24	cd4	cd4	PROPN
ajlm-1224	106	25	/	/	SYM
ajlm-1224	106	26	cd8	cd8	PROPN
ajlm-1224	106	27	ratio	ratio	NOUN
ajlm-1224	106	28	.	.	PUNCT
ajlm-1224	107	1	this	this	PRON
ajlm-1224	107	2	could	could	AUX
ajlm-1224	107	3	be	be	AUX
ajlm-1224	107	4	explained	explain	VERB
ajlm-1224	107	5	by	by	ADP
ajlm-1224	107	6	the	the	DET
ajlm-1224	107	7	maintenance	maintenance	NOUN
ajlm-1224	107	8	of	of	ADP
ajlm-1224	107	9	the	the	DET
ajlm-1224	107	10	peripheral	peripheral	ADJ
ajlm-1224	107	11	tolerance	tolerance	NOUN
ajlm-1224	107	12	of	of	ADP
ajlm-1224	107	13	t	t	PROPN
ajlm-1224	107	14	-	-	PUNCT
ajlm-1224	107	15	cells	cell	NOUN
ajlm-1224	107	16	activated	activate	VERB
ajlm-1224	107	17	by	by	ADP
ajlm-1224	107	18	aicd	aicd	NOUN
ajlm-1224	107	19	mediated	mediate	VERB
ajlm-1224	107	20	by	by	ADP
ajlm-1224	107	21	the	the	DET
ajlm-1224	107	22	interaction	interaction	NOUN
ajlm-1224	107	23	between	between	ADP
ajlm-1224	107	24	cd95	cd95	PROPN
ajlm-1224	107	25	and	and	CCONJ
ajlm-1224	107	26	cd95l.6	cd95l.6	VERB
ajlm-1224	107	27	indeed	indeed	ADV
ajlm-1224	107	28	,	,	PUNCT
ajlm-1224	107	29	over	over	ADV
ajlm-1224	107	30	-	-	PUNCT
ajlm-1224	107	31	activated	activate	VERB
ajlm-1224	107	32	effector	effector	NOUN
ajlm-1224	107	33	t	t	PROPN
ajlm-1224	107	34	-	-	PUNCT
ajlm-1224	107	35	cells	cell	NOUN
ajlm-1224	107	36	are	be	AUX
ajlm-1224	107	37	harmful	harmful	ADJ
ajlm-1224	107	38	to	to	ADP
ajlm-1224	107	39	the	the	DET
ajlm-1224	107	40	immune	immune	ADJ
ajlm-1224	107	41	system	system	NOUN
ajlm-1224	107	42	and	and	CCONJ
ajlm-1224	107	43	must	must	AUX
ajlm-1224	107	44	be	be	AUX
ajlm-1224	107	45	removed	remove	VERB
ajlm-1224	107	46	from	from	ADP
ajlm-1224	107	47	body	body	NOUN
ajlm-1224	107	48	tissues	tissue	NOUN
ajlm-1224	107	49	.	.	PUNCT
ajlm-1224	108	1	also	also	ADV
ajlm-1224	108	2	,	,	PUNCT
ajlm-1224	108	3	there	there	PRON
ajlm-1224	108	4	was	be	VERB
ajlm-1224	108	5	a	a	DET
ajlm-1224	108	6	statistically	statistically	ADV
ajlm-1224	108	7	significant	significant	ADJ
ajlm-1224	108	8	direct	direct	ADJ
ajlm-1224	108	9	correlation	correlation	NOUN
ajlm-1224	108	10	between	between	ADP
ajlm-1224	108	11	the	the	DET
ajlm-1224	108	12	metavir	metavir	PROPN
ajlm-1224	108	13	fibrosis	fibrosis	NOUN
ajlm-1224	108	14	score	score	NOUN
ajlm-1224	108	15	and	and	CCONJ
ajlm-1224	108	16	the	the	DET
ajlm-1224	108	17	cd95	cd95	PROPN
ajlm-1224	108	18	and	and	CCONJ
ajlm-1224	108	19	cd95l	cd95l	NOUN
ajlm-1224	108	20	concentrations	concentration	NOUN
ajlm-1224	108	21	in	in	ADP
ajlm-1224	108	22	these	these	DET
ajlm-1224	108	23	cirrhotic	cirrhotic	ADJ
ajlm-1224	108	24	hbv	hbv	NOUN
ajlm-1224	108	25	-	-	PUNCT
ajlm-1224	108	26	infected	infect	VERB
ajlm-1224	108	27	patients	patient	NOUN
ajlm-1224	108	28	.	.	PUNCT
ajlm-1224	109	1	this	this	PRON
ajlm-1224	109	2	reflected	reflect	VERB
ajlm-1224	109	3	an	an	DET
ajlm-1224	109	4	association	association	NOUN
ajlm-1224	109	5	between	between	ADP
ajlm-1224	109	6	liver	liver	NOUN
ajlm-1224	109	7	injury	injury	NOUN
ajlm-1224	109	8	and	and	CCONJ
ajlm-1224	109	9	activation	activation	NOUN
ajlm-1224	109	10	of	of	ADP
ajlm-1224	109	11	the	the	DET
ajlm-1224	109	12	cd95	cd95	PROPN
ajlm-1224	109	13	-	-	PUNCT
ajlm-1224	109	14	cd95l	cd95l	NOUN
ajlm-1224	109	15	apoptosis	apoptosis	NOUN
ajlm-1224	109	16	pathway	pathway	NOUN
ajlm-1224	109	17	.	.	PUNCT
ajlm-1224	110	1	these	these	DET
ajlm-1224	110	2	results	result	NOUN
ajlm-1224	110	3	corroborate	corroborate	VERB
ajlm-1224	110	4	those	those	PRON
ajlm-1224	110	5	obtained	obtain	VERB
ajlm-1224	110	6	by	by	ADP
ajlm-1224	110	7	peter	peter	PROPN
ajlm-1224	110	8	et	et	PROPN
ajlm-1224	110	9	al	al	PROPN
ajlm-1224	110	10	.	.	PROPN
ajlm-1224	111	1	in	in	ADP
ajlm-1224	111	2	a	a	DET
ajlm-1224	111	3	study	study	NOUN
ajlm-1224	111	4	of	of	ADP
ajlm-1224	111	5	cd95	cd95	PROPN
ajlm-1224	111	6	receptor	receptor	NOUN
ajlm-1224	111	7	and	and	CCONJ
ajlm-1224	111	8	ligand	ligand	ADJ
ajlm-1224	111	9	involvement	involvement	NOUN
ajlm-1224	111	10	in	in	ADP
ajlm-1224	111	11	hepatic	hepatic	ADJ
ajlm-1224	111	12	injury,8	injury,8	NOUN
ajlm-1224	111	13	where	where	SCONJ
ajlm-1224	111	14	cd95	cd95	PROPN
ajlm-1224	111	15	receptor	receptor	NOUN
ajlm-1224	111	16	expression	expression	NOUN
ajlm-1224	111	17	was	be	AUX
ajlm-1224	111	18	very	very	ADV
ajlm-1224	111	19	high	high	ADJ
ajlm-1224	111	20	in	in	ADP
ajlm-1224	111	21	hepatocytes	hepatocyte	NOUN
ajlm-1224	111	22	in	in	ADP
ajlm-1224	111	23	hbv	hbv	NOUN
ajlm-1224	111	24	-	-	PUNCT
ajlm-1224	111	25	related	relate	VERB
ajlm-1224	111	26	cirrhosis.12	cirrhosis.12	NOUN
ajlm-1224	111	27	these	these	DET
ajlm-1224	111	28	results	result	NOUN
ajlm-1224	111	29	are	be	AUX
ajlm-1224	111	30	also	also	ADV
ajlm-1224	111	31	parallel	parallel	ADJ
ajlm-1224	111	32	to	to	ADP
ajlm-1224	111	33	those	those	PRON
ajlm-1224	111	34	obtained	obtain	VERB
ajlm-1224	111	35	in	in	ADP
ajlm-1224	111	36	the	the	DET
ajlm-1224	111	37	case	case	NOUN
ajlm-1224	111	38	of	of	ADP
ajlm-1224	111	39	infections	infection	NOUN
ajlm-1224	111	40	with	with	ADP
ajlm-1224	111	41	hcv	hcv	NOUN
ajlm-1224	111	42	by	by	ADP
ajlm-1224	111	43	hayashi	hayashi	PROPN
ajlm-1224	111	44	and	and	CCONJ
ajlm-1224	111	45	mita,14	mita,14	ADV
ajlm-1224	111	46	where	where	SCONJ
ajlm-1224	111	47	the	the	DET
ajlm-1224	111	48	expression	expression	NOUN
ajlm-1224	111	49	of	of	ADP
ajlm-1224	111	50	cd95	cd95	PROPN
ajlm-1224	111	51	was	be	AUX
ajlm-1224	111	52	upregulated	upregulate	VERB
ajlm-1224	111	53	according	accord	VERB
ajlm-1224	111	54	to	to	ADP
ajlm-1224	111	55	the	the	DET
ajlm-1224	111	56	severity	severity	NOUN
ajlm-1224	111	57	of	of	ADP
ajlm-1224	111	58	inflammation	inflammation	NOUN
ajlm-1224	111	59	of	of	ADP
ajlm-1224	111	60	the	the	DET
ajlm-1224	111	61	liver	liver	NOUN
ajlm-1224	111	62	.	.	PUNCT
ajlm-1224	112	1	there	there	PRON
ajlm-1224	112	2	was	be	VERB
ajlm-1224	112	3	a	a	DET
ajlm-1224	112	4	statistically	statistically	ADV
ajlm-1224	112	5	significant	significant	ADJ
ajlm-1224	112	6	inverse	inverse	NOUN
ajlm-1224	112	7	correlation	correlation	NOUN
ajlm-1224	112	8	between	between	ADP
ajlm-1224	112	9	the	the	DET
ajlm-1224	112	10	fibrosis	fibrosis	NOUN
ajlm-1224	112	11	score	score	NOUN
ajlm-1224	112	12	and	and	CCONJ
ajlm-1224	112	13	the	the	DET
ajlm-1224	112	14	cd4	cd4	PROPN
ajlm-1224	112	15	+	+	PROPN
ajlm-1224	112	16	t	t	PROPN
ajlm-1224	112	17	-	-	PUNCT
ajlm-1224	112	18	cell	cell	NOUN
ajlm-1224	112	19	count	count	NOUN
ajlm-1224	112	20	as	as	ADV
ajlm-1224	112	21	well	well	ADV
ajlm-1224	112	22	as	as	ADP
ajlm-1224	112	23	the	the	DET
ajlm-1224	112	24	cd4	cd4	PROPN
ajlm-1224	112	25	/	/	SYM
ajlm-1224	112	26	cd8	cd8	PROPN
ajlm-1224	112	27	ratio	ratio	NOUN
ajlm-1224	112	28	in	in	ADP
ajlm-1224	112	29	cirrhotic	cirrhotic	ADJ
ajlm-1224	112	30	hbv	hbv	NOUN
ajlm-1224	112	31	-	-	PUNCT
ajlm-1224	112	32	infected	infect	VERB
ajlm-1224	112	33	patients	patient	NOUN
ajlm-1224	112	34	.	.	PUNCT
ajlm-1224	113	1	these	these	DET
ajlm-1224	113	2	results	result	NOUN
ajlm-1224	113	3	reflected	reflect	VERB
ajlm-1224	113	4	an	an	DET
ajlm-1224	113	5	association	association	NOUN
ajlm-1224	113	6	between	between	ADP
ajlm-1224	113	7	the	the	DET
ajlm-1224	113	8	specific	specific	ADJ
ajlm-1224	113	9	cellular	cellular	ADJ
ajlm-1224	113	10	immune	immune	ADJ
ajlm-1224	113	11	response	response	NOUN
ajlm-1224	113	12	via	via	ADP
ajlm-1224	113	13	the	the	DET
ajlm-1224	113	14	activation	activation	NOUN
ajlm-1224	113	15	of	of	ADP
ajlm-1224	113	16	the	the	DET
ajlm-1224	113	17	cd4	cd4	PROPN
ajlm-1224	113	18	+	+	PROPN
ajlm-1224	113	19	t	t	PROPN
ajlm-1224	113	20	-	-	PUNCT
ajlm-1224	113	21	cells	cell	NOUN
ajlm-1224	113	22	who	who	PRON
ajlm-1224	113	23	are	be	AUX
ajlm-1224	113	24	the	the	DET
ajlm-1224	113	25	‘	'	PUNCT
ajlm-1224	113	26	coordinators	coordinator	NOUN
ajlm-1224	113	27	’	'	PUNCT
ajlm-1224	113	28	and	and	CCONJ
ajlm-1224	113	29	the	the	DET
ajlm-1224	113	30	liver	liver	NOUN
ajlm-1224	113	31	lesions	lesion	NOUN
ajlm-1224	113	32	that	that	PRON
ajlm-1224	113	33	occurred	occur	VERB
ajlm-1224	113	34	;	;	PUNCT
ajlm-1224	113	35	this	this	PRON
ajlm-1224	113	36	therefore	therefore	ADV
ajlm-1224	113	37	suggests	suggest	VERB
ajlm-1224	113	38	that	that	SCONJ
ajlm-1224	113	39	the	the	DET
ajlm-1224	113	40	destruction	destruction	NOUN
ajlm-1224	113	41	of	of	ADP
ajlm-1224	113	42	hepatocytes	hepatocyte	NOUN
ajlm-1224	113	43	in	in	ADP
ajlm-1224	113	44	hbv	hbv	NOUN
ajlm-1224	113	45	infection	infection	NOUN
ajlm-1224	113	46	would	would	AUX
ajlm-1224	113	47	be	be	AUX
ajlm-1224	113	48	induced	induce	VERB
ajlm-1224	113	49	by	by	ADP
ajlm-1224	113	50	t	t	PROPN
ajlm-1224	113	51	-	-	PUNCT
ajlm-1224	113	52	cells	cell	NOUN
ajlm-1224	113	53	,	,	PUNCT
ajlm-1224	113	54	using	use	VERB
ajlm-1224	113	55	cd95	cd95	PROPN
ajlm-1224	113	56	-	-	PUNCT
ajlm-1224	113	57	cd95l	cd95l	NOUN
ajlm-1224	113	58	mediation.12	mediation.12	NOUN
ajlm-1224	113	59	there	there	PRON
ajlm-1224	113	60	was	be	VERB
ajlm-1224	113	61	no	no	DET
ajlm-1224	113	62	statistically	statistically	ADV
ajlm-1224	113	63	significant	significant	ADJ
ajlm-1224	113	64	inverse	inverse	NOUN
ajlm-1224	113	65	correlation	correlation	NOUN
ajlm-1224	113	66	between	between	ADP
ajlm-1224	113	67	the	the	DET
ajlm-1224	113	68	fibrosis	fibrosis	NOUN
ajlm-1224	113	69	score	score	NOUN
ajlm-1224	113	70	and	and	CCONJ
ajlm-1224	113	71	cd8	cd8	PROPN
ajlm-1224	113	72	+	+	PROPN
ajlm-1224	113	73	t	t	PROPN
ajlm-1224	113	74	-	-	PUNCT
ajlm-1224	113	75	cell	cell	NOUN
ajlm-1224	113	76	concentration	concentration	NOUN
ajlm-1224	113	77	in	in	ADP
ajlm-1224	113	78	cirrhotic	cirrhotic	ADJ
ajlm-1224	113	79	hbv	hbv	NOUN
ajlm-1224	113	80	-	-	PUNCT
ajlm-1224	113	81	infected	infect	VERB
ajlm-1224	113	82	patients	patient	NOUN
ajlm-1224	113	83	.	.	PUNCT
ajlm-1224	114	1	these	these	DET
ajlm-1224	114	2	results	result	NOUN
ajlm-1224	114	3	show	show	VERB
ajlm-1224	114	4	that	that	SCONJ
ajlm-1224	114	5	expression	expression	NOUN
ajlm-1224	114	6	levels	level	NOUN
ajlm-1224	114	7	of	of	ADP
ajlm-1224	114	8	the	the	DET
ajlm-1224	114	9	constitutive	constitutive	ADJ
ajlm-1224	114	10	receptor	receptor	NOUN
ajlm-1224	114	11	cd95	cd95	PROPN
ajlm-1224	114	12	are	be	AUX
ajlm-1224	114	13	functionally	functionally	ADV
ajlm-1224	114	14	sufficient	sufficient	ADJ
ajlm-1224	114	15	to	to	PART
ajlm-1224	114	16	mediate	mediate	VERB
ajlm-1224	114	17	apoptosis	apoptosis	NOUN
ajlm-1224	114	18	of	of	ADP
ajlm-1224	114	19	hepatocytes	hepatocyte	NOUN
ajlm-1224	114	20	and	and	CCONJ
ajlm-1224	114	21	t	t	NOUN
ajlm-1224	114	22	-	-	PUNCT
ajlm-1224	114	23	cells	cell	NOUN
ajlm-1224	114	24	.	.	PUNCT
ajlm-1224	115	1	limitations	limitation	NOUN
ajlm-1224	115	2	our	our	PRON
ajlm-1224	115	3	study	study	NOUN
ajlm-1224	115	4	did	do	AUX
ajlm-1224	115	5	not	not	PART
ajlm-1224	115	6	evaluate	evaluate	VERB
ajlm-1224	115	7	the	the	DET
ajlm-1224	115	8	activation	activation	NOUN
ajlm-1224	115	9	of	of	ADP
ajlm-1224	115	10	the	the	DET
ajlm-1224	115	11	cd95	cd95	NOUN
ajlm-1224	115	12	-	-	PUNCT
ajlm-1224	115	13	cd95l	cd95l	NOUN
ajlm-1224	115	14	signalling	signal	VERB
ajlm-1224	115	15	pathway	pathway	NOUN
ajlm-1224	115	16	during	during	ADP
ajlm-1224	115	17	the	the	DET
ajlm-1224	115	18	evolution	evolution	NOUN
ajlm-1224	115	19	of	of	ADP
ajlm-1224	115	20	hbv	hbv	NOUN
ajlm-1224	115	21	infection	infection	NOUN
ajlm-1224	115	22	.	.	PUNCT
ajlm-1224	116	1	we	we	PRON
ajlm-1224	116	2	,	,	PUNCT
ajlm-1224	116	3	therefore	therefore	ADV
ajlm-1224	116	4	,	,	PUNCT
ajlm-1224	116	5	propose	propose	VERB
ajlm-1224	116	6	a	a	DET
ajlm-1224	116	7	longitudinal	longitudinal	ADJ
ajlm-1224	116	8	study	study	NOUN
ajlm-1224	116	9	,	,	PUNCT
ajlm-1224	116	10	which	which	PRON
ajlm-1224	116	11	will	will	AUX
ajlm-1224	116	12	evaluate	evaluate	VERB
ajlm-1224	116	13	the	the	DET
ajlm-1224	116	14	activation	activation	NOUN
ajlm-1224	116	15	of	of	ADP
ajlm-1224	116	16	the	the	DET
ajlm-1224	116	17	cd95	cd95	NOUN
ajlm-1224	116	18	-	-	PUNCT
ajlm-1224	116	19	cd95l	cd95l	NOUN
ajlm-1224	116	20	signalling	signal	VERB
ajlm-1224	116	21	pathway	pathway	NOUN
ajlm-1224	116	22	during	during	ADP
ajlm-1224	116	23	the	the	DET
ajlm-1224	116	24	progression	progression	NOUN
ajlm-1224	116	25	of	of	ADP
ajlm-1224	116	26	the	the	DET
ajlm-1224	116	27	viral	viral	ADJ
ajlm-1224	116	28	infection	infection	NOUN
ajlm-1224	116	29	,	,	PUNCT
ajlm-1224	116	30	from	from	ADP
ajlm-1224	116	31	cultures	culture	NOUN
ajlm-1224	116	32	of	of	ADP
ajlm-1224	116	33	hepatocytes	hepatocyte	NOUN
ajlm-1224	116	34	infected	infect	VERB
ajlm-1224	116	35	with	with	ADP
ajlm-1224	116	36	hbv	hbv	NOUN
ajlm-1224	116	37	,	,	PUNCT
ajlm-1224	116	38	and	and	CCONJ
ajlm-1224	116	39	which	which	PRON
ajlm-1224	116	40	will	will	AUX
ajlm-1224	116	41	evaluate	evaluate	VERB
ajlm-1224	116	42	the	the	DET
ajlm-1224	116	43	inhibition	inhibition	NOUN
ajlm-1224	116	44	of	of	ADP
ajlm-1224	116	45	cd95	cd95	PROPN
ajlm-1224	116	46	receptors	receptor	NOUN
ajlm-1224	116	47	as	as	ADP
ajlm-1224	116	48	an	an	DET
ajlm-1224	116	49	immunotherapeutic	immunotherapeutic	ADJ
ajlm-1224	116	50	method	method	NOUN
ajlm-1224	116	51	in	in	ADP
ajlm-1224	116	52	patients	patient	NOUN
ajlm-1224	116	53	with	with	ADP
ajlm-1224	116	54	chronic	chronic	ADJ
ajlm-1224	116	55	hbv	hbv	NOUN
ajlm-1224	116	56	.	.	PUNCT
ajlm-1224	117	1	conclusion	conclusion	VERB
ajlm-1224	117	2	the	the	DET
ajlm-1224	117	3	levels	level	NOUN
ajlm-1224	117	4	of	of	ADP
ajlm-1224	117	5	cd95	cd95	PROPN
ajlm-1224	117	6	and	and	CCONJ
ajlm-1224	117	7	cd95l	cd95l	NOUN
ajlm-1224	117	8	were	be	AUX
ajlm-1224	117	9	higher	high	ADJ
ajlm-1224	117	10	in	in	ADP
ajlm-1224	117	11	cirrhotic	cirrhotic	ADJ
ajlm-1224	117	12	patients	patient	NOUN
ajlm-1224	117	13	compared	compare	VERB
ajlm-1224	117	14	to	to	ADP
ajlm-1224	117	15	non	non	ADJ
ajlm-1224	117	16	-	-	ADJ
ajlm-1224	117	17	cirrhotic	cirrhotic	ADJ
ajlm-1224	117	18	patients	patient	NOUN
ajlm-1224	117	19	.	.	PUNCT
ajlm-1224	118	1	the	the	DET
ajlm-1224	118	2	cd4	cd4	PROPN
ajlm-1224	118	3	+	+	PROPN
ajlm-1224	118	4	t	t	PROPN
ajlm-1224	118	5	-	-	PUNCT
ajlm-1224	118	6	cell	cell	NOUN
ajlm-1224	118	7	counts	count	NOUN
ajlm-1224	118	8	,	,	PUNCT
ajlm-1224	118	9	cd8	cd8	PROPN
ajlm-1224	118	10	+	+	PROPN
ajlm-1224	118	11	t	t	PROPN
ajlm-1224	118	12	-	-	PUNCT
ajlm-1224	118	13	cell	cell	NOUN
ajlm-1224	118	14	counts	count	NOUN
ajlm-1224	118	15	and	and	CCONJ
ajlm-1224	118	16	cd4	cd4	PROPN
ajlm-1224	118	17	/	/	SYM
ajlm-1224	118	18	cd8	cd8	PROPN
ajlm-1224	118	19	ratios	ratio	NOUN
ajlm-1224	118	20	were	be	AUX
ajlm-1224	118	21	respectively	respectively	ADV
ajlm-1224	118	22	lower	low	ADJ
ajlm-1224	118	23	,	,	PUNCT
ajlm-1224	118	24	higher	high	ADJ
ajlm-1224	118	25	,	,	PUNCT
ajlm-1224	118	26	and	and	CCONJ
ajlm-1224	118	27	lower	low	ADJ
ajlm-1224	118	28	in	in	ADP
ajlm-1224	118	29	cirrhotic	cirrhotic	ADJ
ajlm-1224	118	30	patients	patient	NOUN
ajlm-1224	118	31	compared	compare	VERB
ajlm-1224	118	32	to	to	ADP
ajlm-1224	118	33	non	non	ADJ
ajlm-1224	118	34	-	-	ADJ
ajlm-1224	118	35	cirrhotic	cirrhotic	ADJ
ajlm-1224	118	36	patients	patient	NOUN
ajlm-1224	118	37	.	.	PUNCT
ajlm-1224	119	1	thus	thus	ADV
ajlm-1224	119	2	,	,	PUNCT
ajlm-1224	119	3	cd95	cd95	PROPN
ajlm-1224	119	4	-	-	PUNCT
ajlm-1224	119	5	cd95l	cd95l	PRON
ajlm-1224	119	6	could	could	AUX
ajlm-1224	119	7	be	be	AUX
ajlm-1224	119	8	involved	involve	VERB
ajlm-1224	119	9	in	in	ADP
ajlm-1224	119	10	t	t	NOUN
ajlm-1224	119	11	-	-	PUNCT
ajlm-1224	119	12	cell	cell	NOUN
ajlm-1224	119	13	depletion	depletion	NOUN
ajlm-1224	119	14	and	and	CCONJ
ajlm-1224	119	15	hepatic	hepatic	NOUN
ajlm-1224	119	16	cytolysis	cytolysis	NOUN
ajlm-1224	119	17	during	during	ADP
ajlm-1224	119	18	the	the	DET
ajlm-1224	119	19	pathogenesis	pathogenesis	NOUN
ajlm-1224	119	20	of	of	ADP
ajlm-1224	119	21	chronic	chronic	ADJ
ajlm-1224	119	22	hbv	hbv	NOUN
ajlm-1224	119	23	and	and	CCONJ
ajlm-1224	119	24	could	could	AUX
ajlm-1224	119	25	potentially	potentially	ADV
ajlm-1224	119	26	be	be	AUX
ajlm-1224	119	27	used	use	VERB
ajlm-1224	119	28	as	as	ADP
ajlm-1224	119	29	biomarkers	biomarker	NOUN
ajlm-1224	119	30	for	for	ADP
ajlm-1224	119	31	immunological	immunological	ADJ
ajlm-1224	119	32	and	and	CCONJ
ajlm-1224	119	33	hepatic	hepatic	ADJ
ajlm-1224	119	34	monitoring	monitoring	NOUN
ajlm-1224	119	35	in	in	ADP
ajlm-1224	119	36	patients	patient	NOUN
ajlm-1224	119	37	with	with	ADP
ajlm-1224	119	38	chronic	chronic	ADJ
ajlm-1224	119	39	hbv	hbv	NOUN
ajlm-1224	119	40	.	.	PUNCT
ajlm-1224	120	1	acknowledgements	acknowledgement	NOUN
ajlm-1224	120	2	we	we	PRON
ajlm-1224	120	3	thank	thank	VERB
ajlm-1224	120	4	the	the	DET
ajlm-1224	120	5	staff	staff	NOUN
ajlm-1224	120	6	of	of	ADP
ajlm-1224	120	7	the	the	DET
ajlm-1224	120	8	yaoundé	yaoundé	PROPN
ajlm-1224	120	9	general	general	ADJ
ajlm-1224	120	10	hospital	hospital	NOUN
ajlm-1224	120	11	,	,	PUNCT
ajlm-1224	120	12	cameroon	cameroon	NOUN
ajlm-1224	120	13	,	,	PUNCT
ajlm-1224	120	14	and	and	CCONJ
ajlm-1224	120	15	the	the	DET
ajlm-1224	120	16	participants	participant	NOUN
ajlm-1224	120	17	of	of	ADP
ajlm-1224	120	18	this	this	DET
ajlm-1224	120	19	study	study	NOUN
ajlm-1224	120	20	.	.	PUNCT
ajlm-1224	121	1	competing	compete	VERB
ajlm-1224	121	2	interests	interest	NOUN
ajlm-1224	121	3	the	the	DET
ajlm-1224	121	4	authors	author	NOUN
ajlm-1224	121	5	have	have	AUX
ajlm-1224	121	6	declared	declare	VERB
ajlm-1224	121	7	that	that	SCONJ
ajlm-1224	121	8	no	no	DET
ajlm-1224	121	9	competing	compete	VERB
ajlm-1224	121	10	interests	interest	NOUN
ajlm-1224	121	11	exist	exist	VERB
ajlm-1224	121	12	.	.	PUNCT
ajlm-1224	122	1	authors	author	NOUN
ajlm-1224	122	2	’	'	PUNCT
ajlm-1224	122	3	contributions	contribution	NOUN
ajlm-1224	122	4	f.s.a.a	f.s.a.a	PROPN
ajlm-1224	122	5	.	.	PROPN
ajlm-1224	122	6	,	,	PUNCT
ajlm-1224	122	7	p.t	p.t	PROPN
ajlm-1224	122	8	.	.	PROPN
ajlm-1224	122	9	and	and	CCONJ
ajlm-1224	122	10	g.m.i	g.m.i	PROPN
ajlm-1224	122	11	.	.	PUNCT
ajlm-1224	122	12	designed	design	VERB
ajlm-1224	122	13	the	the	DET
ajlm-1224	122	14	project	project	NOUN
ajlm-1224	122	15	and	and	CCONJ
ajlm-1224	122	16	the	the	DET
ajlm-1224	122	17	main	main	ADJ
ajlm-1224	122	18	conceptual	conceptual	ADJ
ajlm-1224	122	19	ideas	idea	NOUN
ajlm-1224	122	20	.	.	PUNCT
ajlm-1224	123	1	g.m.i	g.m.i	PROPN
ajlm-1224	123	2	.	.	PROPN
ajlm-1224	123	3	,	,	PUNCT
ajlm-1224	123	4	p.t	p.t	PROPN
ajlm-1224	123	5	.	.	PROPN
ajlm-1224	123	6	,	,	PUNCT
ajlm-1224	123	7	c.h.m	c.h.m	PROPN
ajlm-1224	123	8	.	.	PUNCT
ajlm-1224	124	1	and	and	CCONJ
ajlm-1224	124	2	g.b.j	g.b.j	NOUN
ajlm-1224	124	3	.	.	PUNCT
ajlm-1224	124	4	worked	work	VERB
ajlm-1224	124	5	on	on	ADP
ajlm-1224	124	6	the	the	DET
ajlm-1224	124	7	technical	technical	ADJ
ajlm-1224	124	8	and	and	CCONJ
ajlm-1224	124	9	methodological	methodological	ADJ
ajlm-1224	124	10	details	detail	NOUN
ajlm-1224	124	11	.	.	PUNCT
ajlm-1224	125	1	f.s.a.a	f.s.a.a	PROPN
ajlm-1224	125	2	.	.	PROPN
ajlm-1224	125	3	and	and	CCONJ
ajlm-1224	125	4	p.t	p.t	PROPN
ajlm-1224	125	5	.	.	PROPN
ajlm-1224	125	6	recruited	recruit	VERB
ajlm-1224	125	7	participants	participant	NOUN
ajlm-1224	125	8	and	and	CCONJ
ajlm-1224	125	9	collected	collect	VERB
ajlm-1224	125	10	blood	blood	NOUN
ajlm-1224	125	11	samples	sample	NOUN
ajlm-1224	125	12	.	.	PUNCT
ajlm-1224	126	1	g.m.i	g.m.i	AUX
ajlm-1224	126	2	.	.	PROPN
ajlm-1224	126	3	,	,	PUNCT
ajlm-1224	126	4	m.t.m	m.t.m	PROPN
ajlm-1224	126	5	.	.	PROPN
ajlm-1224	126	6	,	,	PUNCT
ajlm-1224	126	7	g.b.j	g.b.j	NOUN
ajlm-1224	126	8	.	.	PUNCT
ajlm-1224	126	9	,	,	PUNCT
ajlm-1224	126	10	c.h.m	c.h.m	PROPN
ajlm-1224	126	11	.	.	PROPN
ajlm-1224	126	12	,	,	PUNCT
ajlm-1224	126	13	e.g.	e.g.	ADV
ajlm-1224	126	14	and	and	CCONJ
ajlm-1224	126	15	e.l	e.l	PROPN
ajlm-1224	126	16	.	.	PROPN
ajlm-1224	126	17	participated	participate	VERB
ajlm-1224	126	18	in	in	ADP
ajlm-1224	126	19	the	the	DET
ajlm-1224	126	20	planning	planning	NOUN
ajlm-1224	126	21	and	and	CCONJ
ajlm-1224	126	22	supervision	supervision	NOUN
ajlm-1224	126	23	of	of	ADP
ajlm-1224	126	24	the	the	DET
ajlm-1224	126	25	work	work	NOUN
ajlm-1224	126	26	.	.	PUNCT
ajlm-1224	127	1	f.s.a.a	f.s.a.a	PROPN
ajlm-1224	127	2	.	.	PROPN
ajlm-1224	127	3	performed	perform	VERB
ajlm-1224	127	4	the	the	DET
ajlm-1224	127	5	biological	biological	ADJ
ajlm-1224	127	6	analysis	analysis	NOUN
ajlm-1224	127	7	of	of	ADP
ajlm-1224	127	8	the	the	DET
ajlm-1224	127	9	blood	blood	NOUN
ajlm-1224	127	10	samples	sample	NOUN
ajlm-1224	127	11	.	.	PUNCT
ajlm-1224	128	1	f.s.a.a	f.s.a.a	PROPN
ajlm-1224	128	2	.	.	PROPN
ajlm-1224	128	3	and	and	CCONJ
ajlm-1224	128	4	c.h.m	c.h.m	PROPN
ajlm-1224	128	5	.	.	PUNCT
ajlm-1224	128	6	carried	carry	VERB
ajlm-1224	128	7	out	out	ADP
ajlm-1224	128	8	the	the	DET
ajlm-1224	128	9	statistical	statistical	ADJ
ajlm-1224	128	10	analysis	analysis	NOUN
ajlm-1224	128	11	of	of	ADP
ajlm-1224	128	12	the	the	DET
ajlm-1224	128	13	data	datum	NOUN
ajlm-1224	128	14	and	and	CCONJ
ajlm-1224	128	15	designed	design	VERB
ajlm-1224	128	16	the	the	DET
ajlm-1224	128	17	figures	figure	NOUN
ajlm-1224	128	18	and	and	CCONJ
ajlm-1224	128	19	tables	table	NOUN
ajlm-1224	128	20	.	.	PUNCT
ajlm-1224	129	1	f.s.a.a	f.s.a.a	PROPN
ajlm-1224	129	2	.	.	PROPN
ajlm-1224	129	3	,	,	PUNCT
ajlm-1224	129	4	g.m.i	g.m.i	VERB
ajlm-1224	129	5	.	.	PROPN
ajlm-1224	129	6	,	,	PUNCT
ajlm-1224	129	7	c.h.m	c.h.m	PROPN
ajlm-1224	129	8	.	.	PROPN
ajlm-1224	129	9	,	,	PUNCT
ajlm-1224	129	10	g.b.j	g.b.j	NOUN
ajlm-1224	129	11	.	.	PUNCT
ajlm-1224	129	12	,	,	PUNCT
ajlm-1224	129	13	m.c.o.a	m.c.o.a	PROPN
ajlm-1224	129	14	.	.	PROPN
ajlm-1224	130	1	and	and	CCONJ
ajlm-1224	130	2	m.t.m	m.t.m	PROPN
ajlm-1224	130	3	.	.	PROPN
ajlm-1224	130	4	contributed	contribute	VERB
ajlm-1224	130	5	to	to	ADP
ajlm-1224	130	6	the	the	DET
ajlm-1224	130	7	interpretation	interpretation	NOUN
ajlm-1224	130	8	of	of	ADP
ajlm-1224	130	9	the	the	DET
ajlm-1224	130	10	results	result	NOUN
ajlm-1224	130	11	and	and	CCONJ
ajlm-1224	130	12	the	the	DET
ajlm-1224	130	13	writing	writing	NOUN
ajlm-1224	130	14	of	of	ADP
ajlm-1224	130	15	the	the	DET
ajlm-1224	130	16	manuscript	manuscript	NOUN
ajlm-1224	130	17	.	.	PUNCT
ajlm-1224	131	1	all	all	DET
ajlm-1224	131	2	the	the	DET
ajlm-1224	131	3	authors	author	NOUN
ajlm-1224	131	4	discussed	discuss	VERB
ajlm-1224	131	5	the	the	DET
ajlm-1224	131	6	results	result	NOUN
ajlm-1224	131	7	and	and	CCONJ
ajlm-1224	131	8	commented	comment	VERB
ajlm-1224	131	9	on	on	ADP
ajlm-1224	131	10	the	the	DET
ajlm-1224	131	11	manuscript	manuscript	NOUN
ajlm-1224	131	12	.	.	PUNCT
ajlm-1224	132	1	sources	source	NOUN
ajlm-1224	132	2	of	of	ADP
ajlm-1224	132	3	support	support	NOUN
ajlm-1224	132	4	this	this	DET
ajlm-1224	132	5	research	research	NOUN
ajlm-1224	132	6	received	receive	VERB
ajlm-1224	132	7	no	no	DET
ajlm-1224	132	8	specific	specific	ADJ
ajlm-1224	132	9	grant	grant	NOUN
ajlm-1224	132	10	from	from	ADP
ajlm-1224	132	11	any	any	DET
ajlm-1224	132	12	funding	funding	NOUN
ajlm-1224	132	13	agency	agency	NOUN
ajlm-1224	132	14	in	in	ADP
ajlm-1224	132	15	the	the	DET
ajlm-1224	132	16	public	public	ADJ
ajlm-1224	132	17	,	,	PUNCT
ajlm-1224	132	18	commercial	commercial	ADJ
ajlm-1224	132	19	or	or	CCONJ
ajlm-1224	132	20	not	not	PART
ajlm-1224	132	21	-	-	PUNCT
ajlm-1224	132	22	for	for	ADP
ajlm-1224	132	23	-	-	PUNCT
ajlm-1224	132	24	profit	profit	NOUN
ajlm-1224	132	25	sectors	sector	NOUN
ajlm-1224	132	26	.	.	PUNCT
ajlm-1224	133	1	data	datum	NOUN
ajlm-1224	133	2	availability	availability	NOUN
ajlm-1224	133	3	statement	statement	NOUN
ajlm-1224	133	4	the	the	DET
ajlm-1224	133	5	data	datum	NOUN
ajlm-1224	133	6	supporting	support	VERB
ajlm-1224	133	7	the	the	DET
ajlm-1224	133	8	results	result	NOUN
ajlm-1224	133	9	of	of	ADP
ajlm-1224	133	10	this	this	DET
ajlm-1224	133	11	study	study	NOUN
ajlm-1224	133	12	are	be	AUX
ajlm-1224	133	13	available	available	ADJ
ajlm-1224	133	14	on	on	ADP
ajlm-1224	133	15	request	request	NOUN
ajlm-1224	133	16	from	from	ADP
ajlm-1224	133	17	the	the	DET
ajlm-1224	133	18	corresponding	corresponding	ADJ
ajlm-1224	133	19	author	author	NOUN
ajlm-1224	133	20	,	,	PUNCT
ajlm-1224	133	21	f.s.a.a	f.s.a.a	PROPN
ajlm-1224	133	22	.	.	PUNCT
ajlm-1224	134	1	the	the	DET
ajlm-1224	134	2	data	datum	NOUN
ajlm-1224	134	3	are	be	AUX
ajlm-1224	134	4	not	not	PART
ajlm-1224	134	5	publicly	publicly	ADV
ajlm-1224	134	6	available	available	ADJ
ajlm-1224	134	7	because	because	SCONJ
ajlm-1224	134	8	they	they	PRON
ajlm-1224	134	9	contain	contain	VERB
ajlm-1224	134	10	information	information	NOUN
ajlm-1224	134	11	that	that	PRON
ajlm-1224	134	12	could	could	AUX
ajlm-1224	134	13	compromise	compromise	VERB
ajlm-1224	134	14	the	the	DET
ajlm-1224	134	15	confidentiality	confidentiality	NOUN
ajlm-1224	134	16	of	of	ADP
ajlm-1224	134	17	research	research	NOUN
ajlm-1224	134	18	participants	participant	NOUN
ajlm-1224	134	19	.	.	PUNCT
ajlm-1224	135	1	disclaimer	disclaimer	VERB
ajlm-1224	135	2	the	the	DET
ajlm-1224	135	3	views	view	NOUN
ajlm-1224	135	4	and	and	CCONJ
ajlm-1224	135	5	opinions	opinion	NOUN
ajlm-1224	135	6	expressed	express	VERB
ajlm-1224	135	7	in	in	ADP
ajlm-1224	135	8	this	this	DET
ajlm-1224	135	9	article	article	NOUN
ajlm-1224	135	10	are	be	AUX
ajlm-1224	135	11	those	those	PRON
ajlm-1224	135	12	of	of	ADP
ajlm-1224	135	13	the	the	DET
ajlm-1224	135	14	authors	author	NOUN
ajlm-1224	135	15	and	and	CCONJ
ajlm-1224	135	16	do	do	AUX
ajlm-1224	135	17	not	not	PART
ajlm-1224	135	18	necessarily	necessarily	ADV
ajlm-1224	135	19	reflect	reflect	VERB
ajlm-1224	135	20	the	the	DET
ajlm-1224	135	21	official	official	ADJ
ajlm-1224	135	22	policy	policy	NOUN
ajlm-1224	135	23	or	or	CCONJ
ajlm-1224	135	24	position	position	NOUN
ajlm-1224	135	25	of	of	ADP
ajlm-1224	135	26	any	any	DET
ajlm-1224	135	27	affiliated	affiliated	ADJ
ajlm-1224	135	28	agency	agency	NOUN
ajlm-1224	135	29	of	of	ADP
ajlm-1224	135	30	the	the	DET
ajlm-1224	135	31	authors	author	NOUN
ajlm-1224	135	32	.	.	PUNCT
ajlm-1224	136	1	references	reference	NOUN
ajlm-1224	136	2	dane	dane	PROPN
ajlm-1224	136	3	ds	ds	PROPN
ajlm-1224	136	4	,	,	PUNCT
ajlm-1224	136	5	cameron	cameron	PROPN
ajlm-1224	136	6	ch	ch	PROPN
ajlm-1224	136	7	,	,	PUNCT
ajlm-1224	136	8	briggs	briggs	PROPN
ajlm-1224	136	9	m.	m.	PROPN
ajlm-1224	136	10	virus	virus	PROPN
ajlm-1224	136	11	-	-	PUNCT
ajlm-1224	136	12	like	like	ADJ
ajlm-1224	136	13	particles	particle	NOUN
ajlm-1224	136	14	in	in	ADP
ajlm-1224	136	15	serum	serum	NOUN
ajlm-1224	136	16	of	of	ADP
ajlm-1224	136	17	patients	patient	NOUN
ajlm-1224	136	18	with	with	ADP
ajlm-1224	136	19	australia	australia	PROPN
ajlm-1224	136	20	-	-	PUNCT
ajlm-1224	136	21	antigen	antigen	ADV
ajlm-1224	136	22	-	-	PUNCT
ajlm-1224	136	23	associated	associate	VERB
ajlm-1224	136	24	hepatitis	hepatitis	NOUN
ajlm-1224	136	25	.	.	PUNCT
ajlm-1224	137	1	lancet	lancet	PROPN
ajlm-1224	137	2	.	.	PUNCT
ajlm-1224	138	1	1970;1(7649):695–698	1970;1(7649):695–698	PROPN
ajlm-1224	138	2	.	.	PUNCT
ajlm-1224	139	1	https://doi.org/10.1016/s0140-6736(70)90926-8	https://doi.org/10.1016/s0140-6736(70)90926-8	PROPN
ajlm-1224	139	2	klenerman	klenerman	PROPN
ajlm-1224	139	3	p	p	PROPN
ajlm-1224	139	4	,	,	PUNCT
ajlm-1224	139	5	thimme	thimme	PROPN
ajlm-1224	139	6	r.	r.	PROPN
ajlm-1224	139	7	t	t	PROPN
ajlm-1224	139	8	cell	cell	NOUN
ajlm-1224	139	9	responses	response	NOUN
ajlm-1224	139	10	in	in	ADP
ajlm-1224	139	11	hepatitis	hepatitis	PROPN
ajlm-1224	139	12	c	c	NOUN
ajlm-1224	139	13	:	:	PUNCT
ajlm-1224	139	14	the	the	DET
ajlm-1224	139	15	good	good	NOUN
ajlm-1224	139	16	,	,	PUNCT
ajlm-1224	139	17	the	the	DET
ajlm-1224	139	18	bad	bad	ADJ
ajlm-1224	139	19	and	and	CCONJ
ajlm-1224	139	20	the	the	DET
ajlm-1224	139	21	unconventional	unconventional	ADJ
ajlm-1224	139	22	.	.	PUNCT
ajlm-1224	140	1	gut	gut	NOUN
ajlm-1224	140	2	.	.	PUNCT
ajlm-1224	141	1	2012	2012	NUM
ajlm-1224	141	2	aug;61(8):1226–1234	aug;61(8):1226–1234	NOUN
ajlm-1224	141	3	.	.	PUNCT
ajlm-1224	142	1	https://doi.org/10.1136/gutjnl-2011-300620	https://doi.org/10.1136/gutjnl-2011-300620	PROPN
ajlm-1224	142	2	maryam	maryam	PROPN
ajlm-1224	142	3	k	k	PROPN
ajlm-1224	142	4	,	,	PUNCT
ajlm-1224	142	5	seyed	seyed	PROPN
ajlm-1224	142	6	ma	ma	PROPN
ajlm-1224	142	7	,	,	PUNCT
ajlm-1224	142	8	heidar	heidar	PROPN
ajlm-1224	142	9	s.	s.	PROPN
ajlm-1224	142	10	comparison	comparison	NOUN
ajlm-1224	142	11	of	of	ADP
ajlm-1224	142	12	serum	serum	PROPN
ajlm-1224	142	13	hepatitis	hepatitis	PROPN
ajlm-1224	142	14	b	b	PROPN
ajlm-1224	142	15	virus	virus	NOUN
ajlm-1224	142	16	dna	dna	NOUN
ajlm-1224	142	17	and	and	CCONJ
ajlm-1224	142	18	hbsag	hbsag	NOUN
ajlm-1224	142	19	levels	level	NOUN
ajlm-1224	142	20	between	between	ADP
ajlm-1224	142	21	hbeag	hbeag	NOUN
ajlm-1224	142	22	-	-	PUNCT
ajlm-1224	142	23	negative	negative	ADJ
ajlm-1224	142	24	and	and	CCONJ
ajlm-1224	142	25	hbeag	hbeag	ADV
ajlm-1224	142	26	-	-	PUNCT
ajlm-1224	142	27	positive	positive	ADJ
ajlm-1224	142	28	chronic	chronic	ADJ
ajlm-1224	142	29	hepatitis	hepatitis	NOUN
ajlm-1224	142	30	b	b	PROPN
ajlm-1224	142	31	patients	patient	NOUN
ajlm-1224	142	32	.	.	PUNCT
ajlm-1224	143	1	jundishapur	jundishapur	PROPN
ajlm-1224	143	2	j	j	PROPN
ajlm-1224	143	3	microbiol	microbiol	PROPN
ajlm-1224	143	4	.	.	PUNCT
ajlm-1224	144	1	2015	2015	NUM
ajlm-1224	144	2	mar;8(3):e21444	mar;8(3):e21444	NOUN
ajlm-1224	144	3	.	.	PUNCT
ajlm-1224	145	1	https://doi.org/10.5812/jjm.21444	https://doi.org/10.5812/jjm.21444	PROPN
ajlm-1224	145	2	zhen	zhen	PROPN
ajlm-1224	145	3	-	-	PUNCT
ajlm-1224	145	4	tang	tang	PROPN
ajlm-1224	145	5	j	j	PROPN
ajlm-1224	145	6	,	,	PUNCT
ajlm-1224	145	7	wei	wei	PROPN
ajlm-1224	145	8	l	l	PROPN
ajlm-1224	145	9	,	,	PUNCT
ajlm-1224	145	10	shu	shu	PROPN
ajlm-1224	145	11	-	-	PUNCT
ajlm-1224	145	12	xiang	xiang	PROPN
ajlm-1224	145	13	w	w	PROPN
ajlm-1224	145	14	,	,	PUNCT
ajlm-1224	145	15	et	et	PROPN
ajlm-1224	145	16	al	al	PROPN
ajlm-1224	145	17	.	.	PUNCT
ajlm-1224	146	1	hepatitis	hepatitis	PROPN
ajlm-1224	146	2	b	b	PROPN
ajlm-1224	146	3	virus	virus	NOUN
ajlm-1224	146	4	surface	surface	NOUN
ajlm-1224	146	5	antigen	antigen	NOUN
ajlm-1224	146	6	enhances	enhance	VERB
ajlm-1224	146	7	the	the	DET
ajlm-1224	146	8	sensitivity	sensitivity	NOUN
ajlm-1224	146	9	of	of	ADP
ajlm-1224	146	10	hepatocytes	hepatocyte	NOUN
ajlm-1224	146	11	to	to	ADP
ajlm-1224	146	12	fas	fas	ADJ
ajlm-1224	146	13	-	-	PUNCT
ajlm-1224	146	14	mediated	mediate	VERB
ajlm-1224	146	15	apoptosis	apoptosis	NOUN
ajlm-1224	146	16	via	via	ADP
ajlm-1224	146	17	suppression	suppression	NOUN
ajlm-1224	146	18	of	of	ADP
ajlm-1224	146	19	akt	akt	PROPN
ajlm-1224	146	20	phosphorylation	phosphorylation	NOUN
ajlm-1224	146	21	.	.	PUNCT
ajlm-1224	147	1	j	j	PROPN
ajlm-1224	147	2	immunol	immunol	NOUN
ajlm-1224	147	3	.	.	PUNCT
ajlm-1224	148	1	2018	2018	NUM
ajlm-1224	148	2	oct	oct	NOUN
ajlm-1224	148	3	15;201(8):2303–2314	15;201(8):2303–2314	NUM
ajlm-1224	148	4	.	.	PUNCT
ajlm-1224	149	1	https://doi.org/10.4049/jimmunol.1800732	https://doi.org/10.4049/jimmunol.1800732	NOUN
ajlm-1224	149	2	pizon	pizon	PROPN
ajlm-1224	149	3	m	m	PROPN
ajlm-1224	149	4	,	,	PUNCT
ajlm-1224	149	5	rampanarivo	rampanarivo	PROPN
ajlm-1224	149	6	h	h	NOUN
ajlm-1224	149	7	,	,	PUNCT
ajlm-1224	149	8	tauzin	tauzin	PROPN
ajlm-1224	149	9	s	s	PROPN
ajlm-1224	149	10	,	,	PUNCT
ajlm-1224	149	11	et	et	PROPN
ajlm-1224	149	12	al	al	PROPN
ajlm-1224	149	13	.	.	PUNCT
ajlm-1224	149	14	actin	actin	NOUN
ajlm-1224	149	15	-	-	PUNCT
ajlm-1224	149	16	independent	independent	ADJ
ajlm-1224	149	17	exclusion	exclusion	NOUN
ajlm-1224	149	18	of	of	ADP
ajlm-1224	149	19	cd95	cd95	PROPN
ajlm-1224	149	20	by	by	ADP
ajlm-1224	149	21	pi3k	pi3k	PROPN
ajlm-1224	149	22	/	/	SYM
ajlm-1224	149	23	akt	akt	PROPN
ajlm-1224	149	24	signalling	signal	VERB
ajlm-1224	149	25	:	:	PUNCT
ajlm-1224	149	26	implications	implication	NOUN
ajlm-1224	149	27	for	for	ADP
ajlm-1224	149	28	apoptosis	apoptosis	NOUN
ajlm-1224	149	29	.	.	PUNCT
ajlm-1224	150	1	eur	eur	PROPN
ajlm-1224	150	2	j	j	PROPN
ajlm-1224	150	3	immunol	immunol	NOUN
ajlm-1224	150	4	.	.	PUNCT
ajlm-1224	151	1	2011	2011	NUM
ajlm-1224	151	2	aug;41(8):2368–2378	aug;41(8):2368–2378	NOUN
ajlm-1224	151	3	.	.	PUNCT
ajlm-1224	152	1	https://doi.org/10.1002/eji.201041078	https://doi.org/10.1002/eji.201041078	PROPN
ajlm-1224	152	2	mueller	mueller	PROPN
ajlm-1224	152	3	dl	dl	PROPN
ajlm-1224	152	4	.	.	PROPN
ajlm-1224	152	5	mechanisms	mechanism	NOUN
ajlm-1224	152	6	maintaining	maintain	VERB
ajlm-1224	152	7	peripheral	peripheral	ADJ
ajlm-1224	152	8	tolerance	tolerance	NOUN
ajlm-1224	152	9	.	.	PUNCT
ajlm-1224	153	1	nat	nat	PROPN
ajlm-1224	153	2	immunol	immunol	NOUN
ajlm-1224	153	3	.	.	PUNCT
ajlm-1224	154	1	2010	2010	NUM
ajlm-1224	154	2	jan;11(1):21–27	jan;11(1):21–27	NOUN
ajlm-1224	154	3	.	.	PUNCT
ajlm-1224	155	1	https://doi.org/10.1038/ni.1817	https://doi.org/10.1038/ni.1817	PROPN
ajlm-1224	155	2	green	green	PROPN
ajlm-1224	155	3	dr	dr	PROPN
ajlm-1224	155	4	,	,	PUNCT
ajlm-1224	155	5	droin	droin	VERB
ajlm-1224	155	6	n	n	CCONJ
ajlm-1224	155	7	,	,	PUNCT
ajlm-1224	155	8	pinkoski	pinkoski	ADJ
ajlm-1224	155	9	m.	m.	NOUN
ajlm-1224	155	10	activation	activation	NOUN
ajlm-1224	155	11	-	-	PUNCT
ajlm-1224	155	12	induced	induce	VERB
ajlm-1224	155	13	cell	cell	NOUN
ajlm-1224	155	14	death	death	NOUN
ajlm-1224	155	15	in	in	ADP
ajlm-1224	155	16	t	t	NOUN
ajlm-1224	155	17	cells	cell	NOUN
ajlm-1224	155	18	.	.	PUNCT
ajlm-1224	156	1	immunol	immunol	PROPN
ajlm-1224	156	2	rev	rev	PROPN
ajlm-1224	156	3	.	.	PROPN
ajlm-1224	156	4	2003	2003	NUM
ajlm-1224	156	5	jun;193:70–81	jun;193:70–81	PROPN
ajlm-1224	156	6	.	.	PUNCT
ajlm-1224	157	1	https://doi.org/10.1034/j.1600-065x.2003.00051.x	https://doi.org/10.1034/j.1600-065x.2003.00051.x	PROPN
ajlm-1224	157	2	galle	galle	PROPN
ajlm-1224	157	3	pr	pr	PROPN
ajlm-1224	157	4	,	,	PUNCT
ajlm-1224	157	5	hofmann	hofmann	PROPN
ajlm-1224	157	6	wj	wj	PROPN
ajlm-1224	157	7	,	,	PUNCT
ajlm-1224	157	8	walczak	walczak	ADJ
ajlm-1224	157	9	h	h	NOUN
ajlm-1224	157	10	,	,	PUNCT
ajlm-1224	157	11	et	et	PROPN
ajlm-1224	157	12	al	al	PROPN
ajlm-1224	157	13	.	.	PUNCT
ajlm-1224	157	14	involvement	involvement	NOUN
ajlm-1224	157	15	of	of	ADP
ajlm-1224	157	16	the	the	DET
ajlm-1224	157	17	cd95	cd95	PROPN
ajlm-1224	157	18	(	(	PUNCT
ajlm-1224	157	19	apo-1	apo-1	NOUN
ajlm-1224	157	20	/	/	SYM
ajlm-1224	157	21	fas	fas	ADJ
ajlm-1224	157	22	)	)	PUNCT
ajlm-1224	157	23	receptor	receptor	NOUN
ajlm-1224	157	24	and	and	CCONJ
ajlm-1224	157	25	ligand	ligand	NOUN
ajlm-1224	157	26	in	in	ADP
ajlm-1224	157	27	liver	liver	NOUN
ajlm-1224	157	28	damage	damage	NOUN
ajlm-1224	157	29	.	.	PUNCT
ajlm-1224	158	1	j	j	PROPN
ajlm-1224	158	2	exp	exp	NOUN
ajlm-1224	158	3	med	med	PROPN
ajlm-1224	158	4	.	.	PUNCT
ajlm-1224	159	1	1995;182(5):1223–1230	1995;182(5):1223–1230	NUM
ajlm-1224	159	2	.	.	PUNCT
ajlm-1224	160	1	https://doi.org/10.1084/jem.182.5.1223	https://doi.org/10.1084/jem.182.5.1223	PROPN
ajlm-1224	160	2	liu	liu	PROPN
ajlm-1224	160	3	w	w	PROPN
ajlm-1224	160	4	,	,	PUNCT
ajlm-1224	160	5	lin	lin	PROPN
ajlm-1224	160	6	yt	yt	PROPN
ajlm-1224	160	7	,	,	PUNCT
ajlm-1224	160	8	yan	yan	PROPN
ajlm-1224	160	9	xl	xl	PROPN
ajlm-1224	160	10	,	,	PUNCT
ajlm-1224	160	11	et	et	PROPN
ajlm-1224	160	12	al	al	PROPN
ajlm-1224	160	13	.	.	PUNCT
ajlm-1224	161	1	hepatitis	hepatitis	PROPN
ajlm-1224	161	2	b	b	PROPN
ajlm-1224	161	3	virus	virus	NOUN
ajlm-1224	161	4	core	core	NOUN
ajlm-1224	161	5	protein	protein	NOUN
ajlm-1224	161	6	inhibits	inhibit	VERB
ajlm-1224	161	7	fas	fas	ADJ
ajlm-1224	161	8	-	-	PUNCT
ajlm-1224	161	9	mediated	mediate	VERB
ajlm-1224	161	10	apoptosis	apoptosis	NOUN
ajlm-1224	161	11	of	of	ADP
ajlm-1224	161	12	hepatoma	hepatoma	ADJ
ajlm-1224	161	13	cells	cell	NOUN
ajlm-1224	161	14	via	via	ADP
ajlm-1224	161	15	regulation	regulation	NOUN
ajlm-1224	161	16	of	of	ADP
ajlm-1224	161	17	mfas	mfas	NOUN
ajlm-1224	161	18	/	/	SYM
ajlm-1224	161	19	fasl	fasl	NOUN
ajlm-1224	161	20	and	and	CCONJ
ajlm-1224	161	21	sfas	sfas	NOUN
ajlm-1224	161	22	expression	expression	NOUN
ajlm-1224	161	23	.	.	PUNCT
ajlm-1224	162	1	faseb	faseb	PROPN
ajlm-1224	162	2	j.	j.	PROPN
ajlm-1224	162	3	2015	2015	NUM
ajlm-1224	162	4	mar;29(3):1113–1123	mar;29(3):1113–1123	NOUN
ajlm-1224	162	5	.	.	PUNCT
ajlm-1224	163	1	https://doi.org/10.1096/fj.14-263822	https://doi.org/10.1096/fj.14-263822	PROPN
ajlm-1224	163	2	wherry	wherry	PROPN
ajlm-1224	163	3	ej	ej	PROPN
ajlm-1224	163	4	.	.	PROPN
ajlm-1224	163	5	t	t	PROPN
ajlm-1224	163	6	cell	cell	NOUN
ajlm-1224	163	7	exhaustion	exhaustion	NOUN
ajlm-1224	163	8	.	.	PUNCT
ajlm-1224	164	1	nat	nat	PROPN
ajlm-1224	164	2	immunol	immunol	NOUN
ajlm-1224	164	3	.	.	PUNCT
ajlm-1224	165	1	2011	2011	NUM
ajlm-1224	165	2	jun;12(6):492–499	jun;12(6):492–499	NOUN
ajlm-1224	165	3	.	.	PUNCT
ajlm-1224	166	1	https://doi.org/10.1038/ni.2035	https://doi.org/10.1038/ni.2035	PROPN
ajlm-1224	166	2	schurich	schurich	PROPN
ajlm-1224	166	3	a	a	PROPN
ajlm-1224	166	4	,	,	PUNCT
ajlm-1224	166	5	khanna	khanna	PROPN
ajlm-1224	166	6	p	p	PROPN
ajlm-1224	166	7	,	,	PUNCT
ajlm-1224	166	8	lopes	lopes	PROPN
ajlm-1224	166	9	ar	ar	PROPN
ajlm-1224	166	10	,	,	PUNCT
ajlm-1224	166	11	et	et	PROPN
ajlm-1224	166	12	al	al	PROPN
ajlm-1224	166	13	.	.	PUNCT
ajlm-1224	166	14	role	role	NOUN
ajlm-1224	166	15	of	of	ADP
ajlm-1224	166	16	the	the	DET
ajlm-1224	166	17	coinhibitory	coinhibitory	ADJ
ajlm-1224	166	18	receptor	receptor	NOUN
ajlm-1224	166	19	cytotoxic	cytotoxic	ADJ
ajlm-1224	166	20	t	t	NOUN
ajlm-1224	166	21	lymphocyte	lymphocyte	NOUN
ajlm-1224	166	22	antigen-4	antigen-4	NUM
ajlm-1224	166	23	on	on	ADP
ajlm-1224	166	24	apoptosis	apoptosis	NOUN
ajlm-1224	166	25	-	-	PUNCT
ajlm-1224	166	26	prone	prone	ADJ
ajlm-1224	166	27	cd8	cd8	PROPN
ajlm-1224	166	28	t	t	PROPN
ajlm-1224	166	29	cells	cell	NOUN
ajlm-1224	166	30	in	in	ADP
ajlm-1224	166	31	persistent	persistent	ADJ
ajlm-1224	166	32	hepatitis	hepatitis	PROPN
ajlm-1224	166	33	b	b	PROPN
ajlm-1224	166	34	virus	virus	NOUN
ajlm-1224	166	35	infection	infection	NOUN
ajlm-1224	166	36	.	.	PUNCT
ajlm-1224	167	1	hepatology	hepatology	NOUN
ajlm-1224	167	2	.	.	PUNCT
ajlm-1224	168	1	2011	2011	NUM
ajlm-1224	168	2	may;53(5):1494–1503	may;53(5):1494–1503	PROPN
ajlm-1224	168	3	.	.	PUNCT
ajlm-1224	169	1	https://doi.org/10.1002/hep.24249	https://doi.org/10.1002/hep.24249	PROPN
ajlm-1224	169	2	ahmad	ahmad	PROPN
ajlm-1224	169	3	sm	sm	PROPN
ajlm-1224	169	4	,	,	PUNCT
ajlm-1224	169	5	svane	svane	NOUN
ajlm-1224	169	6	i	i	PROPN
ajlm-1224	169	7	m	m	PROPN
ajlm-1224	169	8	,	,	PUNCT
ajlm-1224	169	9	andersen	andersen	PROPN
ajlm-1224	169	10	mh	mh	PROPN
ajlm-1224	169	11	.	.	PUNCT
ajlm-1224	170	1	the	the	DET
ajlm-1224	170	2	stimulation	stimulation	NOUN
ajlm-1224	170	3	of	of	ADP
ajlm-1224	170	4	pd	pd	PROPN
ajlm-1224	170	5	-	-	PUNCT
ajlm-1224	170	6	l1	l1	NOUN
ajlm-1224	170	7	-	-	PUNCT
ajlm-1224	170	8	specific	specific	ADJ
ajlm-1224	170	9	cytotoxic	cytotoxic	ADJ
ajlm-1224	170	10	t	t	NOUN
ajlm-1224	170	11	lymphocytes	lymphocyte	NOUN
ajlm-1224	170	12	can	can	AUX
ajlm-1224	170	13	both	both	CCONJ
ajlm-1224	170	14	directly	directly	ADV
ajlm-1224	170	15	and	and	CCONJ
ajlm-1224	170	16	indirectly	indirectly	ADV
ajlm-1224	170	17	enhance	enhance	VERB
ajlm-1224	170	18	antileukemic	antileukemic	ADJ
ajlm-1224	170	19	immunity	immunity	NOUN
ajlm-1224	170	20	.	.	PUNCT
ajlm-1224	171	1	blood	blood	NOUN
ajlm-1224	171	2	cancer	cancer	NOUN
ajlm-1224	171	3	j.	j.	PROPN
ajlm-1224	171	4	2014	2014	NUM
ajlm-1224	171	5	jul;4(7):e230	jul;4(7):e230	PROPN
ajlm-1224	171	6	.	.	PUNCT
ajlm-1224	172	1	https://doi.org/10.1038/bcj.2014.50	https://doi.org/10.1038/bcj.2014.50	PROPN
ajlm-1224	172	2	yang	yang	PROPN
ajlm-1224	172	3	z	z	PROPN
ajlm-1224	172	4	,	,	PUNCT
ajlm-1224	172	5	hui	hui	PROPN
ajlm-1224	172	6	c	c	X
ajlm-1224	172	7	,	,	PUNCT
ajlm-1224	172	8	shan	shan	PROPN
ajlm-1224	172	9	-	-	PUNCT
ajlm-1224	172	10	zhong	zhong	PROPN
ajlm-1224	172	11	t	t	PROPN
ajlm-1224	172	12	,	,	PUNCT
ajlm-1224	172	13	et	et	PROPN
ajlm-1224	172	14	al	al	PROPN
ajlm-1224	172	15	.	.	PROPN
ajlm-1224	172	16	feature	feature	NOUN
ajlm-1224	172	17	and	and	CCONJ
ajlm-1224	172	18	significance	significance	NOUN
ajlm-1224	172	19	of	of	ADP
ajlm-1224	172	20	the	the	DET
ajlm-1224	172	21	ratios	ratio	NOUN
ajlm-1224	172	22	of	of	ADP
ajlm-1224	172	23	peripheral	peripheral	ADJ
ajlm-1224	172	24	blood	blood	NOUN
ajlm-1224	172	25	t	t	NOUN
ajlm-1224	172	26	lymphocytes	lymphocyte	VERB
ajlm-1224	172	27	for	for	ADP
ajlm-1224	172	28	patients	patient	NOUN
ajlm-1224	172	29	with	with	ADP
ajlm-1224	172	30	hepatitis	hepatitis	PROPN
ajlm-1224	172	31	b	b	PROPN
ajlm-1224	172	32	virus	virus	NOUN
ajlm-1224	172	33	-	-	PUNCT
ajlm-1224	172	34	related	relate	VERB
ajlm-1224	172	35	acute	acute	NOUN
ajlm-1224	172	36	-	-	PUNCT
ajlm-1224	172	37	on	on	ADP
ajlm-1224	172	38	-	-	PUNCT
ajlm-1224	172	39	chronic	chronic	ADJ
ajlm-1224	172	40	liver	liver	NOUN
ajlm-1224	172	41	failure	failure	NOUN
ajlm-1224	172	42	.	.	PUNCT
ajlm-1224	173	1	biomed	biome	VERB
ajlm-1224	173	2	res	re	NOUN
ajlm-1224	173	3	.	.	PUNCT
ajlm-1224	174	1	2016;27(2):517–520	2016;27(2):517–520	NUM
ajlm-1224	174	2	.	.	PROPN
ajlm-1224	174	3	hayashi	hayashi	PROPN
ajlm-1224	174	4	n	n	CCONJ
ajlm-1224	174	5	,	,	PUNCT
ajlm-1224	174	6	mita	mita	PROPN
ajlm-1224	174	7	e.	e.	PROPN
ajlm-1224	174	8	fas	fas	PROPN
ajlm-1224	174	9	system	system	PROPN
ajlm-1224	174	10	and	and	CCONJ
ajlm-1224	174	11	apoptosis	apoptosis	NOUN
ajlm-1224	174	12	in	in	ADP
ajlm-1224	174	13	viral	viral	ADJ
ajlm-1224	174	14	hepatitis	hepatitis	NOUN
ajlm-1224	174	15	.	.	PUNCT
ajlm-1224	175	1	j	j	PROPN
ajlm-1224	175	2	gastroenterol	gastroenterol	NOUN
ajlm-1224	175	3	hepatol	hepatol	ADJ
ajlm-1224	175	4	.	.	PUNCT
ajlm-1224	176	1	1997	1997	NUM
ajlm-1224	176	2	oct;12(9–10):s223	oct;12(9–10):s223	PROPN
ajlm-1224	176	3	–	–	PUNCT
ajlm-1224	176	4	s226	s226	PROPN
ajlm-1224	176	5	.	.	PUNCT
ajlm-1224	177	1	https://doi.org/10.1111/j.1440-1746.1997.tb00504.x	https://doi.org/10.1111/j.1440-1746.1997.tb00504.x	PROPN